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Life is like riding a bicycle.  
To keep your balance you must keep moving. 
 
Albert Einstein 
 
 
 
 
It always seems impossible until it’s done 
 
Nelson Mandela 
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Abstract 
 
Non-communicable diseases are the leading cause of mortality in the world and place an important 
burden on the society. However, risk factors related to these diseases such insufficient physical 
activity could be prevented. Wide evidence supports the beneficial impact of physical activity against 
premature mortality and chronic diseases. Nevertheless, despite multicomponent training programs 
seem to be the optimal methods to attain these beneficial effects, challenges still remain in the 
development of effective interventions for this population. 
Therefore, the main aim of this study was to evaluate and assess the characteristics of a combined 
exercise program aimed at improving the physical condition and at reducing risk factors of 
individuals with different chronic disorders such as musculoskeletal disorders, type 2 diabetes, 
hypertension and obesity. Weight, waist and hip circumferences, blood pressure, heart rate and 
cardiorespiratory fitness were measured at baseline, 3, 6 and 9 months. 
Results showed clinically relevant reductions in blood pressure but not in heart rate. Changes in 
body composition outcomes were minor and cardiorespiratory fitness improvements were also 
modest although statistically significant and they could be potentially beneficial for some individuals. 
The improvements in flexibility observed could also be important concerning functional status. Even 
though changes after 9 months were greater, some variables showed significant changes already at 
3 months which highlights the short-term benefits of physical activity. 
The lack of effect on some of the outcome measures could have been caused by insufficient 
stimulus, adherence issues influenced by different barriers or other factors. Therefore, this area 
deserves further attention in order to develop interventions that warrant high levels of participation 
and adherence across all population groups in order to improve the physical condition of individuals 
suffering from chronic disorders. 
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1. INTRODUCTION 
1.1. The prevalence of chronic diseases 
Non-communicable diseases (NCDs) are the leading cause of mortality in the world (63%). The major 
NCDs such as cardiovascular diseases (CVD), cancer, diabetes and chronic lung diseases are mainly 
caused by four behavioral risk factors: tobacco, alcohol use, unhealthy diet and insufficient physical 
activity, which lead to four key metabolic or physiological changes such as high blood pressure, 
excess body weight, high blood glucose and high cholesterol (World Health Organization [WHO], 
2011). 
In 2009, high blood pressure (systolic blood pressure ≥140 mmHg or diastolic blood pressure ≥90 
mmHg) was estimated to cause 13% of all deaths worldwide and was the major risk factor for CVD 
(Figure 1). Tobacco use accounted for 9% of all deaths, high blood glucose for 6%, physical inactivity 
for 6% and overweight (Body mass index [BMI] 25-30 kg/m2) and obesity (BMI ≥ 30 kg/m2) 
accounted for 5% of all deaths (WHO, 2011).  
Figure 1. Deaths attributed to 19 leading risk factors, by country income level. Source: World Health Organization, 2009 
 
In the Basque Country, according to the health survey completed in 2013, almost half of the Basque 
population (47% women and 46% men) and 80% of the individuals over 65 years of age suffered 
from some type of chronic disease (Esnaola et al., 2013). The most common chronic diseases among 
the Basque population were high blood pressure (16% women and 15% men) and high cholesterol 
(12% women and 13% men). Back pain (6%), diabetes (5%) and CVD (5%) were the next common 
diseases in men and osteoarthritis (11%), dorsal back pain (9%) and cervical back pain (7%) in 
women (Esnaola et al., 2013). Osteoporosis affected 0.4% of the men and 4% of the women (Esnaola 
et al., 2013). 
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Figure 2. Prevalence of main chronic diseases in different age groups in women and men in the Basque Country. 
 
As it can be seen in Figure 2 above, the prevalence of these diseases was considerably increased in 
the older age groups (Gobierno Vasco, 2013a). 42% and 61% of the women in the older age groups 
(65-74 years of age and over 75 years of age, respectively) suffered high blood pressure while only 
15% of their younger counterparts, 45-64 years of age, were affected. Similar trends were observed 
in men with 51% and 56% affected in the oldest age groups and 21% in the younger 45-64 age 
group. High cholesterol also affected more individuals from the oldest age groups, 31% of women 
and 40% of men 65-74 years of age and 34% of women and 35% of men over 75. In women, 
osteoarthritis was also more prevalent in the older groups (26% and 39% respectively) as well as 
dorsal back pain (17% and 20%) and cervical back pain (13% and 17%). Similar increases as age 
increased were observed in osteoporotic women (Figure3), were 14% of the oldest age groups were 
affected and only 4% in the 45-65 age group. 
 
Figure 3. Prevalence of osteoporosis in different age groups in women in the Basque Country. 
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In men, diabetes prevalence almost tripled from the 45-64 age group to the 65-74 group (7% vs. 
19%) and CVD excluding myocardial infarction was more than three times bigger in the 65-74 age 
group if compared to the younger group (14% vs. 4%). Moreover, the over 75 years of age group 
doubled the prevalence of the 65-74 age group (29% vs. 14%) (Figure 2). 
Concerning body weight (Figure 4), overweight affected more than half (52%) of the Basque 
population (62% of men and 42% of women), 15% of these being obese (Instituto Nacional de 
Estadística [INE], 2012).  Even though the overall prevalence of obesity in the Basque Country had 
stabilized from 2007 to 2013, this prevalence increased in younger women (15-44 years of age) and 
in men 25-44 years of age and over 75 years of age (Esnaola et al., 2013).  
Figure 4. BMI categories in women and men in the Basque Country. 
As other chronic diseases, BMI also showed a tendency to increase as age increased with a trend to 
decrease in the oldest population (Figure 5). Men over 25 years of age and women over 45 had a 
mean BMI over 25 kg/m2 (Gobierno Vasco, 2013b), which is considered overweight among 
international organizations (WHO, 2009).  
Figure 5. BMI in different age groups in women and men in the Basque Country. 
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1.2. The burden of chronic diseases 
The ageing of the population and an increasing prevalence of chronic diseases place a significant 
burden on healthcare resources (Department of Health, 2010) and also on national general income, 
as the loss of productivity due to inability to work weakens the economy of a country (WHO, 2011).  
43% of the Basque population suffers from at least one chronic condition and 24% is affected by two 
or more chronic conditions (Orueta et al., 2014). In accordance with the increase of the prevalence 
of chronic conditions as age increases mentioned before, 66% of the individuals over 65 years of age 
and 76% of the individuals 80-84 years of age suffer from multimorbidity (Orueta et al., 2014). The 
estimations of healthcare cost in chronic patients reach 81% of the total Basque healthcare 
expenditure (87 % for inpatient care and 95% for prescriptions). Furthermore, individuals with 
multimorbidity account for 64% of total resources and those patients with five or more chronic 
conditions (4.3%) account for 25% of the total healthcare budget (Orueta et al., 2014). 
Consequently, the annual total healthcare cost per patient with one chronic condition is 637 € higher 
than for individuals with no conditions. The total cost for those with up to six chronic conditions is 
estimated in 2.303 € (Orueta et al., 2014).   
Additionally, chronic diseases are responsible for 83% of disability in the Basque population. 28% of 
the population 65-74 years of age and 52% of the people over 75 has some kind of mobility 
limitation (Gobierno Vasco, 2013a), women being the most affected in the older age groups (31% in 
the 65-74 age group and 57% in the over 75 age group). Furthermore, 17% of the population over 70 
years of age needs assistance with their personal care activities (Gobierno Vasco, 2013a). 
Functional limitations and disability are mainly caused by musculoskeletal disorders (MSD) such as 
rheumatoid arthritis, osteoarthritis and back pain as they limit daily activities such as walking, 
moving around or carrying objects (Palazzo et al., 2014; Brooks, 2006; Woolf and Plfeger, 2003). 
Decreased physical function is associated with lower probability of being employed and lower 
household income, an increase in work days missed, a higher probability of receiving disability 
income (Dall et al., 2013) and a higher probability of early retirement (Palazzo et al., 2014) . People 
suffering from MSD might also need additional help from family members or health professionals, 
contributing to a supplementary burden apart from the direct medical expenditures and loss in 
productivity mentioned previously (Palazzo et al., 2014).  
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In 2010, 12% of the global health expenditure was estimated to be spent on diabetes, an average of 
$US 1330 per person a year, and these figures are expected to increase 30-34% in 2030 (Zhang et al., 
2010). People with diabetes have more outpatient visits, use more medication, have a higher 
probability of being hospitalized and are more likely to require emergency and long-term care than 
people without the disease (Zhang et al., 2010). The treatment of high blood pressure also burdens 
the healthcare system including physician visits cost, tests, treatment-related hospitalizations and 
medications (Roberts and Small, 2002). Moreover, obesity accounts for between 0.7% and 2.8% of a 
country´s total healthcare expenditures (Withrow and Alter, 2011) and obese people had medical 
costs 30% greater than normal weight individuals possibly attributable to comorbidities such us 
hypertension, coronary heart disease or diabetes among others (Withrow and Alter, 2011). 
However, the burden that NCDs place on the society could be significantly reduced, firstly, with 
population-based prevention interventions in order to reduce risk factors, and secondly, with 
improved healthcare to encourage early detection and appropriate treatments in people already 
affected by NCDs (WHO, 2011). NCDs and obesity related prevention measures (Cecchini et al., 
2010) and healthcare interventions are believed to be cost-effective when comparing them to costly 
procedures that might be necessary in the detection and treatment of the advance stages of 
different diseases (WHO, 2011). 
The economic crisis and the increase on the demand of healthcare resources caused by the ageing of 
the population and the increasing prevalence of chronic diseases require a modification of the 
healthcare system in order to respond to the new demands of the Basque society and reduce public 
healthcare (Departamento de Sanidad, 2012). 
 1.3. Physical inactivity  
Physical inactivity was the fourth risk factor for NCDs and accounted for more than three million 
deaths in 2009 (WHO, 2009). Physical inactivity is estimated to be responsible for 6% of CVD, 7% of 
type 2 diabetes,  10% of cancer and 9% of premature mortality (Lee et al., 2012). In addition, inactive 
people have a 20-30% increased risk of all-cause of mortality (WHO, 2011). 
Worlwide, 31% of the adults (28% men and 34% women) are physically inactive, which means that 
they do not meet the criteria of 150 min of moderate intensity physical activity a week or 75 min of 
vigorous-intensity physical activity a week or an equivalent combination (WHO, 2010). It is also 
known that inactivity increases with age and that is higher in women and in high-income countries 
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(WHO, 2010). Emerging evidence has also associated sedentary time, defined as hours spent sitting, 
watching television or working at a computer, with higher metabolic risk and other harmful health 
outcomes independent of physical activity levels (Cooper et al., 2014).  Accordingly, sedentary 
behavior has internationally been recognized as a public health issue (WHO, 2010). For instance, 
64% of the European adults spend more than 4 hours sitting (WHO, 2010). 
In the Basque Country, 31% of the population does not perform sufficient physical activity (Gobierno 
Vasco, 2013b). Interestingly, as it can be observed in Figure 6, these numbers are lower in the 65-74 
age group (26%) if compared to the younger population from 25-64 year of age (30%). However, in 
the oldest age group over 75 years of age these figures rise dramatically (48%), especially in women 
(55%) if comparing with men (36%) (Gobierno Vasco, 2013b).  
In the last years, the percentage of inactive people has decreased in men (32% in 2007 vs. 27% in 
2013), barely changed in women (35% in 2007 vs. 34% in 2013) but increased in both men and 
women above 75 years of age (Esnaola et al., 2013). 
Figure 6. Physical activity levels in different age groups in the Basque Country. 
Nevertheless, as the WHO suggests, the social and economic impact of NCDs and risk factors such as 
physical inactivity could be prevented through cost-effective and feasible interventions (WHO, 
2011). In particular, it has been estimated that a 1% relative annual reduction of risk factors such as 
excess weight and physical inactivity could reduce healthcare related costs by $8.5 billion in the 
Canadian healthcare system (Krueger et al., 2014). Even short interventions have shown reductions 
in primary care visits (Garriga et al., 2013).  
For this reason, physical activity monitoring is considered highly important in the guidance of the 
development of policies and programs to increase activity levels and reduce sedentary time so as to 
reduce the burden of NCDs (Hallal et al., 2012).   
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1.4. The effect of physical activity on chronic diseases 
Wide evidence supports the preventing effects of physical activity against premature mortality and 
chronic diseases such as CVD, stroke, hypertension, colon and breast cancer, type 2 diabetes and 
osteoporosis (Warbuton et al., 2010). For instance, regular physical activity could reduce the risk of 
ischemic heart disease by 30%, the risk of diabetes by 27% and the risk of breast and colon cancer by 
21-25% (WHO, 2011). It has also been suggested that if inactivity were decreased by 10% or 25%, 
more than 533.000 and 1.3 million deaths respectively could be averted every year (Lee et al., 2012). 
Physically active individuals also have a 31% risk reduction in comparison to inactive individuals 
(Warbuton et al., 2010). The greatest differences in risks occur in individuals with low fitness level 
suggesting that sedentary people can noticeably decrease their mortality risk with small 
improvements in their physical activity level (Warbuton et al., 2010). Nonetheless, a dose-response 
relationship exists where greater health benefits are achieved with higher volumes or intensities of 
activity (Bayego, Vila and Martínez, 2012; Warbuton et al., 2010). 
These health benefits can be achieved if current physical activity guidelines of 30 min five days per 
week of moderate aerobic exercise or vigorous activity for at least 20 min three days a week are met 
(Bayego, Vila and Martínez, 2012; Warburton et al., 2010; WHO, 2010). It is believed that the 
benefits of physical activity outweighs the risk of musculoskeletal injuries and cardiovascular 
accidents such sudden death or myocardial infarction (Bayego, Vila and Martínez, 2012). Besides, 
only 0.19-1.3 musculoskeletal injuries occur every 1.000 hours of exercise, one sudden death every 
215.000 hours of marathon running and 18 cardiovascular events every million hours among inactive 
individuals (Bayego, Vila and Martínez, 2012). 
 
1.4.1. Effect of physical activity in the disorders of the musculoskeletal system 
Osteoarthritis 
Osteoarthritis is characterized by a degeneration and loss of articular cartilage which causes pain, 
aching or stiffness (Beckwee et al., 2013). Obesity and joint injury appear to be the strongest 
modifiable risk factors associated with osteoarthritis (Suri, Morgenroth and Hunter, 2012). 
It is well documented the ability of physical activity reducing pain and disability and improving 
function in individuals with knee and hip osteoarthritis (Brakke, Singh and Sullivan, 2012).  Physical 
activity improves range of motion, balance, propioception (Beckwee et al., 2013; Semanik, Chang 
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and Dunlop, 2012) and strength gain of the surrounding muscles can help stabilizing the affected 
joint (Pedersen and Saltin 2006). Reduction of body weight related to physical activity or other 
weight loss methods can also decrease the mechanical and inflammatory stressors that contribute to 
joint degeneration (Vincent et al., 2012). 
Both strengthening and aerobic exercises have been shown to control pain and improve physical 
function in individuals with osteoarthritis (Loew et al., 2012; Semanik, Chang and Dunlop, 2012) but 
strengthening exercises, aquatic therapy and balance therapies appear to be the most beneficial 
(Brakke, Singh and Sullivan, 2012), especially those performed in supervised settings (Di Domenica et 
al., 2005). Physical activity prescription for these individuals is considered safe and the adverse 
effects such exacerbation of pain, falls or fracture happen to be minimal (Roddy et al., 2005). 
 
Rheumatoid arthritis   
Rheumatoid arthritis is a chronic inflammatory autoimmune disease that affects joints (Cairns and 
Veigh, 2009). Symptoms include muscle weakness, fatigue, joint pain and inflammation and 
subsequent restricted mobility and reduced fitness levels (Iversen, Braweman and Iversen, 2012). In 
addition, comorbid depression is also frequent in these patients (Bruce, 2008). Individuals with 
rheumatoid arthritis are twice as likely to suffer from CVD related with immune-mediated ischemic 
heart disease and atherosclerosis (Iversen, Braweman and Iversen, 2012). Furthermore, inactivity 
associated to these patients contributes to developing hypertension, obesity or other metabolic 
disorders (Iversen, Braweman and Iversen, 2012).  
The main role of physical activity is to increase muscle strength and improve aerobic fitness in order 
to prevent other diseases related to inactivity (Pedersen and Saltin, 2006). Physical activity also 
appears to stimulate anti-inflammatory responses of the body (Pedersen and Saltin, 2006) and to 
positively impact mental health such depression and quality of life of these patients (Zippenfening 
and Sirbu, 2014). 
Programs combining aerobic fitness and strength training have been suggested to be the most 
appropriate for patients with rheumatoid arthritis as they can improve both aerobic capacity and 
muscle strength necessary for physical functioning (Cairns and Veigh, 2009). A dose-response 
relationship exists between exercise and the impact on the immune system, with strenuous and 
eccentric exercise showing the greatest changes in immunologic response (Iversen, Braweman and 
Iversen, 2012). Adverse events or exacerbation of the disease and pain have rarely been reported 
(Iversen, Braweman and Iversen, 2012). 
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Osteoporosis 
Osteoporosis is a progressive chronic bone disease characterized by low bone mass and 
deterioration of bone tissue that increases bone fragility and the incidence of fractures (Pigozzi et 
al., 2009).  
Mechanical stimulus of bone tissue accelerates bone formation in normal bone and may attenuate 
bone loss in osteoporotic individuals (Howe et al., 2011; Schwarz, Courteix and Karlsson, 2006). 
Physical activity can prevent or reverse at least 1% of bone loss per year in the lumbar spine and the 
femoral neck of pre and post-menopausal women (Warburton et al., 2010). The increase in muscle 
cross-sectional area and muscle strength induced by physical activity also improves balance, 
potentially reducing the risk and number of falls and incidence of fractures (Warburton et al., 2010).  
Taking into account that most falls are associated with modifiable factors such as weakness or 
unsteady gait (Rubenstein, 2006), the widely supported protective effect of physical activity against 
fall risk (Shubert, 2011; Kemmler et al., 2010) seems fundamental in this population with a high 
susceptibility to injury, as 10-20% of the falls in the elderly result in injury, hospitalization or death 
(Rubenstein, 2006). 
Even though different types of physical activity, such as walking, have shown positive effects on 
bone density in older postmenopausal women (Muir et al., 2013), an extensive review by Howe et al. 
(2011) reported that the most effective type of exercise on bone mineral density for the neck of 
femur appeared to be progressive resistance strength training of the lower extremity. Resistance 
and agility exercises have also been suggested to reduce fall risk mediated mainly by improved 
postural stability and strength gain (Liu-Ambrose et al., 2004).  
 
Fibromyalgia  
Fibromyalgia is a chronic disorder that involves widespread pain, rapid fatigue, reduced muscle 
strength and cognitive dysfunction (Wolfe et al., 2010; Pedersen and Saltin, 2006). These symptoms 
affect negatively the individual´s physical functionality, mental health and quality of life (Busch et al., 
2011). 
Physical activity has been shown to improve functioning, reduce pain and fatigue (Busch et al., 2011) 
and improve mental health, quality of life and reduce the impact of the disease on the person´s daily 
life (Cadenas and Ruiz, 2014). 
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Different types of exercise such as dance, water activities, taichi, yoga, pilates, Nordic walking and 
general conditioning have shown improvements in pain control, physical function and psychological 
factors such as depression or anxiety (Cadenas and Ruiz, 2014; Busch et al., 2011). Moreover, 
multidisciplinary interventions that include an educational and a psychological component combined 
with physical activity seem to be the most beneficial in improving quality of life (Cadenas and Ruiz, 
2014). Even 30 minutes of self-selected physical activity a day induces changes in perceived physical 
function and pain (Fontaine, Conn and Clauw, 2010). 
 
1.4.2. Effect of physical activity in type 2 diabetes 
Type 2 diabetes represents 80-90% of all diabetes and is characterized by elevated or abnormally 
high blood glucose levels and other metabolic disturbances due to insufficient insulin secretion and 
reduced insulin sensitivity (Colberg, 2012). Complications related to sustained elevated blood 
glucose at the macrovascular level include coronary heart disease, stroke and lower extremity 
ischemia, and microvascular damage such as nephropathy, retinopathy and neuropathies (O´Hagan, 
De Vito and Boreham, 2013; Pedersen and Saltin, 2006). The prevalence of other risk factors in 
diabetic individuals is also high, for instance, overweight (80%), hypertension (60-80%) and 
dyslipidemia (40-50%) (Pedersen and Saltin, 2006). Furthermore, CVD is the major cause of disability 
and mortality in diabetic individuals (Creager et al., 2003; Meigs, 2003). 
Physical activity enhances insulin sensitivity and glucose uptake in the exercised muscle lowering 
blood glucose levels (O´Hagan, De Vito and Boreham, 2013; Pedersen and Saltin, 2006). Physical 
activity also has beneficial effects on body weight, fasting glucose, fasting insulin and insulin 
resistance, blood cholesterol, blood pressure (O´Hagan, De Vito and Boreham, 2013; Brun et al., 
2008) and endothelial function (Okada et al., 2010), all these factors contributing to the 
normalization of CV risk in diabetics (Schreuder et al., 2014). In addition, reductions in glycated 
haemoglobin (HbA1C), a key marker of long-term glycaemic control considered an indicator of 
treatment efficacy (O´Hagan, De Vito and Boreham, 2013), have also been observed, this effect not 
being mediated by weight loss (Sigal et al., 2006). Accordingly, reductions in risks of type 2 diabetes 
have been shown to be independent of BMI suggesting that physical activity can still be beneficial in 
the risk reduction of type 2 diabetes even if weight loss is not achieved (Jeon et al., 2007). Moreover, 
exercise can preserve improvement in insulin sensitivity and other metabolic parameters even 
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Physical activity offers an average risk reduction of 42% in active individuals (Warbuton et al., 2010) 
and 2.5 hours per week of brisk walking can reduce the risk of developing diabetes by 63-69% 
(Laaksonen et al., 2005). The beneficial effects of physical activity in glucose metabolism may not be 
intensity dependent (O´Hagan, De Vito and Boreham, 2013; Colberg, 2012), which could be helpful 
to improve patients’ adherence. Similar to other conditions, the dose-response relationship allows 
important reductions in risk even with small changes in activity levels (Warbuton et al., 2010; 
Laaksonen et al., 2005) especially in individuals at high risk (Gill and Cooper, 2008). However, more 
prolonged or intense activity stimulates insulin action for longer (Colberg, 2012) and those at the 
highest risk of developing type 2 diabetes are likely to particularly benefit from exercising at high 
levels (Gill and Cooper, 2008).  
Both aerobic and resistance training have showed improvements in glucose control (Yang et al., 
2014; Snowling and Hopkins, 2006), nonetheless,  programs that combine both aerobic and 
resistance training have been suggested to be the most effective in attaining maximal health 
benefits (Schwingshackl et al., 2014; Colberg, 2012). Multi-component lifestyle interventions which 
include dietary intervention and both aerobic and resistance training have also been showed to 
improve impaired fasting glucose and glucose tolerance in addition to inducing a modest weight lost 
in at risk prediabetic individuals (Aguiar et al., 2014). Other types of activities such as stair climbing, 
cycling (Ansari, 2009), brisk walking (Jeon et al., 2007) or changes into an active lifestyle (Laaksonen 
et al., 2005) have also been associated with substantial reductions in risk of type 2 diabetes. Home-
based programs have also shown reductions in the insulin-resistance index and in prescribed anti-
diabetic drugs (Brun et al., 2008). It has been suggested that even a decrease in sedentary time 
alone could also reduce metabolic risk in patients with type 2 diabetes (Cooper et al., 2014).  
 
1.4.3. Effect of physical activity in high blood pressure and heart rate 
High blood pressure is defined as a systolic pressure of ≥140 mmHg or a diastolic pressure of ≥90 
mmHg (Mancia et al., 2013) and is an important risk factor for CVD such as stroke, acute myocardial 
infaction, cardiac insufficiency and sudden death (Pedersen and Saltin, 2006). Additionally, high 
blood pressure is related with an increased incidence of CV and all-cause mortality (Pescatello et al., 
2004). Equally, elevated resting heart rate has been associated with CVD, coronary heart disease and 
all-cause mortality independent of systolic blood pressure or physical activity (Cooney et al., 2010) 
and also independent of health status (Graham et al., 2007). In accordance, Palatini et al. (2002) 
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declared that a resting heart rate higher than 80 bmp could lead to an 89% increase in mortality risk 
if compared with individuals with lower heart rate.   
Blood pressure reduction after an isolated exercise session (post-exercise hypotension) or after long-
term exercise training can reach 5-7 mmHg and last for 12-22 hours depending on the duration and 
the intensity of exercise (Pescatello et al., 2004). Physical activity is related to risk reductions of 30-
50% for cardiovascular mortality and of 20-50% for all-cause mortality (Rossi et al., 2012; Nocon et 
al., 2008). Moreover, 33% relative incidence reduction of CVD has been observed with regular 
physical activity (Warburton et al., 2010). A 20 mmHg decrease in systolic blood pressure and a 10 
mmHg decrease in diastolic  blood pressure have been suggested to reduce cardiovascular risk in 
half (Pedersen and Saltin, 2006). Interestingly, even minimal reductions of 2 mmHg in systolic and 
diastolic blood pressure could decrease the risk of stroke by 14% and 17% and the risk of coronary 
artery disease by 9% and 6% respectively (Pescatello et al., 2004). 
Some of the mechanisms behind the blood pressure-lowering effect of physical activity include: 
decreased catecholamine levels (Pescatello et al., 2004), reduction of vascular stiffness (Havlik et al., 
2005) and a reduction of vasoconstriction induced by a decreased activity of sympathetic nerve 
system (Manfredini et al., 2009). The increase in blood flow produced by physical activity also 
stimulates the endothelium derived nitric oxide production which induces muscle relaxation and 
vasodilation, causing a decrease in the total peripheral resistance (Manfredini et al., 2009). 
Regarding heart rate, long-term aerobic exercise has been suggested to have a direct effect in the 
autonomic control of the heart, increasing parasympathetic activity and decreasing sympathetic 
activity, mechanisms that in combination induce reductions in resting heart rate (Carter, Banister 
and Blaber, 2003). 
Even though different modalities of exercise such as aerobic training, dynamic resistance training, 
and combined training have shown to significantly decrease blood pressure, isometric resistance 
exercise has been recently suggested to offer the greatest reductions in systolic blood pressure 
(Cornelissen and Smart, 2013). In terms of intensity, moderate and high intensity aerobic training 
have been suggested to offer greater reductions if compared with low intensity aerobic training 
(Cornelissen and Smart, 2013; Bayego, Vila and Martínez, 2012; Warbuton et al., 2010).  
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1.4.4. Effect of physical activity in obesity 
Obesity, defined as a BMI ≥30 kg/m2 (WHO, 2009), is characterized by excessive fat accumulation in 
adipose tissue and other organs (Ahima, 2011). Obesity is associated with the incidence of multiple 
comorbidities including obstructive sleep apnea (Carter and Watenpaugh, 2008), cancer, 
osteoarthritis and increased systemic inflammation (Lavie, Milani and Ventura, 2009). It also places a 
large impact on CV risk factors such as insulin sensitivity, type 2 diabetes, hypertension and 
dyslipidemia, as well affecting negatively CV structure and function including abnormal left 
ventricular geometry, endothelial dysfunction, heart failure and coronary heart disease among 
others (Lavie, Milani and Ventura, 2009). Obesity is also related to disability, productivity decline 
(Ahima, 2011) and with increased death risk (Pischon et al., 2008). 
In addition, abdominal obesity, measured as waist circumference or waist-hip ratio (WHO, 2008), it 
has also been independently associated with mortality (Guallar-Castillón et al., 2009; Pischon et al., 
2008) and observed to significantly fluctuate within a narrow range of BMI (WHO, 2008).  
Physical activity increases energy expenditure and stimulates lipolysis, reducing fat mass and/or 
increasing lean tissue mass (Pedersen and Saltin, 2006). Additionally, physical activity improves 
various risk factors associated with obesity that have previously been mentioned, such as 
hypertension, insulin resistance and dyslipidemia (Warburton et al., 2010).  
Current recommendations of 150 min/week of moderate physical activity may control weight or 
assist on maintenance of weight-loss (Jakicic and Otto, 2005; Slentz et al., 2004).  However, changes 
in body weight and body composition without a reduction in calorie intake seem to be minimal at 
this exercise volume (Fogelhom, Stallknecht and Van Baak, 2006) and intensity (Beavers et al., 2014). 
Nevertheless, emerging evidence supports the belief that an increase in physical activity can reduce 
the risk of obesity-related comorbidities and improve risk factors related to obesity such as cardio-
respiratory fitness and insulin sensitivity despite minimal or no weight loss (Fogelhom, Stallknecht 
and Van Baak, 2006; Jakicic and Otto, 2005). The benefits include significant increases in fat-free 
mass (Donnelly et al., 2009), reductions in total fat mass, abdominal fat, visceral fat and cardio-
metabolic risk factors, and improvements in skeletal muscle mass and cardiorespiratory fitness (Ross 
and Bradshaw, 2009; Pedersen and Saltin, 2006). In the same direction, Heitmann et al. (2009) 
suggested that BMI is related with increased mortality in sedentary individuals but not in active 
individuals meaning that physical activity may modify the health risk of BMI.  
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Combined endurance and resistance training has been shown to be more effective in improving 
body composition, as the increases in lean body mass and the decreases in visceral and 
subcutaneous fat are greater than with endurance training alone (Schwingshack et al., 2014; Park et 
al., 2003). This may prove to be advantageous as abdominal fat has been suggested to be a better 
predictor of the development of type 2 diabetes and CVD than the total amount of fat (Ibañez et al., 
2010; Fencki et al., 2006). In addition, resistance training combined with weight-loss diet has been 
shown to improve muscle composition (Avila et al., 2010) and diminish the muscle mass loss induced 
by a decreased energy intake (Ibañez et al., 2010). Furthermore, this kind of exercise also improves 
function in obese individuals as it facilitates the ability to lift their own body weight. This 
improvement could also have the potential of enhancing physical activity adherence levels (Jakicic 
and Otto, 2005). 
 1.5. Physical activity interventions to improve chronic diseases  
1.5.1. Interventions to improve body composition 
Obesity prevention strategies and health promotion interventions often encourage participation in 
physical activity (Cecchini et al., 2010). However, even though the beneficial impact of physical 
activity in body composition is well documented, activity type, volume and intensity of the activity 
remain to be determined as to clarify the most beneficial combination for weight loss and change in 
body composition. Therefore, in the next review, the effects of different interventions will be 
discussed in an attempt to elucidate some of the optimal exercise to improve body composition 
(Table 1). 
From the interventions reviewed, five were performed in North America (Willis et al., 2012; Bateman 
et al., 2011; Church et al., 2010; Davidson et al., 2009; Sigal et al., 2007), four in Europe (Skrypnik et 
al., 2015; Paoli et al., 2013; Stefanov et al., 2013; Stensvold et al., 2010) and one in Asia (Park et al., 
2003). Age of the participants ranged from 18 to 80 and two studies included only women (Skrypnik 
et al., 2015; Park et al., 2003) and one only men (Paoli et al., 2013). Participants were overweight or 
obese (BMI 25-35 kg/m2) and in three of the studies participants were also type 2 diabetics (Church 
et al., 2010; Sigal et al., 2007) or individuals with metabolic syndrome (Stensvold et al., 2010).  
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Most of the studies compared the impact of resistance training (RT), aerobic training (AET) and 
combined training (CT) in body composition, except Park et al. (2003) and Skrypnik et al. (2015) that 
compared AET and CT only, and Stefanov et al. (2013) that compared supervised CT versus non-
supervised CT. Stensvold et al. (2010) included interval training in the aerobic training arm and Paoli 
et al. (2013) compared high-intensity combined circuit training, low-intensity combined circuit 
training and AET. Most of the interventions included some kind of diet monitoring (food diary or 
food questionnaire) in order to control for diet induced changes, except Bateman et al. (2011) that 
only prescribed participants not to change their usual diet and Park et al. (2003) that did not report 
any sort of nutritional counseling. Four interventions did not include a control group (Skrypnik et al., 
2015; Paoli et al., 2013; Willis et al., 2012; Bateman et al., 2011). 
The longest interventions were nine months long (Church et al., 2010) and the shortest three 
months (Skrypnik et al., 2015; Paoli et al., 2013; Stensvold et al., 2010). However, most interventions 
were six months (Stefanov et al., 2013; Davidson et al., 2009; Sigal et al., 2007; Park et al., 2003) or 
eight months long (Willis et al., 2012; Bateman et al., 2011). The intervention by Sigal et al. (2007) 
was supervised only for the first four weeks and biweekly after that. Attendance ranged from 91% to 
73.4% in supervised groups and 54.8% in the non-supervised group described by Stefanov et al. 
(2013). Nevertheless, some interventions did not report any kind of adherence measure (Church et 
al., 2010; Stensvold et al., 2010; Park et al., 2003). 
In terms of body composition, most authors reported significant changes in body weight with AET or 
CT but not with RT (Willis et al., 2012; Bateman et al., 2011; Church et al., 2010; Davidson et al., 
2009; Sigal et al., 2007). Between AET and CT, most of the studies showed CT to be slightly more 
effective in decreasing body weight than AET but these differences failed to be statistically 
significant between these two groups. In contrast, Stensvold et al. (2010), who used aerobic interval 
training in the endurance groups, did not observe significant changes in body weight in any of the 
groups, possibly explained by the short duration of the intervention (three months). The largest 
decrease in body weight in the CT group (6.4 kg) was reported by Park et al. (2003). However, 
changes reported by other authors ranged from -2.71 kg to -1.50 kg, suggesting that those great 
decreases in body weight could have been confounded by an uncontrolled decrease in calorie intake 
mentioned previously.  In addition, high-intensity circuit training showed to be more effective 
decreasing body weight than low-intensity circuit training but similar to AET (Paoli et al., 2013). 
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Concerning waist circumference, some authors observed greater changes in AET and CT groups 
compared with RT (Willis et al., 2012; Bateman et al., 2011; Davidson et al., 2009). On the contrary, 
others (Church et al., 2010; Stensvold et al., 2010; Sigal et al., 2007) found that the RT group showed 
similar decreases if compared to other groups. The greatest decreases in waist circumference were 
observed by Stefanof et al. (2013) with 10 cm in the supervised CT group and 7.8 cm in the non-
supervised CT group. Nonetheless, it should be noted that both groups received healthy lifestyle 
counseling and that each participant was provided with a low calorie customized diet which could 
explain the large reduction in waist circumference compared to the other studies. In most studies 
changes in the CT groups were slightly greater (from -7.65 cm to -1.66 cm) than the AET groups, 
even though these changes were not statistically significant. In contrast, Stensvold et al. (2010) 
reported the smallest decrease in the CT group (-0.7cm) if compared to the AET (-1.3cm) or the RT (-
1.4cm). However, it is important to consider that the resistance intervention in the CT group was 
performed only one day a week and the aerobic part two days a week, if compared to other studies 
were the resistance part in the CT was performed two or three days a week and the aerobic part 
three days a week, which could explain smaller decreases in waist circumference. 
Similar to other outcomes, fat mass was observed to be reduced mostly by AET and CT with slightly 
greater non-significant changes in the CT group (Willis et al., 2012; Church et al., 2010; Sigal et al., 
2007; Park et al., 2003). However, Skrypnik et al. (2015) and Stensvold et al. (2010) found AET to 
reduce more fat mass than the other groups. Nevertheless, Church et al. (2010) and Stensvold et al. 
(2010) also found the RT to significantly reduce fat mass. Reductions in the CT groups ranged from 
0.8 kg to 2.66 kg, however, Paoli et al. (2013) reported greater reductions (-5.4 kg) in the high 
intensity circuit training group. 
Most of the studies also observed that increases in lean body mass were induced by either RT or CT 
(Skrypnik et al., 2015; Paoli et al., 2013; Willis et al., 2012; Stensvold et al., 2010; Sigal et al., 2007; 
Park et al., 2003). However, Church et al. (2010) observed that whereas the RT gained 0.8 kg of lean 
body mass, the CT did not. This could be explained by the differences in the volume of the exercise 
of the two groups with RT performing two sets of strength exercises three days a week and the CT 
group only one set of the same exercises two days a week. In contrast with these results, Stensvold 
et al. (2010) observed increases in lean body mass in the CT group (1.4 kg) with resistance training 
performed only one day a week. However, three sets of exercises were used. Surprisingly, Sigal et al. 
(2007) did not observed any significant reductions in lean body mass in any of the groups and 
Stensvold et al. (2010) did not detect significant increases in lean body mass in the RT group despite 
significant changes in strength. Greater increases in lean body mass were induced by high-intensity 
INTRODUCTION 
 
17 
 
vs. low-intensity circuit training (Paoli et al., 2013). Furthermore, in many studies, the AET group 
showed a decrease in lean body mass (Paoli et al., 2013; Willis et al., 2012; Church et al., 2010; Sigal 
et al., 2007) or a non-significant increase (Skrypnik et al., 2015; Stensvold et al., 2010; Park et al., 
2003). 
Regarding other metabolic outcomes, Sigal et al. (2007) found that all groups induced 
improvements in glycemic control but reported significantly greater effects in the CT group than AET 
or RT alone. Interestingly, individuals with higher baseline HbA1c showed greater improvements 
regardless of the training group whereas the ones with better glycemic control only attained 
improvements with CT. Bateman et al. (2011) also found that metabolic parameters improved in the 
AET and CT groups but not in the RT group. However, it should be noted that the volume of exercise 
on the CT group of these two studies was double than the other groups. Therefore, it could be 
difficult to determine if the greater effects observed were due to the additional exercise time or to 
the combination of aerobic and resistance training. Nevertheless, Church et al. (2010) also compared 
the effect of different exercise modes on HbA1C while maintaining similar training durations in all 
groups (140 min/week) and found that only the CT group significantly improved HbA1C. Similar 
results were observed by Davidson et al. (2009) where CT induced the greatest changes in insulin 
resistance whereas RT did not. Conversely, Stensvold et al. (2010) did not observed changes in HbA1C 
in any of the groups.  
In summary, CT performed three days a week showed to be the optimal training method to improve 
body composition reducing weight, waist circumference and fat mass and increasing lean body mass. 
Interestingly, high-intensity circuit training seemed to have additional impact in fat and lean body 
mass. Furthermore, CT showed to be also the most effective improving insulin resistance and 
glycemic control. Nevertheless, it is important to note that the duration of exercise in the CT group 
of some of the studies (Willis et al., 2012; Bateman et al., 2011; Sigal et al., 2007) was double than in 
the AET or RT alone. Thus, it could be difficult to determine if the additional benefits observed were 
accrued due to the optimal combination of both exercise modes or due to the longer duration of the 
intervention. Interestingly, in these studies, the CT group had similar adherence than the rest of the 
groups even though the exercise volume was greater, meaning that the combination of different 
exercises in this training method could be appealing for participants. Moreover, even though 
supervised interventions seem to induce greater improvements, non-supervised interventions also 
showed to induce significant benefits. Also, three month programs were sufficient to show 
significant benefits, suggesting that these kinds of programs could be attractive and cost-effective 
for community-based interventions aimed at overweight or obese individuals. 
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1.5.2. Interventions to improve blood pressure 
Moderate aerobic exercise has been generally recommended for the prevention and treatment of 
high blood pressure.  However, in recent years resistance exercise has been also been suggested as 
an appropriate supplementation regime. Nevertheless, some negative effects of resistance training 
such as central arterial compliance (Kawano et al., 2008) have questioned the appropriateness of 
this exercise approach. Thus, the following review will summarize some of the effects of aerobic, 
resistance and combined exercise on blood pressure (Table 2).  
Three of the papers reviewed were performed in North America (Bateman et al., 2011; Collier et al., 
2008; Sigal et al., 2007) six in Europe (Skrypnik et al., 2015; Paoli et al., 2013; Soroush et al., 2013; 
Stefanov et al., 2013; Cornelissen et al., 2010; Stensvold et al., 2010) and one in Asia (Nemoto et al., 
2007). Age of the participants ranged from 18 to 70 years of age but in most of the studies 
participants were middle-aged and older adults. One study included only women (Skrypnik et al., 
2015) and another one only men (Paoli et al., 2013). Participants were normotensive (systolic blood 
pressure <120 mmHg, diastolic blood pressure <80 mmHg) (Bateman et al., 2011; Soroush et al., 
2013) pre-hypertensive (systolic blood pressure 120-140 mmHg, diastolic blood pressure 80-90 
mmHg)  (Paoli et al., 2013; Stefanov et al., 2013; Sigal et al., 2007) but mostly pre and stage 1 
hypertensives (systolic blood pressure ≥140 mmHg, diastolic blood pressure ≥90 mmHg)(Skrypnik et 
al., 2015; Cornelissen et al., 2010; Stensvold et al., 2010; Collier et al., 2008; Nemoto et al., 2007). 
Most studies only included participants who were not under hypertensive medication, except 
Stensvold et al. (2010) that reported the use of different hypertensive medication in some of the 
participants.  Skrypnik et al. (2015) and Nemoto et al. (2007) did not report inclusion/exclusion 
criteria regarding hypertensive medication. 
Three studies compared the impact of RT, AET and CT on blood pressure (Bateman et al., 2011; 
Stensvold et al., 2010; Sigal et al., 2007). Skrypnik et al. (2015) and Paoli et al. (2013) compared AET 
and CT only, Collier et al. (2008) RT and AET only and Stefanov et al. (2013) compared supervised CT 
versus non-supervised CT. Cornelissen et al. (2010) compared high-intensity and low-intensity AET 
and Soroush et al. (2013) and Nemoto et al. (2007) both performed unsupervised pedometer based 
walking interventions, the later one comparing moderate continuous walking and high-intensity 
interval walking. Stensvold et al. (2010) included interval training in the aerobic training part and 
Paoli et al. (2013) compared high-intensity combined circuit training, low-intensity combined circuit 
training and AET. Six interventions did not include a control group (Skrypnik et al., 2015; Paoli et al., 
2013; Soroush et al., 2013; Bateman et al., 2011; Cornelissen et al., 2010; Collier et al., 2008).  
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The longest intervention was eight months long (Bateman et al., 2011) and the shortest one month 
(Collier et al., 2008). Most interventions ranged from three to six months (Skrypnik et al., 2015; Paoli 
et al., 2013; Soroush et al., 2013; Stefanov et al., 2013; Bateman et al., 2011; Cornelissen et al., 2010; 
Stensvold et al., 2010; Nemoto et al., 2007; Sigal et al., 2007). Attendance ranged from 99% to 73.4% 
in supervised groups and 54.8% in the non-supervised group described by Stefanov et al. (2013). In 
the non-supervised pedometer based walking interventions 40-60% of the participants did not 
reached the minimum targets (Soroush et al., 2013; Nemoto et al., 2007). 
All studies reported significant decreases in blood pressure in all groups, except Stensvold et al. 
(2010), Sigal et al. (2007), Stefanov et al. (2013) in the non-supervised CT group and Bateman et al. 
(2011). Nevertheless, in these later studies, even though the changes did not reach statistical 
significance they could be of clinical importance (Pescatello et al., 2004). For instance, Bateman et al. 
(2011) reported reductions in the CT group of 3 mmHg in both systolic and diastolic blood pressure 
while AET and RT did not show reductions. In contrast, Sigal et al. (2007) found the greatest changes 
in the RT group (-5mmHg systolic blood pressure, -2mmHg diastolic blood pressure) whereas the CT 
only reduced -2 mmHg in systolic blood pressure. Stensvold et al. (2010) found the greatest changes 
with a trend towards statistical significance only on the AET group (-5.5 mmHg systolic blood 
pressure, -4.1 mmHg diastolic blood pressure). Nevertheless, other groups in this study showed 
considerable decreases in systolic blood pressure (-2.8mmHg in the RT group and -4.2mmHg in the 
CT group) whereas the CT showed increases in diastolic blood pressure. It is important to consider 
than some individuals in the study were under hypertensive medications which could have 
influenced the results.  
In the studies where statistically significant reductions were found, Skrypnik et al. (2015) and Collier 
et al. (2008) reported comparable declines in blood pressure between different training modes. Paoli 
et al. (2013) on the other hand, observed that different intensities exerted different changes in 
blood pressure even though all training modes induced significant reductions in both systolic and 
diastolic blood pressure. In particular, the low-intensity circuit training group, which combined AET 
and RT at moderate intensity, induced greater reductions in systolic blood pressure (-11 mmHg) than 
the high-intensity circuit training group (-7 mmHg) or the AET group (-5 mmHg). Nemoto et al. (2007) 
reported significantly greater reductions in systolic blood pressure in the high-intensity interval 
walking group (-9 mmHg) if compared to the moderate-intensity continuous walking group (-3 
mmHg). Similarly, the high-intensity AET in the intervention by Cornelissen et al. (2010) also showed 
higher decreases in systolic blood pressure (-6 mmHg) if compared to the low-intensity AET (-3.8 
mmHg) even if these differences were not statistically significant. 
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Concerning diastolic blood pressure and in terms of intensity, Paoli et al. (2013) observed that high-
intensity circuit training produced the greatest reductions (-6 mmHg) if compared to the other 
groups (2-3mmHg) and Nemoto et al. (2007) also found slightly greater changes in the high-intensity 
group (-5 mmHg) compared to the low intensity walking group (-2 mmHg).  
Soroush et al. (2013) also described reductions after a moderate intensity pedometer based walking 
program in systolic (-5 mmHg) and diastolic blood pressure (-4 mmHg). It is important to note that in 
both walking interventions (Soroush et al., 2013; Nemoto et al., 2007) despite improvements in 
blood pressure, no significant improvements in cardiorespiratory fitness were reported after 
moderate intensity walking, possibly due to the inconsistent compliance of the participants or 
insufficient intensity levels. On the other hand, high-intensity interval walking, which was 
monitorized by accelerometry, was observed to successfully induce improvements in 
cardiorespiratory fitness (Nemoto et al., 2007). 
Concerning other vascular changes, Stensvold et al. (2010) observed that all exercise groups (RT, AET 
and CT) significantly reduced endothelial function, important factor for atherosclerosis, hypertension 
and CVD, despite the small duration of this intervention (three months). Also, Collier et al. (2008) 
found that vasodilatory capacity improved in both RT and AET, these changes being greater after 
moderate intensity RT. However, arterial stiffness was increased in the RT group while it was 
decreased in the AET group. Nevertheless, the increase in arterial stiffness observed after RT it has 
been suggested to be compensated by the increase in blood flow (Collier et al., 2008). 
In the studies were resting heart rate was measured (Skrypnik et al., 2015; Cornelissen et al., 2010; 
Collier et al., 2008; Nemoto et al., 2007), AET seem to induce greater decreases in resting heart rate 
than CT (-7.43 bpm vs. -3.41 bpm) (Skrypnik et al., 2015) and also greater than RT (-5 bpm vs. 2 bpm) 
(Collier et al., 2008). Concerning intensity, both low and high-intensity AET induced comparable 
reductions (Cornelissen et al., 2010; Nemoto et al., 2007). 
In conclusion, despite the contradictory results regarding the optimal mode of exercise to improve 
blood pressure, it seemed that any type of exercise exerted a beneficial effect on it. Reductions in 
systolic blood pressure ranged from -5 mmHg to -2.8 mmHg after RT, from -7 mmHg to -0.60 mmHg 
after AET and from -11 mmHg to -2 mmHg after CT. Changes in diastolic blood pressure also ranged 
from -4.1 mmHg to -0.16 after RT, from -5.5 mmHg to -0.87 after AET and from -4 mmHg to 0.8 
mmHg after CT. Interestingly, high-intensity AET was observed to induce decreases around -7.5 
mmHg in systolic blood pressure and – 5 mmHg in diastolic which did not seem to differ considerably 
from other studies that performed AET at moderate intensities (-7 mmHg systolic and -5.5 mmHg in 
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diastolic blood pressure) (Skrypnik et al., 2015). Nevertheless, high-intensity and low-intensity 
combined circuit training induced different changes in systolic and diastolic blood pressure, 
suggesting that the beneficial effect of exercise could be intensity dependent regardless of the 
exercise mode. Regarding HR, AET seemed to be the optimal exercise mode to reduce heart rate 
regardless of the intensity. 
It is important to note that supervised programs might be more appropriate for lowering blood 
pressure as non-supervised programs might not reach desirable intensities to induce changes in 
blood pressure due to the difficulty for the individuals to control and regulate intensities on their 
own. Also, normotensive, pre-hypertensive and stage 1 hypertensive individuals seemed to show 
similar reductions in blood pressure and the length of the intervention did not seem to affect the 
beneficial effects of physical activity, as one month interventions showed to be as effective in 
lowering blood pressure and heart rate as longer interventions. These findings emphasize the 
beneficial short-term impact of physical activity in lowering blood pressure which is of great clinical 
importance especially in the management of blood pressure in advanced stages of hypertension but 
also as a protective measure in normotensive individuals. 
 
1.5.3. Interventions to improve flexibility 
Flexibility is a key factor for the performance of the activities of daily living (American College of 
Sport Medicine [ACSM], 2014; Nguyen and Cihlar, 2013). Particularly, hamstring flexibility is essential 
for good posture and for mobility activities such as walking, stair climbing or getting in and out of a 
car, in addition to preventing low-back pain and reducing the risk of falls (Rikli and Jones, 2013). High 
levels of flexibility have been shown to be associated with objectively assessed functional status, 
consequently enhancing the performance in important daily activities (Fatouros et al., 2006) and 
contributing to independent living (Ernsth-Bravell, Zarit and Johansson, 2011). There is conflicting 
evidence in regard of the optimal exercise combination to increase lower body flexibility as some 
have suggested that the improvements in flexibility after resistance exercise could be similar or 
greater than the increase produced by flexibility training alone (Fatouros et al., 2006, Swank et al., 
2003). Therefore, 10 interventions aimed at improving functional fitness will be reviewed in order to 
clarify the optimal exercise mode to enhance lower body flexibility (Table 3). 
Six of the studies reviewed were performed in Europe (Sousa et al., 2014; Sanudo et al., 2011; 
Carvalho, Marques and Mota, 2009; Cancela and Ayán, 2007; Fatouros et al., 2006; Kalapotharakos 
et al., 2005), two in Brazil (Hallage et al., 2010; Barbosa et al., 2002), one in the United States 
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(Villareal et al., 2011) and one in Turkey (Toraman, Erman and Agyar, 2004). Participants in all the 
studies were older individuals over 60 years of age. Two studies included only men (Sousa et al., 
2014; Fatouros et al., 2006) and five only women (Sanudo et al., 2011; Hallage et al., 2010; Carvalho, 
Marques and Mota, 2009; Cancela and Ayán, 2007; Barbosa et al., 2002). Most studies included 
apparently healthy and sedentary participants except Sanudo et al. (2011) that included women with 
fibromyalgia.  
Interventions included in the studies were AET and CT (Sousa et al., 2014), two CTs that included a 
different RT arm (Cancela and Ayán, 2007), CT (Sanudo et al., 2011; Villareal et al., 2011; Carvalho, 
Marques and Mota, 2009; Toraman, Erman and Agyar, 2004), AET (Hallage et al., 2010), RT (Barbosa 
et al., 2002) and RT at different intensities (Fatouros et al., 2006; Kalapotharakos et al., 2005). Most 
studies included stretching exercises in both the warm-up and cool-down phases except Sanudo et 
al. (2011) that included stretching only at the end of the session and Villareal et al. (2011) that 
included stretching exercises only at the beginning of the session. Only Sanudo et al. (2014) and 
Carvalho, Marques and Mota (2009) reported details regarding the stretching protocol such as 
number of exercises, repetitions or holding time for each stretch. Two studies did not perform 
stretching exercises to assess the independent effects of RT in flexibility (Fatouros et al., 2006; 
Barbosa et al., 2002) and one did not specify the inclusion of stretching exercise in its protocol 
(Hallage et al., 2010). Four studies did not include a control group (Sanudo et al., 2011; Villareal et 
al., 2011; Hallage et al., 2010; Cancela and Ayán, 2007). 
Length of the interventions widely varied, nine months being the longest (Sousa et al., 2014), five 
weeks the shortest (Cancela and Ayán, 2007) and three months being the most common (Sanudo et 
al., 2011; Villareal et al., 2011; Hallage et al., 2010; Kalapotharakos et al., 2005). The rest of 
interventions were eight months (Carvalho, Marques and Mota, 2009), six months (Fatouros et al., 
2006), 10 weeks (Barbosa et al., 2002) and nine weeks long (Toraman, Erman and Agyar, 2004). 
Attendance ranged from 82% (Sousa et al., 2014) to 100% (Villareal et al., 2011). However, three 
studies did not report adherence (Sanudo et al., 2011; Cancela and Ayán, 2007; Barbosa et al., 2002). 
Flexibility was measured in all studies as part of a more thorough functional fitness assessment, 
except in Barbosa et al. (2002) were flexibility was the only outcome variable. Flexibility was mostly 
measured by the sit-and-reach test (Cancela and Ayán, 2007; Fatouros et al., 2006; Kalapotharakos 
et al, 2005; Barbosa et al., 2002) as explained by the ACSM (2014) or its modified version the chair 
sit-and-reach test (Sousa et al., 2014; Hallage et al., 2010; Carvalho, Marques and Mota, 2009; 
Toraman, Erman and Agyar, 2004) as explained by Rikli and Jones (2013). Range of movement 
measured by goniometry was only measured by Sanudo et al. (2011) and Villareal et al. (2011). 
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Results showed that all interventions induced significant improvements in lower body flexibility 
except Toraman, Erman and Agyar (2004). However, it is important to note that even though 
changes in flexibility were not statistically significant in this intervention, the effect size was large 
(d=1.4) after a nine week CT intervention which included five minute stretching at the beginning and 
at the end of the session. It is possible that the small sample size of this intervention (n=42) could 
have affected these results. 
Sousa et al. (2014) compared the effect of AET and CT in functional fitness and observed that even 
though both groups performed the same flexibility exercises, the CT group attained significantly 
greater changes in lower body flexibility than the AET group (5.2 cm vs. 3.9 cm). This could be 
attributed to the additional resistance session performed once a week, suggesting a larger 
mechanical stimulation of the joints after RT. Nevertheless, it is important to consider that the AET 
group also performed 10 minutes of strengthening exercises using only body weight, apparently not 
sufficient to provoke the same adaptations that the ones caused by RT. 
In contrast with these results, Cancela and Ayán (2007) compared two CT groups, both with an AET 
part performed in water. One performed a high intensity RT on machines and the other one that 
performed 15 minutes of calisthenics per session which included muscular endurance exercises 
without machines. The calisthenics groups showed greater increase in flexibility if compared to the 
high intensity RT one, however, these differences were not statistically significant (3.29 cm vs.1.61 
cm). 
Sanudo et al. (2011) also found significant improvements after a three month CT performed two 
days a week that included 10 minutes of stretching at the end of the session. Similarly, Villareal et al. 
(2011) found significant increases (9 degrees) in hamstring range of movement after a three month 
CT that included 15 minutes of stretching exercises at the beginning of the session performed three 
days a week. In the same way, Carvalho, Marques and Mota (2009) reported significant changes (4.8 
cm) after eight months of CT training executed two days a week and that included five minutes of 
stretching in the warm-up and cool-down phases. 
AET alone was also observed to significantly improve lower body flexibility (Hallage et al., 2010). 
Low-impact step aerobics performed three days a week for three months showed improvements of 
3.8 cm in the chair sit-and-reach test. Nevertheless, the authors considered that the large increase 
could be explained by the participants´ low values at baseline. On the other hand, the authors did 
not report the execution of any stretching exercises, therefore, it is difficult to discern if the 
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improvements in flexibility were induced by the step aerobics alone or by some stretching exercises 
that were not reported.  
Regarding the effect of RT exercise in flexibility, Kalopotharakos et al. (2005) compared a moderate 
and a high intensity RT executed three days a week for three months that included five minutes of 
stretching  in the warm-up and cool-down phases. Researchers observed that both intensities 
showed comparable improvements in flexibility (5 cm vs. 3.45 cm) and in other functional 
performance activities.  
Nonetheless, as most of the CT or RT programs reviewed included stretching exercises before and/or 
after their program, it could be difficult to distinguish if improvements in flexibility were due to 
these stretching exercises or by the independent effects of resistance training induced by an 
increase in range of mobility when performing resistance exercises (Cancela and Ayán, 2007). For 
that purpose, Fatouros et al. (2006) and Barbosa et al. (2002) excluded stretching exercises from 
their resistance programs in order assess the independent effect of RT training in flexibility. 
Fatouros et al. (2006) observed that trunk flexibility increased in all exercise groups (low, moderate 
and high-intensity RT) and that these increases were significantly greater in the moderate and high 
intensity groups (3.3 cm and 3.8 cm respectively) if compared to the low-intensity group (1.9 cm). 
These results are in agreement with Kalopotharakos et al. (2005) who found similar improvements 
between moderate and high- intensity RT.  Interestingly, after the six month detraining period the 
moderate and high intensity groups maintained their adaptations above baseline values whereas the 
low-intensity group inverted the improvements (Fatouros et al., 2006). Barbosa et al. (2002) also 
observed similar improvements in flexibility (4 cm) after a high-intensity RT performed three days a 
week for 10 weeks without the presence of any stretching exercises. 
The range of improvement in the chair sit-and-reach test varied from 4.8 cm (Carvalho, Marques and 
Mota, 2009) to almost 13 cm (Toraman, Erman and Agyar, 2004) after CT and around 3.9 cm after 
AET (Sousa et al., 2014; Hallage et al., 2010). In the sit-and-reach test increases ranged from 1.61 cm 
to 3.29 cm depending on the CT (Cancela and Ayán, 2007) and from 1.9 cm to 5 cm depending on 
the RT intensity (Fatouros et al., 2006; Kalopotharakos et al., 2005). 
To sum up, it seems that small doses of stretching exercises either at the beginning or at the end of a 
training session could induce significant improvements in lower body flexibility. Moreover, these 
improvements could be also achieved by performing strength training alone, as resistance exercises 
executed through a full range of motion using agonist and antagonist muscle groups might reduce 
stiffness of the muscle and enhance flexibility (Fatouros et al., 2006; Barbosa et al., 2002). Both 
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calisthenics and traditional RT training on machines showed to be appropriate in the increase of 
flexibility, however, moderate or high intensities seem to be more effective than lower intensities of 
RT in both the accrual and the maintenance of flexibility levels. Baseline physical fitness level also 
seems to be an important factor to consider when designing exercise protocols, as  weight-bearing 
exercises have been shown to induce improvements in flexibility in previously sedentary individuals 
but not in experienced ones which might need a supplementary stimulus in order to increase 
flexibility and other functional outcomes (Kim et al., 2014). 
 
1.5.4. Interventions to improve cardiorespiratory fitness 
High levels of cardiorespiratory fitness are associated with reduced CV mortality and lower incidence 
of other risk factors such as hypertension, obesity and type 2 diabetes (Swift et al., 2013). In terms of 
functionality, cardiorespiratory fitness is also essential in order to perform important daily activities 
such as walking, stair climbing or shopping (Rikli and Jones, 2013). Moderate aerobic exercise that 
involves large muscle groups such walking or cycling has been recommended as the ideal mode of 
exercise in order to improve cardiorespiratory fitness (ACSM, 2014). Nevertheless, combined 
exercise and different intensities have shown similar or greater improvements. For this reason, in 
the following review some of the different activities to increase cardiorespiratory fitness will be 
discussed (Table 4).  
From the 14 studies reviewed, six studies were performed in Europe (Skrypnik et al., 2015; Sousa et 
al., 2014; Soroush et al., 2013; Sanudo et al., 2011; Stensvold et al., 2010; Carvalho, Marques and 
Mota, 2009), four in the U.S.A (Willis et al., 2012; Bateman et al., 2010; Church et al., 2010; Davidson 
et al., 2009), two in Japan (Nemoto et al., 2007; Park et al., 2003), one in Brazil (Hallage et al., 2010), 
and one in Turkey (Toraman, Erman and Agyar, 2004). Most studies included middle aged and/or 
older individuals but some of them also included younger adults (Skrypnik et al., 2015; Soroush et 
al., 2013; Willis et al., 2012; Bateman et al., 2010; Church et al., 2010). Five studies included only 
women (Skrypnik et al., 2015; Sanudo et al., 2011; Hallage et al., 2010; Carvalho, Marques and Mota, 
2009; Park et al., 2003) and one only men (Sousa et al., 2014).  
Participants´ inclusion critera included sedentary and apparently healthy individuals (Sousa et al., 
2014; Hallage et al., 2010; Carvalho, Marques and Mota, 2009; Nemoto et al., 2007; Toraman, Erman 
and Agyar, 2004), overweight or obese (Skrypnik et al., 2015; Soroush et al., 2013; Willis et al., 2012; 
Bateman et al., 2010; Davidson et al., 2009;  Park et al., 2003), type 2 diabetics (Church et al., 2010), 
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individuals with metabolic syndrome (Stensvold et al., 2010) or individuals with fibromyalgia 
(Sanudo et al., 2011).  
From all the interventions reviewed, five compared the effect of RT, AET and CT in cardiorespiratory 
fitness (Willis et al., 2012; Bateman et al., 2010; Church et al., 2010; Stensvold et al., 2010; Davidson 
et al., 2009), three studies compared AET and CT (Skrypnik et al., 2015; Sousa et al., 2014; Park et al., 
2003), one measured only AET (Hallage et al., 2010), three studies measured only CT (Sanudo et al., 
2011; Carvalho, Marques and Mota, 2009; Toraman, Erman and Agyar, 2004) and two evaluated the 
effect of walking interventions in cardiorespiratory fitness (Soroush et al., 2013; Nemoto et al., 
2007). Five interventions did not include a control group (Skrypnik et al., 2015; Soroush et al., 2013; 
Willis et al., 2012; Bateman et al., 2010; Hallage et al., 2010). 
Length of interventions ranged from nine weeks (Toraman, Erman and Agyar, 2004) to nine months 
(Sousa et al. 2014; Church et al., 2010). Attendace varied from 77% to 91% and in the non-
supervised pedometer based walking interventions (Soroush et al. 2013; Nemoto et al., 2007), 40-
60% of the individuals did not reached the minimum targets, 10.000 steps and 8.000 steps 
respectively.   
Nine studies used  maximal oxygen uptake (VO2max) to measure cardiorespiratory fitness (Skrypnik et 
al., 2015; Soroush et al., 2013; Willis et al., 2012; Bateman et al., 2011; Church et al., 2010; Stensvold 
et al., 2010; Davidson et al., 2009; Nemoto et al., 2007; Park et al., 2003) and six studies used the six-
minute walk test (6MW) (Sousa et al., 2014; Sanudo et al., 2011; Hallage et al., 2010; Carvalho, 
Marques and Mota, 2009; Toraman, Erman and Agyar, 2004) as described by Rikli and Jones (2013). 
The 6MW has revealed high correlations with submaximal treadmill tests and has also shown to be 
appropriate in detecting performance improvements in both healthy individuals and in patients with 
CVD, diabetes or musculoskeletal disorders (Rikli and Jones, 2013). 
Results showed that most interventions induced significant improvements in cardiorespiratory 
fitness except Soroush et al. (2013), Church et al. (2010), Davidson et al. (2009) and Carvalho, 
Marques and Mota (2009).  
Among the interventions that compared RT, AET and CT, two observed that all exercise modes 
induced significant changes in cardiorespiratory fitness (Willis et al., 2012; Bateman et al., 2010). 
However, AET and CT produced greater changes than RT, these changes being similar between AET 
and CT. Similarly, Stensvold et al. (2010) described significant and similar improvements in the AET 
and CT groups but not in the RT group. In opposition to these results, Church et al. (2010) and 
Davidson et al. (2009) did not observe significant increases in cardiorespiratory fitness in any of the 
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exercise groups even though their interventions lasted nine and six months respectively and sessions 
were performed 3-5 days a week. This lack of effect could be explained by an insufficient intensity of 
the aerobic exercise performed, considering that the prescription was more focused on volume 
rather than on intensity. In addition, even though patients in all interventions were sedentary, 
differences in general fitness could have also affected the results, with the most deconditioned 
individuals achieving greater improvements if compared to the fitter ones. 
As previously referred, when comparing AET and CT, it was observed that both exercises modes 
induced similar adaptations in cardiorespiratory fitness (Skrypnik et al., 2015; Sousa et al., 2014; Park 
et al., 2003). Interestingly, in the interventions by Sousa et al. (2014) and Park et al. (2003), the CT 
group performed aerobic exercise with less frequency than the AET group (two days vs. three days in 
Sousa et al. (2014) and three days vs. six days in Park et al. (2003)), which could suggest that 
improvements in cardiorespiratory fitness could be achieved with moderate volumes (2-3 days a 
week) or that these additional improvements in cardiorespiratory fitness could also be attributed to 
resistance training. Nevertheless, it is important to note that the performance on the 6MW is 
dependent on aerobic endurance and also on lower limb strength (Rikli and Jones, 2013) which could 
explain the improvements in this test after a combined training (Sousa et al., 2014). The slight 
greater improvements in VO2max achieved by the CT group if compared to the AET in Park et al. 
(2003) deserve further attention. 
Other CT interventions showed controversial results. While Sanudo et al. (2011) and Toraman, 
Erman and Agyar (2004) observed significant improvements in cardiorespiratory fitness after 
relatively short interventions (three months and nine weeks respectively), Carvalho, Marques and 
Mota (2009) did not report significant changes after an eight month intervention. This could be 
explained by the low volume of sessions per week (two) or by the use of the Borg scale for 
controlling intensity which could have hindered the possibility of achieving an appropriate intensity. 
However, other interventions using the Borg scale (Sousa et al., 2014) and others performing CT two 
days a week (Sanudo et al., 2011) showed significant increases in cardiorespiratory fitness. As 
mentioned before, the relatively good baseline cardiorespiratory fitness level of participants could 
have impeded greater significant improvements in this intervention. 
Hallage et al. (2010) also reported significant improvements in cardiorespiratory fitness after a low 
impact steps aerobics intervention executed three days a week for three months. Nemoto et al. 
(2007) also observed significant changes in cardiorespiratory fitness after a high intensity interval 
walking intervention performed four days a week for five months. However, the moderate 
continuous walking group from the same intervention did not achieve significant improvements. 
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These results are in accordance with Soroush et al. (2013) who did not observed significant changes 
after an unsupervised pedometer based walking intervention. These findings underline the 
importance of intensity when performing aerobic exercise. 
In summary, aerobic training seems to be the optimal exercise in order to improve cardiorespiratory 
fitness, either performed alone or in combination with resistance training. Even though light to 
moderate exercise might be appropriate for deconditioned patients (ACSM, 2014) moderate to 
vigorous exercise performed 3-5 days a week is recommended to improve cardiorespiratory fitness 
in healthier individuals. Furthermore, both supervised and unsupervised protocols showed to 
improve cardiorespiratory fitness despite the fact that supervised interventions had better 
adherence (Stefanov et al., 2013).  
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It could be concluded that extensive evidence supports the beneficial impact of physical activity in 
different chronic diseases and against premature mortality. These positive effects of physical activity 
include improvements in body composition, which is of great importance in the prevention and 
management of obesity. Also, significant reductions in blood pressure and improvements in 
cardiorespiratory fitness offer protection for patients suffering from CVD, hypertension or metabolic 
disorders such as type 2 diabetes. Furthermore, individuals with diverse MSD can also benefit from 
physical activity as their physical function, pain and quality of life improves under its effect. 
Multicomponent training protocols which combine aerobic, resistance and stretching exercises 
performed at moderate intensities at least three times a week seem to be the optimal method to 
attain these beneficial effects as it induces changes in cardiorespiratory fitness, strength and 
flexibility, all vital capacities for an enhanced functionality and quality of life.  Nevertheless, 
significant improvements have been observed with smaller doses and at lower intensities, which 
supports the importance of the development of programs that encourage physical activity 
participation especially in the more deconditioned segment of the population.   
These programs have the potential of reducing the number of inactive individuals and consequently 
decreasing the high prevalence of chronic diseases present in the Basque population. However, 
despite the widely recognized beneficial effects of physical activity, challenges still remain in the 
development of effective interventions (Conn, Valentine and Cooper, 2002). 
For this purpose, a combined exercise program was developed in order to examine and assess the 
characteristics of a potential effective intervention aimed at improving the physical condition and 
the quality of life and to reduce risk factors of individuals with different chronic disorders. This 
physical activity monitoring and evaluation of interventions seems essential in guiding the 
development of policies and population-based intervention programs. 
We hypothesized that after taking part in the nine month combined program participants would not 
only improve their physical condition but also the symptoms related with their disorder. Moreover, 
we also believed that these changes in time would differ among different population groups. Also, a 
high motivation and satisfaction with the program was expected.  
Finally, this intervention is expected to serve in the expansion and design of strategies and programs 
to increase physical activity and reduce sedentary behavior in order to decrease the burden that 
ageing, chronic conditions and disability lay on our society. 
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Table 1. Summary of the reviewed studies on body composition 
Reference Participants Intervention 
Results (Pre-post intervention differences. Shown in outcome units) 
Comments 
Main outcomes Exercise groups 
Skrypnik et al., 
2015 
Poland 
n= 44 
obese women  
(BMI ≥30kg/m2) 
 
Age 18-65 
I1: AET. (50-80%HRmax) 45 min 
3days/week 
I2: CT. RT (20 min) + AET (25 min 
50-80%HRmax). 3days/week 
 
 
 
3 months 
 
-Body weight (kg) 
-BMI (kg/m2) 
-Waist circumference (cm) 
-WHR 
-Fat mass (kg) 
-Lean body mass (kg) 
 AET 
-2.20* 
-0.84* 
-5.26* 
-0.02* 
-2.73* 
0.63 
CT 
-2.71* 
-0.99* 
-7.65* 
-0.04* 
-2.66* 
0.79* 
 - Food intake records to 
assure diet unchanged. 
-Attendance 86.4%. 
 
Paoli et al.,  
2013 
Italy 
n=58 
healthy, sedentary 
men 
(BMI <25kg/m2) 
 
Age 55-70 
I1: AET. Cicloergom. (50%HRReserve) 
40 min. 3days/week 
I2: LI- Circuit T. 2 sets [8´ AET 
(50%HRReserve) + RT (7 ex, 15 reps)] 
50 min. 3days/week 
I3: HI- Circuit T. 2 sets [8´ AET (3´ 
50%HRReserve+ 1´ 75%Reserve) + RT 
(RestPauseTechnique)] 
50 min. 3days/week 
 
 
3 months 
 
-Body weight (kg) 
-Fat mass (kg) 
-Lean body mass (kg) 
 
 
 
 
 
 
 
 AET 
-3.2* 
-1.5* 
-1.7 
 
LI-CT 
-2.6* 
-2.9* 
1.1*# 
 
HI-CT 
-3.1* ^ 
-5.4* # ^ 
2.3*^ 
 
-Food questionnaire to 
control diet changes. 
-Same attendance in all 
groups. 
Stefanov et al.,  
2013 
Bulgary 
n=85 
sedentary, overweight 
(BMI ≥25kg/m2) 
 
Age 40-60 
 
 
I1: Supervised CT. AET (50-
75%HRmax). 150 min/week + RT 
free weight, resistance bands, 
crunches. 2-3 sets, 8-14 rep. 30-60 
min. 2days/week 
I2: Non-supervised CT (same as 
supervised). 
C:Control 
 
 
6 months 
 
-Body weight (kg) 
-BMI (kg/m2) 
-Waist circumference (cm) 
-Fat mass (kg) 
-Lean body mass (kg) 
-Attendance 
 
 CT-S 
↓* 
-1.6* 
-10* 
-1.8* 
1.7* 
73.4% 
 
CT-NS 
↓* 
-1.0* 
-7.8* 
-2.1* 
2.0* 
54.8% 
Control 
↑ 
- 
↓* 
↑ 
↓ 
 
 
-All groups healthy lifestyle 
counseling and provided 
with low calorie diet. 
 
Willis et al.,  
2012 
U.S.A 
n=119 
sedentary,  
overweight/obese  
(BMI 25-35kg/m2)  
 
Age 18-70 
I1: RT. 3 sets, 8 ex, 8-12 rep (8-
12RM). 3days/week 
I2: AET. (65-80%VO2 max).  
120 min/week 
I3: CT. RT+AET 
 
 
8 months 
 
-Body weight (kg) 
-Waist circumference (cm) 
-Fat mass (kg) 
-Lean body mass (kg) 
-Attendance 
 
RT 
0.83* 
-0.06 
-0.26 
1.09* # 
83.6% 
AET 
-1.76* Ŧ 
-1.01* Ŧ 
-1.66* Ŧ 
-0.10 
89% 
CT 
-1.63* Ŧ 
-1.66* Ŧ 
-2.44* Ŧ 
0.81* # 
82% 
 -Food diary to track changes 
in diet. 
Bateman et al., 
2011 
U.S.A 
n=196 
sedentary,  
overweight/obese  
(BMI 25-35kg/m2) 
dyslipidemic  
 
Age 18-70 
I1: RT. 3 sets, 8 ex, 8-12 rep (8-
12RM). 3days/week 
I2: AET.(65-80% VO2 max) 
120 min/week 
I3: CT. RT+AET 
 
 
8 months 
 
-Body weight (kg) 
-Waist circumference (cm) 
-Metabolic score 
-Attendance 
RT 
-0.70 
0.25 
→ 
83.8% 
AET 
-1.54 * 
-1.12 
↑ 
91% 
CT 
-1.90 * 
-2.48* Ŧ 
↑* Ŧ 
77.7% 
 -Prescription not to change 
diet. 
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Reference Participants Intervention 
Results (Pre-post intervention differences. Shown in outcome units) 
Comments 
Main outcomes Exercise groups 
Church et al.,  
2010 
U.S.A 
n=262 
sedentary,  
type2 diabetics 
(BMI ≥34kg/m2) 
 
 
Age 30-75 
I1: RT. 2 sets, 9 ex. 10-12 rep.  
140min/week. 3days/week 
I2: AET. (50-80% VO2max) 140 
min/week. 3days/week 
I3: CT. RT (1 set, 9 ex). 2 
days/week) + AET. 140min/week 
C: Control. stretching and 
relaxation 
 
9 months 
 
-Body weight (kg) 
-Waist circumference (cm) 
-Fat mass (kg) 
-Lean body mass (kg) 
-HbA1C 
 
RT 
-0.3 
-1.9 
-1.4* 
0.8 
→ 
 
AET 
-0.8 
-1.5 
-0.6 
-0.5 Ŧ 
→ 
 
CT 
-1.5* Ŧ 
-2.8 
-1.7* # 
0 Ŧ 
↓* 
 
Control 
0.4 
0.7 
0.1 
0.1 
↑ 
-Diet questionnaire to 
assess changes. 
-Attendance? 
 
Stensvold et al., 
2010 
Norway 
n=43 
metabolic syndrome  
(BMI ≥30kg/m2) 
 
 
Age 50.2±9.5 
I1: RT. 3 sets, 80% (1RM), 8-12 
rep. 3days/week 
I2: AIT. Interval training on 
treadmill. 4 x 4 min (90-95% 
HRmax) + 3 min (70% HRmax). 
3days/week 
I3: CT. RT (1day/week)+ AIT 
(2days/week) 
C:Control 
 
3 months 
 
-Body weight (kg) 
-BMI (kg/m2) 
-Waist circumference (cm) 
-Fat mass (kg) 
-Lean body mass (kg) 
- HbA1C 
 
RT 
-0.7 
0.1 
-1.4* 
-1.9* 
0.9 
0.03 
 
AET 
-1.4 
-0.4 
-1.3* 
-2.1* 
0.7 
-0.25 
 
CT 
0.4 
0.1 
-0.7* 
-0.8 
1.4* 
0.03 
 
Control 
0.7 
0.1 
1.7* 
-0.3 
1* 
0.10 
 
-Habitual lifestyle diet. Food 
questionnaire to assess 
changes. 
-Attendance? 
 
Davidson et al., 
2009 
U.S.A 
 
n=136 
sedentary, abdominally  
obese older adults 
(waist-circumf.  
≥102 men 
 and ≥88 women) 
 
Age 60-80  
I1: RT. 1 set,9 ex, volitional fatigue 
(aprox.20 min). 3days/week 
I2: AET. 30 min, moderate 
treadmill walking (60-75% HRmax). 
5 days/week 
I3: CT. RT+AET. 3 days/week 
C:Control 
 
6 months  
 
-Body weight (kg) 
- BMI (kg/m2) 
-Waist circumference (cm) 
 -Insulin resistance 
 
RT 
-0.64 
-0.26 
-3.18* 
→ 
 
 
AET 
-2.77 *Ŧ 
-0.96* Ŧ 
-5.08* Ŧ 
↓* Ŧ 
 
CT 
-2.31*Ŧ 
-0.84* Ŧ 
-4.61* 
↓* Ŧ 
 
 
Control 
0.28 
0.10 
0.28 
→ 
 
 
 
 
-Nutrition counseling for all 
groups. Food diary to 
monitor changes. 
-Attendance 91% in all 
groups  
Sigal et al.,  
2007 
Canada 
n=251 
sedentary,  
type 2 diabetics 
(BMI ≥34kg/m2) 
 
Age 39-70 
I1: RT. 2-3 sets, 7 ex, 7-9 rep (7-
9RM). 3days/week 
I2: AET. (60-75% HRmax), 15-45 
min/day. 3days/week 
I3: CT. RT + AET. 3days/week 
C:Control 
 
6 months 
 
-Body weight (kg) 
-BMI (kg/m2) 
-Waist circumference (cm) 
-Fat mass (kg) 
-Lean body mass (kg) 
-HbA1C 
-Attendance 
RT 
-1.1 
-0.4 
-3* 
-1.3 
0.3 
↑* 
85% 
AET 
-2.6* 
-0.8* 
-3* 
-1.6* 
-1 
↑* 
80% 
CT 
-2.6* 
-0.8* 
-4* 
-1.9* 
-0.7 
↑* Ŧ  # 
86% 
Control 
-0.3 
-0.1 
-1 
0.2 
-0.5 
→ 
 
-Dietary counseling. Food 
diary to track changes in 
diet.  
 
Park et al.,  
2003 
Korea/Japan 
 
n=30 
healthy overweight  
women 
(BMI ≥25kg/m2) 
 
 
Age 40-45 
I1: AET. (60-70%HRmax) 
 60 min/day. 6days/week 
I2: CT. AET (3days/week) + RT (60-
70% 1RM ,60 min/day, 
3days/week) 
C:Control 
 
6 months  
 
-Body weight (kg) 
-Body fat (%) 
-Lean body mass (kg) 
 
 
 AET 
-4.7* 
-9.2* 
0.9 
 
CT 
-6.4* 
-10.3* 
5.6* 
 
Control 
0.6 
2.3 
-0.4 
 
-No diet control 
-Attendance? 
-Small sample 
I: intervention groups, C: control group, RT: resistance training, AET: aerobic exercise training, CT: combined training,  LI: low –intensity, HI: high intensity, S: supervised, NS: non-supervised, BMI: body max index, WHR: 
waist-hip ratio, HRmax: maximum heart rate, HRReserve: hear rate reserve (HRmax – HRRest), VO2max: maximal oxygen uptake, ex: exercises, rep: repetitions, RM: maximum repetitions, HbA1C : glycated hemoglobin, *pre-post 
significant differences (p<0.05), Ŧ significant differences vs. RT (p<0.05), # significant differences vs. AET (p<0.05), ^ significant differences HI-CT  vs. LI-CT(p<0.05), →: no change 
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Table 2. Summary of reviewed studies on blood pressure 
Reference Participants Intervention 
Results (Pre-post intervention differences. Shown in outcome units) 
Comments 
Main outcomes Exercise groups 
Skrypnik et al., 
2015 
Poland 
n= 44 
obese women  
 
Pre&stage1 hypertensive1 
 
Age 18-65 
I1: AET. 3days/week 
I2: CT. RT + AET. 3days/week 
+Details in Table 1 
 
 
 
3 months 
 
-Systolic BP (mmHg) 
-Diastolic BP (mmHg 
 -HR (bmp) 
 AET 
-6.76* 
-5.48* 
-7.43* 
 
 
CT 
-8.88* 
-3.94* 
-3.41* 
 
 
 - Food intake records to 
assure diet unchanged. 
-Attendance 86.4%. 
-Medication? 
Paoli et al.,  
2013 
Italy 
n=58 
healthy, sedentary 
men 
 
Pre- hypertensive1 
 
Age 55-70 
I1: AET. 40 min. 3days/week 
I2: LI-Circuit Training. 50 min.  
3days/week 
I3: HI-Circuit Training. 3days/week 
+Details in Table 1 
 
 
3 months 
 
-Systolic BP (mmHg) 
-Diastolic BP (mmHg) 
 
 
 
 
 AET 
-5* 
-3* 
LI-CT 
-11* #^ 
-2* 
HI-CT 
-7* 
-6* # ^ 
-Food questionnaire to 
control diet changes. 
-Same attendance in all 
groups. 
Soroush et al., 
2013 
Sweden 
N=355 
overweight 
 
Normotensive1 
Age 20-65 
I1: Walking.  10.000 steps daily 
 
6 months 
 
-Systolic BP (mmHg) 
-Diastolic BP (mmHg) 
-Aerobic fitness (VO2max) 
 
 AET 
-5* 
-4* 
→ 
  -Unsupervised, pedometer 
based. 
Stefanov et al.,  
2013 
Bulgary 
n=85 
sedentary, overweight 
 
Pre- hypertensive1 
 
Age 40-60 
 
 
I1: Supervised CT (AET, 150 
min/week + RT. 2days/week). 
I2: Non-supervised CT (same as 
supervised). 
C:Control 
+Details in Table 1 
 
 
6 months 
 
-Systolic BP (mmHg) 
-Diastolic BP (mmHg) 
-Attendance 
 
 CT-S 
-10.7*^ 
-4.8* 
73.4% 
 
CT-NS 
-1.8 
-2.3 
54.8% 
Control 
-2.3 
0.9 
 
 
-All groups healthy lifestyle 
counseling and provided 
with low calorie diet. 
-No medication. 
Bateman et al., 
2011 
U.S.A 
n=196 
sedentary,  
overweight/obese  
 
Normotensive1 
 
Age 18-70 
I1: RT. 3 sets, 8 ex, 8-12 rep (8-
12RM). 3days/week 
I2: AET.(65-80% VO2 max) 
120 min/week 
I3: CT. RT+AET 
 
 
8 months 
 
-Systolic BP (mmHg) 
-Diastolic BP (mmHg) 
-Attendance 
RT 
2.32 
-0.16 
83.8% 
AET 
-0.57 
-0.87 
91% 
CT 
-3.08 
-3.32* 
77.7% 
 -Prescription not to change 
diet. 
 
Cornelissen et 
al., 2010 
Belgium 
n=48 
sedentary, healthy 
(SBP≥120 mmHg/ 
DBP≥80 mmHg) 
 
Age >55 
I1: LI-AET. 33% HRReserve.50 min 
3days/week 
I2: HI- AET. 66% HRReserve. 50 min 
3days/week 
 
 
2.5 months 
 
-Systolic BP (mmHg) 
- HR (bpm) 
 
 
 
LI-AET 
-3.8* 
-5.1* 
 
HI-AET 
-6* 
-5.4* 
 
 
 
-No medication. 
-Attendance? 
Stensvold et al., 
2010 
Norway 
n=43 
metabolic syndrome  
 
I1: RT. 3days/week 
I2: AIT. 3days/week 
I3: CT. RT (1day/week)+ AIT 
 
-Systolic BP (mmHg) 
-Diastolic BP (mmHg) 
RT 
-2.8 
-1.7 
AET 
-5.5T 
-4.1 T 
CT 
-4.2 
0.8 
Control 
0.7 
-0.6 
-Habitual lifestyle diet. Food 
questionnaire to assess 
changes. 
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Reference Participants Intervention 
Results (Pre-post intervention differences. Shown in outcome units) 
Comments 
Main outcomes Exercise groups 
Pre&stage1 hypertensive1 
 
Age 50.2±9.5 
(2days/week) 
C:Control 
 +Details in Table 1 
 
3 months 
-Endothelial function 
 
↑* 
 
↑* 
 
↑* 
 
→ 
 
-Some participants on 
hypertensive medication. 
-Attendance? 
 
Collier et al.,  
2008 
U.S.A 
n=30 
 
Pre&stage1 hypertensives 
 
Age 30-60 
I1: RT.3 sets, 9 ex, 10 rep (65% 
10RM). 3days/week 
I2: AET. 30 min treadmill (65% 
VO2max). 3days/week 
 
1 month 
 
-Systolic BP (mmHg) 
-Diastolic BP (mmHg) 
-HR (bpm) 
-Vascular conductance 
-Forearm blood flow 
-Arterial stiffness 
RT 
-4.4* 
-4.1* 
2* # 
↑* 
↑* # 
↑* 
AET 
-4.6* 
-3.1* 
-5* Ŧ 
↑* 
↑* 
↓* 
 
 
 -No medication. 
-Attendance 99%. 
Nemoto et al., 
2007 
Japan 
n=246 
sedentary, healthy 
 
 
Pre&stage1 hypertensive1 
 
 
Age 44-78 
 
I1: Moderate continuous walking. 
(50% VO2max). 8000 steps/day 
4days/week 
I2: HI Interval walking. 5 sets x [2-
3 min LI walking (40% VO2max)+ 3 
min HI walking (70-80% VO2max) 
4days/week 
I3: No walking 
 
5 months 
 
-Body weight (kg) 
-Systolic BP (mmHg) 
-Diastolic BP (mmHg) 
-HR (bpm) 
-Aerobic fitness (VO2max) 
 
 Mod-AET 
-1.2* 
-3* 
-2* 
-2 
↓ 
 
HI-AET 
-0.8* 
-9* ^ 
-5* 
-1.5 
↑* 
 
Control 
0.8* 
-1.5 
-1 
-2.5 
↓ 
-Unsupervised, pedometer 
based 
-Medication? 
Sigal et al.,  
2007 
Canada 
n=251 
sedentary, type 2 diabetics 
 
Pre- hypertensive1 
 
Age 39-70 
I1: RT. 3days/week 
I2: AET. 3days/week 
I3: CT. RT + AET. 3days/week 
C:Control 
+Details in Table 1 
 
6 months 
 
-Systolic BP (mmHg) 
-Diastolic BP (mmHg) 
-Attendance 
RT 
-5 
-2 
85% 
AET 
-3 
-2 
80% 
CT 
-2 
0 
86% 
Control 
-4 
-1 
 
-Dietary counseling. Food 
diary to track changes in 
diet.  
 
1 Normotensive= SBP<120mmHg, DBP<80mmHg. Pre-Hypertensive=SBP 120-140mmHg, DBP 80-90mmHg. Stage1-Hypertensive= SBP>140mmHg, DBP>90mmHg. (Mancia et al., 2013), I: intervention groups, C: control 
group, RT: resistance training, AET: aerobic exercise training, CT: combined training,  AIT: aerobic interval training, LI: low –intensity, HI: high intensity, S: supervised, NS: non-supervised, BMI: body max index, BP: 
blood pressure, mmHg: millimeter of mercury, HR: heart rate, bmp: beats per minute, HRmax: maximum heart rate, HRReserve: hear rate reserve (HRmax – HRRest), VO2max: maximal oxygen uptake, ex: exercises, rep: 
repetitions, RM: maximum repetitions, *pre-post significant differences (p<0.05), Ŧ significant differences vs. RT (p<0.05), # significant differences vs. AET (p<0.05), ^ significant differences HI vs. LI or supervised vs. 
non-supervised(p<0.05), T trend towards significance, →: no change 
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Table 3. Summary of reviewed studies on flexibility 
Reference Participants Intervention 
Results (Pre-post intervention differences. Shown in outcome units) 
Comments 
Main outcomes Exercise groups 
Sousa et al.,  
2014 
Portugal 
n= 59 
men, healthy 
independent living 
 
Age 65-79 
I1: AET. Moderate (Borg 12-13), 60 
min. 3days/week 
I2: CT. RT (3 sets, 7 ex, 8-12 reps. 
65%-75% 1RM. 1 day/week) + AET 
(2days/week) 
C:Control 
 
9 months 
 
-Lower body flexibility  
Chair sit-and-reach (cm) 
-Attendance 
 AET 
 
3.9* 
82% 
CT 
 
5.2*# 
86% 
Control 
 
-4.7 
 
-AET  strength exercises 
too 
-Stretching performed in 
warm-up and cool-down (5 
min each) 
Sanudo et al.,  
2011 
Spain 
n=30 
women with fibromyalgia 
 
Age 65-79 
I1: CT. RT (1 set, 8 ex, 8-10 rep, 1-3 
kg)+ AET (10-15 min, 65-70% HRmax ) 
+ stretching (1 set, 8-9 ex, 3 reps, 
holding 30s each. 10 min) 
2days/week 
C:Control 
 
3 months 
 
-Lower body flexibility  
ROM Hip (deg) 
 
 
  CT 
 
↑* 
 
 
 
 
 
Control 
 
→ 
 
-Stretching performed at 
the end of the session 
- Attendance? 
Villareal et al.,  
2011 
U.S.A. 
n= 9 
obese, sedentary, 
moderately frail 
 
Age 65-80 
I1: CT. Flexibility (15 min)+RT (1-2 
sets, 9 ex, 8-12 reps, 80% 1RM, 30 
min) + AET (75% HRmax, 30 min) + 
balance (15 min). 3days/week 
 
 
3 months 
 
-Lower body flexibility  
ROM  Hamstring flexion (deg) 
 
  CT 
 
9* 
 -Small sample 
-Stretching performed at 
the beginning of the 
session 
-Attendance 100% 
Hallage et al., 
 2010 
Brazil/U.S.A 
n= 13 
healthy women 
 
Age >60 
I1: AET. Low impact Step Aerobics 
(50-70% HRmax), 30-60 min 
3days/week 
 
 
3 months 
 
-Lower body flexibility  
Chair sit-and-reach (cm) 
 
 AET 
 
3.8* 
 
  -Small sample 
-Maintain current habits 
-Attendance 85% 
-Stretching? 
Carvalho et al.,  
2009 
Portugal 
n= 65 
sedentary, 
 healthy women 
 
Age 64-85 
I1: CT. RT (1-3 sets, 8-15 reps, 
circuit with elastic bands and free 
weights, 12-16 RPE) + AET (12-14 
RPE, 20-25 min)+ agility + stretching 
(1set, 10 ex, 3-4 reps, holding 10-
30s). 60 min. 2days/week 
C:Control 
 
 
8 months 
 
-Lower body flexibility  
Chair sit-and-reach (cm) 
 
  CT 
 
4.8* 
 
 
Control 
 
-4.2* 
 
-Stretching performed in 
warm-up and cool-down (5 
min each) 
-Attendance 91% 
Cancela et al.,  
2007 
Spain 
n= 62 
healthy women 
 
Age >65 
I1: CT1. Water ex (45 min. 
2days/week) + RT (3 sets, 7 ex, 10 
reps, 75% 1RM. 3days/week) 
I2: CT2. Water ex (45 min. 
2days/week) + calisthenics (45 min. 
3days/week) 
 
5 weeks 
 
-Lower body flexibility  
Sit-and-reach (cm) 
  CT1 
 
1.61* 
CT2 
 
3.29* 
-High intensity strength 
training 
-High volume 
-Stretching performed in 
warm-up and cool-down (5 
min each) 
- Attendance? 
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Reference Participants Intervention 
Results (Pre-post intervention differences. Shown in outcome units) 
Comments 
Main outcomes Exercise groups 
Fatouros et al.,  
2006 
Greece 
n= 58 
healthy, 
 sedentary men 
 
Age 65-78 
I1: LI RT. 2-3 sets, 10 ex, 6-10 reps  
45-50% 1RM. 3days/week 
I2: MI RT. 2-3 sets, 10 ex, 6-10 reps 
60-65% 1RM. 3days/week 
I3: HI RT. 2-3 sets, 10 ex, 6-10 reps  
80-85% 1RM. 3days/week 
C:Control 
 
6 months 
 
- Lower body flexibility  
Sit-and-reach (cm) 
 
LI RT 
 
1.9* 
MI RT 
 
3.3*^ 
HI RT 
 
3.8*^ 
Control 
 
-0.3 
-No stretching performed  
-Intensity dependent 
improvement 
-Attendance 98% 
Kalapotharakos et 
al., 2005 
Greece 
n= 46 
healthy sedentary 
 
Age >60 
I1: MI RT. 3 sets, 8 ex, 15 reps 
60% 1RM. 3days/week 
I2: HI RT. 3 sets, 8 ex, 8 reps  
80% 1RM. 3days/week 
C:Control 
 
3 months 
 
- Lower body flexibility  
Sit-and-reach (cm) 
 
 MI RT 
 
5* 
HI RT 
 
3.45* 
Control 
 
0.05 
-Stretching performed in 
warm-up and cool-down (5 
min each) 
-No sig differences 
between ex groups 
-Short 
-Attendance 98% 
Toraman et al.,  
2004 
Turkey 
n= 42 
healthy sedentary 
 
Age 60-80 
I1: CT. AET (50-60% HRReserve)+ RT (3 
sets, 10 ex, 8-12 reps, 50-80% 1RM) 
3days/week 
C:Control 
 
9 weeks 
 
-Lower body flexibility  
Chair sit-and-reach (cm) 
 
  CT 
 
12.98 
 
 
Control 
 
0.7 
 
 
-Stretching performed in 
warm-up and cool-down (5 
min each) 
-Attendance 90% 
-Short intervention 
Barbosa et al.,  
2002 
Brazil 
n= 22 
healthy, 
 sedentary women 
Age 60-80 
I1: RT. 3-5 sets, 8 ex, 6-15 reps, 65-
85% 1RM, 85 min. 3days/week 
C:Control 
 
10 week 
 
- Lower body flexibility  
Sit-and-reach (cm) 
 
RT 
 
4* 
  Control 
 
-0.7 
-No stretching performed. 
-Attendance? 
-Small sample 
I: intervention groups, C: control group, RT: resistance training, AET: aerobic exercise training, CT: combined training, ,  LI: low –intensity, MI: moderate intensity, HI: high intensity, ROM: range of movement, deg: 
degrees, RPE: Borg rating of perceived exertion, HRmax: maximum heart rate, HRReserve: hear rate reserve (HRmax – HRRest), ex: exercises, rep: repetitions, RM: maximum repetitions, *pre-post significant differences 
(p<0.05), Ŧ significant differences vs. RT (p<0.05), # significant differences vs. AET (p<0.05), ^ significant differences  vs. LI (p<0.05), , →: no change 
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Table 4. Summary of reviewed studies on cardiorespiratory fitness 
Reference Participants Intervention 
Results (Pre-post intervention differences. Shown in outcome units) 
Comments 
Main outcomes Exercise groups 
Skrypnik et al., 
2015 
Poland 
n= 44 
obese women (BMI 
≥30kg/m2) 
 
Age 18-65 
I1: AET.  3days/week 
I2: CT. RT + AET. 3days/week 
+Details in Table 1 
 
 
3 months 
 
-VO2max (ml/kg /min) 
 
 AET 
3.03* 
 
CT 
3.82* 
 
 - Food intake records to 
assure diet unchanged. 
-Attendance 86.4%. 
 
Soroush et al., 
2013 
Sweden 
N=355 
overweight 
 
Age 20-65 
I1: Walking.  10.000 steps daily 
 
 
 
6 months 
 
-VO2max (ml/kg /min) 
 
 
 AET 
→ 
  -Unsupervised, pedometer 
based. 
Willis et al.,  
2012 
U.S.A 
n=119 
sedentary, 
 overweight/obese  
(BMI 25-35kg/m2)  
 
Age 18-70 
I1: RT. 3days/week 
I2: AET. (65-80%VO2 max) 
120 min/week 
I3: CT. RT+AET 
+Details in Table 1 
 
 
8 months 
 
-VO2max (ml/kg /min) 
 
 
RT 
1.26* 
 
 
AET 
3.43* 
 
CT 
4.25* 
 
 -Food diary to track changes 
in diet. 
 
Bateman et al., 
2011 
U.S.A 
n=196 
sedentary,  
overweight/obese 
 (BMI 25-35kg/m2) 
dyslipidemic  
 
Age 18-70 
I1: RT. 3days/week 
I2: AET. 65-80% VO2 max  
120 min/week 
I3: CT. RT+AET 
+Details in Table 1 
 
 
8 months 
 
-VO2max (ml/kg /min) 
 
RT 
1.23* 
 
AET 
3.33* 
 
CT 
3.67* 
 
 -Prescription not to change 
diet. 
 
Church et al.,  
2010 
U.S.A 
n=262 
sedentary,  
type2 diabetics 
(BMI ≥34kg/m2) 
 
 
Age 30-75 
I1: RT. 140min/week. 3days/week 
I2: AET. 140min/week. 
3days/week 
I3: CT. RT (2 days/week) + AET 
(140min/week) 
C:Control. stretching and 
relaxation 
+Details in Table 1 
 
 
9 months 
 
-VO2max (ml/kg /min) 
 
RT 
0.0 
 
AET 
0.5 
 
CT 
1.0 Ŧ 
 
 
Control 
-0.3 
 
-Diet questionnaire to 
assess changes. 
-Taking medication. 
-Attendance? 
 
Stensvold et al., 
2010 
Norway 
n=43 
metabolic syndrome  
(BMI ≥30kg/m2) 
 
 
Age 50.2±9.5 
I1: RT. 3days/week 
I2: AIT. Interval training on 
treadmill. 3days/week 
I3: CT. RT (1day/week)+ AIT 
(2days/week) 
C:Control 
+Details in Table 1 
 
3 months 
 
-VO2max (ml/kg /min) 
 
 
RT 
1.4 
 
AET 
4.4* 
 
 
CT 
3.1* 
 
 
Control 
-1.1 
 
-Habitual lifestyle diet. Food 
questionnaire to assess 
changes. 
-Attendance? 
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Reference Participants Intervention 
Results (Pre-post intervention differences. Shown in outcome units) 
Comments 
Main outcomes Exercise groups 
Davidson et al., 
2009 
U.S.A 
 
n=136 
sedentary, abdominally  
obese older adults 
 
Age 60-80  
I1: RT. 3days/week 
I2: AET. 30 min, moderate 
treadmill walking. 5 days/week 
I3: CT. RT+AET. 3 days/week 
C:Control 
+Details in Table 1 
 
 
6 months 
 
-VO2max (ml/kg /min) 
 
RT 
0.05 
 
AET 
0.25 Ŧ 
 
CT 
0.23 Ŧ 
 
Control 
-0.10 
 
 
 
 
-Nutrition counseling for all 
groups. Food diary to 
monitor changes. 
-Attendance 91% in all 
groups. 
Nemoto et al., 
2007 
Japan 
n=246 
sedentary, healthy 
 
Age 44-78 
 
I1: Moderate continuous walking.  
8000 steps/day. 4days/week 
I2: HI Interval walking.  
4days/week 
I3: No walking 
+Details in Table 2 
 
 
5 months 
 
-VO2max (ml/min) 
 
 Mod-AET 
→ 
 
HI-AET 
↑*^ 
 
Control 
↓ 
-Unsupervised, pedometer 
based. 
Park et al.,  
2003 
Korea/Japan 
 
n=30 
healthy  
overweight women 
(BMI ≥25kg/m2) 
 
 
Age 40-45 
I1: AET.60 min/day. 6days/week 
I2: CT. AET (3days/week) + RT 
3days/week) 
C:Control 
+Details in Table 1 
 
 
 
6 months  
 
-VO2max (ml/kg /min) 
 
 
 
AET 
8.9* 
CT 
10.2* 
Control 
-0.6 
-No diet control. 
-Small sample. 
-Attendance? 
 
Sousa et al.,  
2014 
Portugal 
n= 59 
men, healthy 
independent living 
 
Age 65-79 
I1: AET. Moderate (Borg 12-13), 60 
min. 3days/week 
I2: CT. RT (3sets, 7 ex, 8-12 reps. 
65%-75% 1RM.1 day/week) + AET 
(2days/week) 
C:Control 
 
9 months 
 
-Distance (m) 6MW  
-Adherence 
 AET 
29.5* 
82% 
CT 
25.6* 
86% 
Control 
-19 
-Continue normal 
medication and dietary 
patterns. 
-AET group strength 
exercises too. 
 
Sanudo et al.,  
2011 
Spain 
n=30 
women with fibromyalgia 
 
Age 65-79 
I1: CT. RT + AET (10-15 min, 65-
70% HRmax ) + stretching (10  min) 
2days/week 
C:Control. Under medical 
treatment 
+Details in Table 3 
 
 
3 months 
 
-Distance (m) 6MW  
 
 
  CT 
↑* 
 
 
 
Control 
→ 
 
-Attendance? 
Hallage et al.,  
2010 
Brazil/U.S.A 
n= 13 
healthy women 
 
Age >60 
I1: AET. Low impact Step Aerobics 
(50-70% HRmax), 30-60 min 
3days/week 
 
3 months 
 
-Distance (m) 6MW  
 
 AET 
56.1* 
  -Maintain current habits. 
-Attendance 85% 
-Small sample 
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Reference Participants Intervention 
Results (Pre-post intervention differences. Shown in outcome units) 
Comments 
Main outcomes Exercise groups 
Carvalho et al., 
2009 
Portugal 
n= 65 
sedentary  
healthy women 
 
Age 64-85 
I1: CT. RT + AET (12-14 RPE, 20-25 
min) + stretching and agility. 60 
min. 2days/week 
C:Control 
+Details in Table 3 
 
 
8 months 
 
-Distance (m) 6MW  
 
  CT 
15.7 
Control 
-28.8* 
-Attendance 91% 
Toraman et al., 
2004 
Turkey 
n= 42 
healthy sedentary 
 
Age 60-80 
I1: CT. Stretching + AET (50-60% 
HRReserve)+ RT. 3days/week 
C:Control 
+Details in Table 3 
 
9 week 
 
-Distance (m) 6MW  
 
  CT 
63.3* 
Control 
0.6 
-Also educational period. 
-Attendance 90% 
-Short intervention. 
 
I: intervention groups, C: control group, RT: resistance training, AET: aerobic exercise training, CT: combined training, NA: no applicable,  LI: low –intensity, HI: high intensity, BMI: body max index, 6MW: six-minute 
walk test, HRmax: maximum heart rate, HRReserve: hear rate reserve (HRmax - HRRest), VO2max: maximal oxygen uptake, ex: exercises, reps: repetitions, RM: maximum repetitions, *pre-post significant differences (p<0.05), Ŧ 
significant differences vs. RT (p<0.05), # significant differences vs. AET (p<0.05), ^ significant differences HI vs. LI (p<0.05), T trend towards significance, →: no change 
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2. OBJECTIVES 
 2.1. General objectives 
The main objective of this research was to assess the effectiveness of a therapeutic exercise program 
aimed to improve the physical condition of individuals with different chronic disorders.  
The main disorders included in the program were musculoskeletal disorders, type 2 diabetes, 
hypertension and obesity. After nine months of combined exercise sessions, changes in different 
physical measures were assessed.  
In addition, this research performed an evaluation of the exercise program to detect strengths and 
areas of improvement in order to guide the design and development of future exercise programs for 
this specific population. 
 2.2. Specific objectives 
x To describe the socio-demographic characteristics of the population who attended the exercise 
program from 2000 to 2012. Participants´ gender, age, occupation and main disorder were 
analyzed for this purpose. 
 
x To assess participation and adherence to the exercise program. Therefore, number of 
participants per year and days assisted were examined. 
 
x To evaluate the effect of the exercise program on different physical parameters. Changes in 
anthropometric measures such weight, BMI, waist circumference and waist-hip ratio, flexibility, 
blood pressure, heart rate and cardiorespiratory fitness were explored to this end. 
 
x To compare the effect of the program on different population groups. To this intent, physical 
measures were analyzed in women and men, in different age groups and in different diagnosis 
groups. 
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x To investigate the association between changes in different physical parameters in order to 
establish possible dose-response relationships. 
 
x To evaluate motivation and satisfaction of the participants towards the exercise program in 
order to uncover strengths and possible improvement areas. Self-designed motivation and 
satisfaction questionnaires were used for this aim. 
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3. METHODOLOGY 
The present study is a retrospective analysis and evaluation of a therapeutic exercise program 
performed in Vitoria-Gasteiz between 2000 and 2012 in the Sports Medicine Centre of 
Mendizorrotza. This program was designed to improve the physical condition and symptoms of 
people with different chronic disorders such as MSD, type 2 diabetes, hypertension and obesity.  
 3.1. Subjects 
3.1.1. Inclusion criteria 
Participants needed to be referred by their family doctor and assessed by the sports doctor 
responsible of the exercise program. 
Only individuals with at least one of the following disorders or risk factors were accepted in the 
program: 
x Type 2 diabetes (glycemia >100 mg/dl and <250 mg/dl). Only no-insulin dependents were 
included 
x Moderate hypertension (systolic blood pressure of 160-179 mmHg and/or diastolic blood 
pressure of 100-109 mmHg)  
x Overweight (BMI >25 kg/m2) or moderate obesity (BMI 30-40 kg/m2)  
x Musculoskeletal disorders: participants had one of the following: spinal column problems, 
osteoarthritis, arthritis, osteoporosis or fibromyalgia 
x Hypercholesterolemia 
x Dyslipidemia 
x Smoking 
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3.1.2. Exclusion criteria 
-Absolute contraindications: 
x Recent acute myocardial infarction 
x Instable angina 
x Important cardiac arrhythmia 
x Pericarditis or acute miocarditis 
x Endocarditis 
x Severe aortic stenosis 
x Embolism or acute pulmonary infarction 
x Morbid obesity 
x Severe physical handicap 
-Relative contraindications: 
x Ventricular conduction abnormality 
x Uncontrolled hypertension 
x Type I diabetes or uncontrolled type 2 diabetes 
x Moderate cardiac valvular disease 
x Electrolyte anomaly 
x Fever 
x Psychiatric disorders or inability to collaborate. 
 
3.1.3. Group allocation and categorization 
Participants were referred by their family doctor to the Sport Medicine Centre where a sports doctor 
performed a thorough evaluation and personal interview in order to assess any possible disease or 
other limitations to perform physical activity. The medical report written by the family doctor, 
current medication and its relationship with physical activity were also considered to allocate 
participants in the appropriate exercise group. Initially, participants were divided in four main 
exercise groups according to their main disorder: MSD, hypertension, type 2 diabetes and obesity.  
As number of participants increased, more specific exercise groups were created in order to cater to 
participants’ needs. For instance, from the MSD group six other different subgroups were created 
according to the different disorders: spinal column disorders, osteoarthritis, osteoporosis, 
fibromyalgia, “MSD general”, that included patients with other problems of the musculoskeletal 
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system as knee, shoulder or other combination of problems that could not be included in the 
previous groups and “MSD special”, which included either younger patients with back problems or 
patients with rare disorders such as Parkinson, amyotrophic lateral sclerosis  or  different kind of 
paralysis as a consequence of various reasons such car accidents or strokes. 
Individuals with hypertension as primary or secondary disorder were also categorized in four groups: 
normal, grade 1, grade 2 and grade 3 hypertension according to the European Society of 
Hypertension and European Society of Cardiology (Mancia et al., 2013) (Table 5). 
 
Table 5. Definitions and classification of blood pressure levels (mmHg) by the European Society of Hypertension and 
European Society of Cardiology (2013 Guidelines). 
 
This study complies with the ethical standards of the ethics comitee of the University of the Basque 
Country on Research on Human subjects. Besides, it was performed according to the ethical 
standards of the Helsinki Declaration. Due to the design of the study written informed consent was 
not possible to be obtained. In anycase, participants´ identity was anonymised using numeric codes. 
 3.2. Intervention 
The exercise program was designed with the following general and specific aims: 
General: 
x To improve  symptoms of the different chronic disorders  
x To prevent degenerative disorders and reduce risk factors 
x To improve health and quality of life  
x To promote healthy and active living 
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Specific: 
x To increase participants´ knowledge about their own disorder  
x To increase nutritional knowledge 
x To show and teach proper and safe ways to perform physical activity 
x To encourage independent participation in physical activity 
x To reduce primary care visits, medication consumption and to create a therapeutic 
complement for primary care clinic protocols 
 
The total length of the program was nine months, with one hour sessions performed three times a 
week. The sessions combined aerobic and resistance exercise and were supervised by physical 
activity professionals.  The structure of a standard session can be seen in Table 6. 
The different exercise groups followed the same standard session design but included individualized 
exercises according to personal needs (Appendix 1). Intensity, progression and individualization was 
ensured and controlled by physical activity professionals. Sessions were performed in different civic 
centers located around the city. 
Table 6. Structure of a standard session. 
 
 
CONTENT OBJECTIVES 
WARM-UP 
 10-15´ 
Stretching 
Mobility exercises 
-Preparation for exercise 
-Injury prevention 
MAIN 
 PART  
30-45´ 
Flexibility 
-Improve or maintain range of motion 
-Improve gait, balance and coordination 
-Decrease rigidity 
Strength 
-Increase strength 
-Increase maximum number of repetitions 
-Improve maximum contraction 
Aerobic 
Moderate  
(60-80% HRmax) 
-Increase cardiorespiratory endurance 
-Increase caloric expenditure 
-Blood pressure control 
Functional activities 
-Improve functional capacity for everyday life activities 
-Improve self-confidence 
-Improve quality of life 
COOL-
DOWN  
5-10´ 
Stretching 
Relaxation 
-Progressive calm down 
-Enhance recovery 
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During the exercise sessions the following criteria were considered exclusive, therefore, any kind of 
exercise was immediately stopped to avoid complications to the participants:  
x Glycemia      >300 mg/dl  
<100 mg/dl – extra consumption of carbohydrates 
x Hypertension   Resting : >180 mmHg systolic, >110 mmHg diastolic  
    Post-exercise: >250 mmHg systolic, >110 mmHg diastolic  
x Musculoskeletal disorders Pain in the execution of exercises  
 
After patients completed the nine month program they were not able to participate again except if 
they had a different diagnose. Nevertheless, in order to encourage independent participation in 
physical activity, participants were given the option of attending an open class, were they were 
allowed to use the exercise room on their own.  Participants were also encouraged to create walking 
groups and to join regular supervised exercised lessons offered by the city council. 
 During the program, the sports doctor conducted different seminars and workshops related with 
the different disorders, their relationship with physical activity and also nutritional counseling in 
order to promote healthy and active living. Some of the physical activity recommendations 
individualized by disorder can be seen in Appendix 2. 
 3.3. Measurements 
All measurements (anthropometric measures, flexibility, blood pressure, heart rate and 
cardiorespiratory fitness) were performed at baseline, at three, six and nine months. All 
measurements were undertaken by the same trained nurse and physical activity professionals.  
 
3.3.1. Anthropometric measures 
Measurements were conducted with participants wearing light clothing and no shoes. Weight (kg) 
was measured to the nearest 0.1 kg (Digital SECA scale, Germany) and height (cm) to the nearest 0.5 
cm (SECA stadiometer, Germany). BMI was calculated as weight (kg) per height2 (m2).  Obesity was 
defined as BMI ≥30 kg/m2, overweight as BMI 25-29.9 kg/m2, normal weight as BMI 18.5-24.9 kg/m2 
and underweight as BMI < 18.5 kg/m2 (WHO, 2011).  
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Waist circumference (cm) was measured at the level of the iliac crest and hip circumference at the 
maximum protuberance of the buttocks. Both were measured at the nearest 0.5 cm.  
Participants were categorized in three waist circumference groups according to the risk of metabolic 
complications (WHO, 2008): high or substantially increased risk of metabolic complications (>88 cm 
in women and >102 cm in men), increased risk for metabolic complications (80-87 cm in women and 
94-101 cm in men) and an optimal waist circumference (<80 cm in women and <94 cm in men).  
Waist-hip ratio (WHR) was calculated as waist circumference divided by hip circumference. Values 
≥0.85 cm in women and ≥0.90 cm in men were considered as substantially increased risk for 
metabolic complications and values below those as normal (WHO, 2008).  
 
In the results section waist circumference was used as the preferred measure to describe abdominal 
obesity considering the wider availability of studies using this measure if compared to WHR and the 
appropriateness that some authors have expressed in the use waist circumference (Seidell et al., 
2010; WHO, 2008). 
 
3.3.2. Flexibility 
The “Sit-and-reach” bench was used (EVEQUE flexibility bench, United Kingdom) to evaluate the 
flexibility of the extensor muscles of the trunk and the hamstrings. From seated position in the floor, 
the back resting in vertical position, extended legs, feet soles rested in the box and ankles flexed at 
90º degrees, the participant flexed the trunk to try to reach with his or her finger tips a far as 
possible, maintaining the posture for two seconds. Each participant had two tries and the highest 
score reached was recorded. 
 
3.3.3. Blood pressure and heart rate 
Both systolic and diastolic blood pressure and heart rate were measured in seated position at rest, 
before the cardiorespiratory fitness test and immediately after the test. A digital electronic 
tensiometer (OMROM, Japan) was used to measure blood pressure and a hear rate monitor to 
measure heart rate (Polar, Finland).  
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3.3.4. Cardiorespiratory fitness 
Cardiorespiratory fitness was assessed by the six-minute walk test (6MW) which consists in walking 
around a course covering as much distance as possible in six minutes. This test is believed to be a 
good indicator of aerobic endurance in young and older adults and appropriate for detecting 
intervention induced changes both in healthy individuals and in patients with different disorders 
such CVD, diabetes or fibromyalgia (Rikli and Jones, 2013). 
 
3.3.5. Motivation and satisfaction 
A motivation questionnaire specially designed for the program (Appendix 3) was used to evaluate 
participants´ enjoyment towards physical activity, general opinion of the program (instructors, 
facilities, and other participants), self-confidence, social support, motivation to assist to the sessions 
and credibility on the method.  
A satisfaction questionnaire specially designed for the program (Appendix 3) was also used to 
evaluate changes induced by the program in self-esteem, functionality and the ability to control their 
disorder, general expectations on the program, safety and general satisfaction with the individual 
attention offered.  
Motivation and satisfaction were measured at the end of the program, at nine months. 
 3.4. Data analysis 
Data analysis was performed using IBM Statistical Package for Social Sciences (SPSS- 21.0). The 
normal distribution of the variables was tested using the Kolmogorov-Smirnov test. Most variables 
did not have a normal distribution, thus, non-parametric tests were used for analysis. In all cases 
statistical significance was set at p<0.05. 
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3.4.1. Socio-demographic characteristics and diagnosis of participants and 
differences among groups 
Socio-demographic variables such as gender, age and occupation and diagnosis were used to 
describe the sample. Age was described using the mean and standard deviation (SD) and was also 
transformed into a categorical variable by grouping participants into age decades (21-30, 31-40….81-
90).  
Categorical variables were described using the number of participants (n) and proportion of 
participants over the total (%). 
Comparisons of the socio-demographic characteristics and diagnosis between women and men, 
among different age decades and among different diagnosis groups were performed using the Chi 
Square test. Fisher´s Exact test was used when the expected count in a cell was below five. 
As a post-hoc test, standardized residuals were calculated in order to determine which cells 
contributed to the significant Chi Square test results.  
 
3.4.2. Participation and adherence 
Descriptive statistics were used to describe participation and adherence of participants in the 
program. Number of participants, number of dropouts, percentage of different dropout causes and 
number of injury consultations were reported for every year of the program.  
Participation in the program was described by number of terms participated (one, two or three) and 
adherence by days assisted (n) and average assistance (%).  
Categorical variables were described using the number of participants (n) and proportion of patients 
over the total (%). 
Differences in participation and adherence among groups were compared using the Mann-Whitney 
test (two groups) and the Kruskall-Wallis test (more than 2 groups) for continuous variables. 
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3.4.3. Baseline physical measures and differences among groups 
Baseline physical measures were described using the mean and standard deviation (SD) for 
continuous variables. BMI categories (obese, overweight, normal and underweight) and waist 
circumference categories (high or substantially increased risk, increased risk and optimal) were 
described using the proportion of participants over the total (%). 
Differences in baseline physical measures among groups were compared using the Mann-Whitney 
test (two groups) and the Kruskall-Wallis test (more than 2 groups) for continuous variables, and the 
Chi Square test for categorical variables. 
Analysis among different diagnose groups were also divided by gender considering the differences 
observed between men and women. This procedure was not possible to be performed with some of 
the variables among different age groups due to the small sample size of many of the subgroups. 
Post-hoc analysis to follow-up significant Kruskal-Wallis test, were performed using pairwise 
comparisons as shown in the model viewer. In the cases were these pairwise comparisons showed 
no significant differences even though the original Kruskal-Wallis test showed to be significant, the 
Mann-Whitney test was performed to further assess pairwise significant differences. 
 
3.4.4. Changes in physical measures and differences among groups 
Changes in physical measures along the program (baseline, three months, six months and nine 
months) were analyzed using Friedman´s ANOVA. Wilcoxon´s signed rank test was used to follow-up 
significant ANOVAs, performing pairwise comparison between baseline measurements and 
measurements at three, six and nine months. 
Effect size was measured by Cohen´s d in order to assess if changes from baseline to the different 
follow-ups were large (0.8), medium (0.5) or small (0.2) (Field, 2013). 
Changes in physical measures were also analyzed by gender, age and diagnose using the same 
statistical tests. Changes in physical measures in different diagnose groups were also divided by 
gender considering the differences observed between men and women. This procedure was not 
possible to be performed with the different age groups due to the small sample size of many of the 
groups. Tests could not be performed in the 81-90 age group and in some of the physical measures 
in other age groups due to the null or low sample size (n≤1). 
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3.4.5. Association between changes in physical measures 
In order to analyze the association between different physical measures, firstly, the percentage 
change occurred between baseline and nine months was calculated for each variable using the 
following formula: D=[(T2-T1)/T1]*100, where T1 stands for baseline values and T2 for values at nine 
months.  
Secondly, bivariate correlations of these percentage changes were performed using Spearman´s 
correlation coefficient (rs). These coefficients lie between -1 and +1, values closer to -1 showing a 
negative association, values closer to +1 a positive association and values closer to 0 showing no 
association. Also, 95% confidence intervals (CI) for these coefficients were calculated and reported in 
square brackets. 
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4. RESULTS 
4.1. Description of the sample 
4.1.1. Socio-demographic characteristics and diagnosis of the total sample 
A total of 3492 patients attended the first visit to the sports doctor, referred by their family doctor, 
and from these, 79% (n=2760) decided to start the program.  Socio-demographic characteristics of 
the participants such as gender, age, occupation and diagnosis are summarized in Table 7.  77.4% of 
the participants (n=2137) were women and 22.6% (n=623) men and their mean age was 56.12 ± 
11.63. The youngest participant was 21 years of age and the oldest 89. 
As can be seen in Figure 7, almost 70% of the participants were above 50 years of age, the 51-60 
decade being the largest age group (33%).  The main occupation of the participants was housework 
(34.8%) and 20.2% of them were retired. 
 
The most common primary disorder among the participants was MSD (n=1952), followed by 
hypertension (n=541), type 2 diabetes (n=135) and obesity (n=132) (Table 7 and Figure 8). 
 
 
Figure 7. Age distribution of participants. 
Values are shown in percentages (%). 
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Table 7. Socio-demographic characteristics of participants. Values are shown in number of individuals (n) and in 
percentages(%). 
 
 
Total n n % 
Gender 2760     
Women 
 
2137 77.4 
Men 
 
623 22.6 
Age (years) 2760     
21-30  
 
51 1.8 
31-40  
 
231 8.4 
41-50  
 
552 20.0 
51-60  
 
903 32.7 
61-70  
 
714 25.9 
71-80  
 
292 10.6 
81-90  
 
17 0.6 
Occupation 2283     
Retired 
 
461 20.2 
Housework 
 
795 34.8 
Disability 
 
25 1.1 
Student 
 
4 0.2 
Unemployed 
 
24 1.1 
Directors, managers 
 
1 0.0 
Scientific, intellectual professionals 
 
128 5.6 
Technical/diploma professionals 
 
110 4.8 
Administrative personnel 
 
174 7.6 
Services, commercial sector 
 
152 6.7 
Farmers, fishermen 
 
6 0.3 
Skilled workers 
 
137 6.0 
Facility, machine operators 
 
68 3.0 
Elementary occupations 
 
196 8.6 
Religious  
 
2 0.1 
Diagnosis 2760     
Musculoskeletal system disorders 
 
1952 70.7 
Type 2 diabetes 
 
135 4.9 
Hypertension 
 
541 19.6 
Obesity 
 
132 4.8 
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Figure 8. Participants’ main diagnosis. Values are shown in percentages (%). 
O b e s ity
T yp e  2  d ia b e te s
H yp e r te n s io n
M u s c u lo s k e le ta l d is o r d e r s
4 .8%
1 9 .6 %
4 .9%
7 0 .7 %
 
In the MSD group (n=1952), 91% of the individuals had some type of MSD alone, 5% had also 
hypertension as secondary disorder and 3% were also obese (Figure 9). Regarding the type of MSD, 
almost half of them (47%) had spinal column problems, 17% osteoarthritis, 8% fibromyalgia and 2% 
osteoporosis. 6% of the participants were in the “MSD general” group and 18% in the “MSD special” 
group (Figure 10). As previously explained, participants in the “MSD general” group had other 
problems of the musculoskeletal system as knee, shoulder or other combination of problems that 
could not be included in the previous groups and the ones in the “MSD special” group were either 
younger patients with back problems or patients with rare disorders such as Parkinson, amyotrophic 
lateral sclerosis or different kinds of paralysis as a consequence of various reasons such car accidents 
or strokes. 
 
Figure 9. Distribution of secondary disorders in the MSD group. Values are shown in percentages (%). 
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Figure 10. Distribution of different disorders among the MSD group. Values are shown in percentages (%). 
 
In the diabetes group (n=135), only 16% of the participants had diabetes alone, 45% had diabetes 
and some type of MSD as a secondary disorder (13% spinal column problems and 11% 
osteoarthritis), 27% had hypertension (13% of these also some kind of MSD) and 13% were obese 
apart from diabetic (Figure 11). 
 
Figure 11. Distribution of secondary disorders in the diabetes group. Values are shown in percentages (%). 
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Among the hypertension group (n=541), 6% of the individuals had hypertension alone, 80% had 
some kind of MSD as a secondary disorder (20% osteoarthritis and 30% spinal column problems), 4% 
were diabetic and 9% were obese (Figure 12). 
 
Figure 12. Distribution of secondary disorders in the hypertension group. Values are shown in percentages (%). 
 
On the obesity group (n=132), 14% were obese alone, 77% had some kind of MSD (19% 
osteoarthritis and 30% spinal column problems) and 9% had hypertension (Figure 13). 
 
Figure 13. Distribution of secondary disorders in the obesity group. Values are shown in percentages (%). 
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4.1.2. Socio-demographic and diagnosis differences among groups 
4.1.2.1. Socio-demographic and diagnosis differences by gender 
As mentioned before, 77.4% of the participants were women and the 22.6% were men. There were 
no significant differences in age between the two groups. However, significant differences (X2 (14) 
=595.29, p <0.001) were found between men and women concerning their occupation. As seen in 
Table 8, 40.1% of the men were retired, 15.9% were skilled workers, 8.4% were facility or machine 
operators and 0.2% were taking care of the housework. On the other hand, only 14.1% of the 
women were retired as their only “occupation” and 45.4% were housewives.  Fewer women also 
occupied positions as skilled workers (3%) and operators (1.3%). 
When looking at the diagnosis of the sample by gender, some significant differences (p<0.001) were 
found between women and men. As can be seen in Figure 14, the most common primary disorder 
among women was MSD (72%), followed by hypertension (18%), obesity (5%) and diabetes (4%). 
Among men, the prevalence of obesity (3%) was significantly lower than in women, and 
hypertension (25%) and diabetes (8%) higher than in women (X2 (3) =32.27, p<0.001).  
 
Table 8. Occupation by gender. Values are shown in number of participants (n) and percentages (%). 
Occupation Women Men 
 
 
n % n % sig 
Retired 246 14.1 215 40.1 ** 
Housework 794 45.4 1 0.2 ** 
Disability 14 0.8 11 2.1  
Student 2 0.1 2 0.4  
Unemployed 15 0.9 9 1.7  
Directors, managers 1 0.1 0 0.0  
Scientific, intelectual professionals 85 4.9 43 8.0  
Technical/diploma professionals 85 4.9 25 4.7  
Administrative personnel 137 7.8 37 6.9  
Services, commercial sector 123 7.0 29 5.4  
Farmers, fishermen 2 0.1 4 0.7  
Skilled worker 52 3.0 85 15.9 ** 
Facility, machine operators 23 1.3 45 8.4 ** 
Elementary occupations 166 9.5 30 5.6  
Religious  2 0.1 0 0.0  
Sig: significant differences, ** (p<0.05) 
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Figure 14. Differences in diagnosis by gender. Values are shown in percentages (%). 
 
In the MSD group, no significant differences were found between women and men regarding their 
secondary disorder. However, significant differences were found in the MSD subgroups (X2 (5) 
=85.83, p<0.001) (Figure 15). Significantly more men (29%) were included in the MSD special groups 
comparing to women (16%). 3% of women had osteoporosis whereas none of the men were 
included in this group. Regarding fibromyalgia, significantly more women (10%) suffered from this 
disorder comparing with men (2%). In the general MSD group, there were significantly fewer men 
(3%) than women (7%).  
 
Figure 15. Differences in distribution of different MSD disorders between women and men. Values are shown in 
percentages (%). 
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In the hypertension group, significantly more men (9%) than women (5%) had hypertension alone 
and significantly more men (7%) than women (3%) had also diabetes as a secondary disorder. 
Regarding the diabetes and obesity groups, no significant differences in secondary disorder 
subgroups between women and men were found.  Similarly, no significant differences in systolic and 
diastolic BP categories were found between women and men.  
 
4.1.2.2. Socio-demographic and diagnosis differences by age 
Occupation was significantly different among age groups (X2(84) =1327.87, p<0.001). Significantly 
more individuals in the oldest groups (61-70, 71-80 and 81-90) were retired and more individuals in 
the 51-60, 61-70 and 71-80 groups took care of housework if compared to the other groups. 
Scientific or intellectual professionals and administrative personnel were more predominant in the 
younger groups (21-30, 31-40 and 41-50). Skilled workers and facility or machine operators were 
also more predominant on the youngest groups (21-30 and 31-40), service or commercial workers 
on the 31-40 and 41-50 groups and elementary occupations on the 31-40, 41-50 and 51-60 groups. 
Individuals with disability were mainly in the 51-60 group and unemployed individuals in the 31-40 
group. 
The prevalence of the primary diseases also varied significantly (X2 (18) =339.14, p<0.001) among 
age groups. MSD were highest (94%) in the 31-40 age group, type 2 diabetes in the 61-70 age group 
(8%), hypertension in the 71-80 age group (42%) and obesity had similar distribution (4-6%) in 
almost all age groups except in the 71-80 age group that was significantly lower (2%) (Figure 16).  
Figure 16. Differences in distribution of the different primary disorders among age groups. Values are shown in 
percentages (%). 
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In the MSD group, the 61-70 age group was found to have significantly higher percentage (32.5%)of 
individuals with hypertension as a secondary disorder than the rest of the age groups  (X2 (18)=32.1, 
p=.021). In addition, significant differences were also found among MSD subgroups (X2 (30)=776.41, 
p<0.001) (see Table 9). The 21-30, 31-40 and 41-50 age groups had significantly more patients in the 
MSD special group (89%, 64% and 26% respectively). The 51-60 age group also had significantly more 
patients in the spinal column group (56%) and the 61-70 and the 71-80 age groups had significantly 
more patients in the osteoarthritis group than the rest of the groups. 
 
Table 9. Distribution of MSD subgroups among age groups. Values are shown in number of participants (n) and 
percentages (%). 
 
 
In the hypertension group, the 51-60 age group had significantly more patients in the 
Hypertension+Obesity group (59%) if compared with the rest of age groups (X2 (18) =47.89, 
p<0.001). No significant differences were found among age groups in the diabetes and obesity 
secondary disorders or in blood pressure categories.  
 
Spinal Column Osteoarthritis Osteoporosis Fibromyalgia MSD special MSD general 
Age n % n % n % n % n % n % 
21-30 3 7% 0 0% 0 0% 1 2% 40 89% 1 2% 
31-40 53 25% 6 3% 1 1% 14 7% 138 64% 4 2% 
41-50 253 53% 26 5% 3 1% 53 11% 126 26% 21 4% 
51-60 359 56% 127 20% 12 2% 55 9% 36 6% 52 8% 
61-70 200 49% 115 28% 18 4% 30 7% 21 5% 28 7% 
71-80 50 34% 63 43% 12 8% 9 6% 2 1% 11 8% 
81-90 3 33% 3 33% 1 11% 0 0% 1 11% 1 11% 
MSD: musculoskeletal disorders 
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4.2. Participation and adherence 
The number of participants that assisted in the program can be seen in Figure 17. Average number 
of participants per year was n=236, the greatest number of participants n=285 (in 2001) and the 
lowest n=111 (in 2012). 
Figure 17. Number of participants attending the program along the years. Values are shown in number of 
participants(n). 
 
The number of dropouts and the main reported causes for dropping out can be seen in Figure 18. 
The average number of dropouts per year was n=100, with the highest number of dropouts being 
n=138 (in 2004) and the lowest n=30 (in 2012). The main reasons for dropping out were personal 
issues (33-59%), followed by illness (2-34%). Low assistance was also an important reason to exclude 
participants from the program (2-27%). 
The number of injury consultations can be seen in Figure 19. The average injury consultations per 
year was n=60, the highest number of injury consultations n=106 (in 2001) and the lowest n=12 (in 
2011). 
From all the participants (n= 2760), 46% (n=1251) completed the nine month program (21% of these 
(n=575), did it without the summer break in between, from October to June). 31% of the participants 
(n=849) completed one term (three months) and 23% (n=655) completed two terms (Figure 20).  The 
mean number of days attended were 51 out of a total of 67 days and average assistance was 73%. 
However, participants that completed the whole program (three terms) had significantly higher 
average assistance (76%) than the ones that participated only one term (68%), H(4)=23.78, p<0.001. 
Men also had higher average assistance than women, 75% vs. 72% (U=666.903, p<0.001). As can be 
seen in Figure 21, as age increased the average assistance also increased significantly (H(6)=193.098 
p <0 .001). Patients from the hypertension group also had higher average assistance (77%) than the 
MSD (72%) and the obesity group (70%), H(3)=38.01 p<0.001). 
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Figure 18. Number of dropouts and main reasons for dropping out along the program. Values are shown in number of 
dropouts and percentages (%). 
 
Figure 19. Number of injury consultations along the program. Values are shown in number of consultations. 
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Figure 20. Participation in the program. Number of terms attended without and with the summer in between. Values are 
shown in percentages (%). 
 
 
Figure 21. Differences in average assistance among age groups. Values are shown in percentages (%). 
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4.3. Baseline physical measures 
4.3.1. Baseline physical measures of the total sample 
Physical measures of the participants at baseline are shown in Table 10.  
 
Table 10. Baseline physical measures. Values are shown in mean values and standard deviation (SD). 
  n Mean SD 
Height (cm) 2441 160.01 90.06 
Weight (kg) 2538 70.82 12.99 
BMI (kg/m2) 2347 27.58 4.76 
Waist circumference (cm) 211 98.39 12.30 
Waist-hip ratio 200 0.91 0.08 
Flexibility (cm) 1552 11.51 9.39 
Resting systolic BP (mmHg) 601 146.41 14.66 
Resting diastolic BP (mmHg) 601 84.52 7.63 
After-exercise systolic BP (mmHg) 563 144.96 16.25 
After-exercise diastolic BP (mmHg) 563 83.38 8.78 
Resting HR (bpm) 315 76.03 12.91 
After-exercise HR (bpm) 316 97.35 17.61 
Total distance in 6MW (m) 309 472.89 65.31 
n: number of individuals, SD: standard deviation, BMI: body max index, BP: blood pressure, HR: heart rate,  6MW: six-
minute walk test, mmHg: millimeter of mercury, bpm: beats per minute 
 
Mean BMI of the sample was 27.58±4.76 kg/m2 and as it can be seen on Figure 17, 43% of the total 
sample was overweight (BMI 25-30 kg/m2), 26% obese (BMI ≥30 kg/m2) and 1% underweight 
(BMI<18.5 kg/m2). According to the cut-off points suggested by the WHO (2008), 71% of the sample 
had a waist circumference that could substantially contribute to an increased risk of metabolic 
complications (>88 cm in women and >102 cm in men), 18% had a waist circumference that could 
contribute to an increased risk for metabolic complications (80-87 cm in women and 94-101 cm in 
men) and 11% had an optimal waist circumference (<80 cm in women and <94 cm in men) (Figure 
22). 
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Figure 22. BMI categories in total sample, women and men. Values are shown in percentages (%). 
 
Among all the patients with hypertension as a primary or secondary disorder (n=601), 23% had 
normal or controlled systolic blood pressure, 56% had grade 1 systolic hypertension, 19% grade 2 
systolic hypertension and 3% had grade 3 systolic hypertension (see Figure 8). Regarding diastolic 
blood pressure, 64% had normal or controlled diastolic blood pressure, 33% grade 1 hypertension 
and 3% had grade 2 hypertension (Figure 23).  
 
Figure 23. Categories for systolic and diastolic blood pressure. Values are shown in percentages (%). 
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4.3.2. Baseline physical measures by group 
4.3.2.1. Baseline physical measures by gender 
When looking at the baseline physical measures by gender, results showed significant differences 
(p<0.05) between women and men in height, weight (but not in BMI), waist circumference, WHR, 
flexibility, resting and after-exercise heart rate and total distance in the 6MW(Table 11 ).  
Men were significantly (p<0.001) taller (170.81±7.42 vs. 157±6.84 cm) and heavier than women 
(79.78±11.74 vs.  68.22±12.16 kg) but both had similar BMI (27.36±3.86 and 27.64±5 kg/m2 
respectively). Women were significantly (p<0.001) more flexible (12.2±9.28 vs. 8.5±9.35 cm), had a 
smaller waist circumference (95.62±11.90 vs. 104.75±10.86 cm) and smaller WHR comparing to men 
(0.88 vs. 0.99). Men also had significantly lower resting heart reate (71.97±14.71 vs. 77.63±11.77 
bpm, p <0.001), lower after-exercise heart rate (92.84±18.55 vs. 99.14±16.94 bpm, p=0.01), and 
covered a higher total distance on the 6MW (491.91±71.75 vs. 465.2±61.03 m, p<0.001). 
Significantly more men were overweight (54%) if compared to women (40%) (X2 (3)=31.13, p <0.001) 
but both groups had similar amount of obese subjects (20% vs. 28%) (Figure 22). No significant 
differences were found in waist circumference categories between women and men but both groups 
showed a large number of individuals in the high risk group (78% in women and 56% in men) (Figure 
24). 
Table 11. Differences in physical measures between women and men (Mann-Whitney test). Values are shown in mean 
values and standard deviation (SD).  
  
Women   Men 
     n Mean SD n Mean SD p z d 
Height (cm) 1908 157.00 6.84 533 170.81 7.42 <0.001 29.31 -1.93 
Weight (kg) 1965 68.22 12.16 573 79.78 11.74 <0.001 19.75 -0.96 
BMI (kg/m2) 1827 27.64 5.00 520 27.36 3.86 0.70 -0.36 0.06 
Waist circumference (cm) 147 95.62 11.90 64 104.75 10.86 <0.001 -4.72 -0.80 
Waist-hip ratio 136 0.88 0.06 64 0.99 0.06 <0.001 9.79 -1.83 
Flexibility (cm) 1265 12.20 9.28 287 8.50 9.35 <0.001 -5.81 0.39 
Resting systolic BP (mmHg) 430 146.19 14.70 171 146.98 14.60 0.53 0.61 -0.05 
Resting diastolic BP (mmHg) 430 84.27 7.69 171 85.16 7.47 0.16 1.4 -0.11 
After-exercise systolic BP (mmHg) 395 144.41 16.34 168 146.24 16.05 0.33 0.96 -0.11 
After-exercise diastolic BP (mmHg) 395 83.12 9.39 168 83.99 7.17 0.15 1.42 -0.1 
Resting HR  (bpm) 226 77.63 11.77 89 71.97 14.74 <0.001 -3.64 0.42 
After- exercise HR (bpm) 226 99.14 16.94 90 92.84 18.55 0.01 -2.83 0.35 
Total distance in 6MW (m) 220 465.20 61.03 89 491.91 71.75 <0.001 3.45 -0.4 
n: number of individuals, SD: standard deviation, BMI: body max index, BP: blood pressure, HR: heart rate, 6MW: six-minute walk test, mmHg: 
millimeter of mercury, bpm: beats per minute,p: significance value, z: z-score, d: effect size (Cohen´s d) 
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Figure 24. Waist circumference categories in total sample, women and men. Values are shown in percentages (%). 
 
 
4.3.2.2. Baseline physical measures by age 
Tests conducted to evaluate the differences in physical measures among different age groups in 
women and men showed significant (p<0.05) differences in height, weight, BMI , resting and after-
exercise systolic blood pressure, resting and after-exercise heart rate  and total distance in the 6MW 
in women and in height, BMI, flexibility and after-exercise heart rate  in men (Table 12).  
 
Table 12. Differences in physical measures among age groups in women and men (Kruskal-Wallis Test).  
  
Women 
  
Men 
  n H(x) p n H(x) p 
Height (cm) 1908 275.42(6) <0.001 533 118.18(6) <0.001 
Weight (kg) 1965 42.52(6) <0.001 573 7.16(6) 0.30 
BMI (kg/m2) 1827 177.11(6) <0.001 520 54.72(6) <0.001 
Waist circumference (cm) 147 7.64(5) 0.18 64 9.62(5) 0.08 
Waist-hip ratio 136 1.75(5) 0.88 64 3.03(5) 0.69 
Flexibility (cm) 1265 8.38(6) 0.21 287 15.74(5) 0.01 
Resting systolic BP (mmHg) 430 13.62(6) 0.03 171 2.11(5) 0.83 
Resting diastolic BP (mmHg) 430 7.26(6) 0.29 171 5.84(5) 0.32 
After-exercise systolic BP (mmHg) 395 13.41(6) 0.02 168 5.65(5) 0.34 
After-exercise diastolic BP (mmHg) 395 9.45(5) 0.09 168 1.17(5) 0.95 
Resting HR (bpm) 226 12.98(6) 0.04 89 5.10(5) 0.4 
After-exercise HR (bpm) 226 25.50(6) <0.001 90 14.13(5) 0.02 
Total distance in 6MW (m) 220 26.14(6) <0.001 89 6.43(5) 0.26 
 n: number of individuals, SD: standard deviation, BMI: body max index, BP: blood pressure, HR: heart rate, 6MW: six-minute walk test, 
mmHg: millimeter of mercury, bpm: beats per minute,p: significance value, H(x):Kruskal-Wallis test (degrees of freedom) 
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Significant differences were also found in BMI categories between different age groups (X2(18) 
=264.22, p<0.001) where the 61-70 age group had more overweight and obese participants than the 
rest of the groups (Figure 25). There were no significant differences among age groups in waist 
circumference categories but as can be seen in Figure 26, all age groups had a high percentage (84-
91%) of individuals with increased and substantially increased waist circumference that could lead to 
metabolic complications. 
 
Figure 25. BMI categories in total sample and different age groups. Values are shown in percentages (%). 
 
 
Figure 26. Waist circumference categories in total sample and different age groups. Values are shown in percentages 
(%). 
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Table 13. Differences in physical measures between age groups in women and men. Pairwise comparisons. Values are 
shown in mean values and standard deviation (SD). 
 
 
 
Women 
 
Men 
 
Age 
group n Mean SD sig n Mean SD sig 
Height (cm) 21-301 29 162.53 6.40  14 178.43 8.53 *4,5,6 
 
31-402 145 162.66 6.54  46 177.91 5.93 *4,5,6 
 
41-503 373 159.98 6.77 *6 98 174.28 7.31 *4,5,6 
 
51-604 654 156.47 6.12 *6 156 169.98 6.64  
 
61-705 486 154.95 6.07  164 168.29 6.23  
 
71-806 209 153.57 6.38  52 166.54 6.13  
  81-907 12 153.92 5.62  3 167.67 5.51  
Weight (kg) 21-301 31 63.75 11.93  14 74.93 10.77  
 
31-402 155 65.58 12.24 *4,5 49 82.07 10.69  
 
41-503 396 66.87 12.45 *4,5 112 80.04 13.82  
 
51-604 664 69.76 13.00  167 80.33 11.06  
 
61-705 489 69.21 11.16  170 79.29 11.61  
 
71-806 218 66.47 10.25  57 78.20 10.14  
 
81-907 12 63.91 7.36  4 82.20 17.82  
BMI (kg/m2) 21-301 29 24.05 5.26 *4,5,6 14 23.54 2.93 *4,5,6 
 
31-402 142 24.71 4.65 *4,5,6 44 25.84 3.12 *4,5,6 
 
41-503 363 26.00 4.89 *4,5,6 97 26.27 4.77 *4,5,6 
 
51-604 620 28.46 5.26  153 27.73 3.52  
 
61-705 458 28.81 4.42  158 28.10 3.53  
 
71-806 203 28.05 4.04  51 28.23 3.05  
 
81-907 12 27.00 2.99  3 30.27 7.87  
Waist circumference (cm) 21-301 2 97.50 13.43  0    
 
31-402 2 104.00 0.00  1 116.00   
 
41-503 14 94.50 11.87  2 124.00 0.00  
 
51-604 44 98.02 12.36  21 104.48 10.75  
 
61-705 54 96.24 11.37  26 103.11 10.56  
 
71-806 31 91 11.74  13 103.00 8.68  
 
81-907 0    1 126.00   
Waist-hip ratio 21-301 2 0.89 0.00  0    
 
31-402 2 0.85 0.06  1 1.07   
 
41-503 13 0.88 0.06  2 1.00 0.03  
 
51-604 40 0.88 0.06  21 0.99 0.08  
 
61-705 51 0.89 0.06  26 1.00 0.05  
 
71-806 28 0.88 0.05  13 0.99 0.06  
 
81-907 0    1 0.97   
Flexibility (cm) 21-301 20 11.73 6.37  8 14.13 8.46 *6(MW) 
 
31-402 105 13.49 8.15  32 10.73 7.89 *6(MW) 
 
41-503 280 12.52 9.86  66 10.54 9.23 *5,6(MW) 
 
51-604 433 12.70 9.17  87 8.57 8.36 *6(MW) 
 
61-705 307 11.50 9.46  70 6.40 10.49  
 
71-806 114 10.51 8.80  24 3.94 9.13  
 
81-907 6 7.25 11.77  0    
Resting systolic BP 21-301 2 125.00 21.21  1 150.00   
(mmHg) 31-402 1 150.00   0    
 
41-503 25 144.60 20.16 *6(MW) 8 149.88 13.84  
 
51-604 139 143.73 15.25 *6(MW) 41 145.44 14.15  
 
61-705 167 147.38 13.98 *6(MW) 82 146.50 15.56  
 
71-806 90 148.47 12.94  36 148.69 12.55  
 
81-907 6 148.67 9.63  3 151.67 26.50  
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Women 
 
Men 
 
Age 
group n Mean SD sig n Mean SD sig 
Resting diastolic BP    21-301 2 72.50 10.61  1 90.00 -  
(mmHg) 31-402 1 90.00 -  0 - -  
 
41-503 25 86.80 8.93  8 87.25 9.48  
 
51-604 139 84.81 7.80  41 86.12 6.52  
 
61-705 167 83.90 7.46  82 85.30 8.05  
 
71-806 90 83.50 7.46  36 83.25 6.90  
 
81-907 6 86.00 5.48  3 83.67 2.31  
After-exercise systolic BP  21-301 2 110.00 14.14  1 140.00 -  
(mmHg) 31-402 0 - -  0 - -  
 
41-503 22 144.32 25.38  7 143.86 16.90  
 
51-604 125 142.22 16.29 *6(MW) 39 143.15 12.76  
 
61-705 152 145.02 15.16 *6(MW) 83 145.67 17.24  
 
71-806 88 147.17 15.07  35 151.00 15.22  
 
81-907 6 146.00 7.87  3 154.33 26.16  
After-exercise diastolic BP  21-301 2 70.00 14.14  1 85.00 -  
(mmHg) 31-402 0 - -  0 - -  
 
41-503 22 85.50 10.82  7 83.29 9.86  
 
51-604 125 84.81 12.03  39 83.95 6.40  
 
61-705 152 82.41 7.41  83 84.14 7.80  
 
71-806 88 81.67 7.12  35 83.94 6.45  
 
81-907 6 83.00 8.25  3 82.33 3.21  
Resting HR  21-301 4 85.00 8.83  0 - -  
(bpm) 31-402 7 86.43 15.61  1 89.00 -  
 
41-503 23 84.17 12.21 *4,5,6(MW) 3 75.00 11.53  
 
51-604 69 77.06 11.56  26 71.58 14.20  
 
61-705 73 77.05 11.50  37 72.49 16.54  
 
71-806 49 74.33 10.46  21 68.95 11.49  
 
81-907 1 80.00 -  1 100.00 -  
After-exercise HR 21-301 4 114.25 16.92  0    
(bpm) 31-402 7 114.71 21.57  1 132.00   
 
41-503 23 111.00 16.59 *4,5,6 3 102.33 9.81  
 
51-604 69 97.74 15.74  27 96.33 17.56  
 
61-705 73 97.21 15.48  37 93.14 17.12 *6(MW) 
 
71-806 49 94.55 16.47  21 82.86 17.71  
 
81-907 1 120.00   1 130.00   
Total distance in 6MW 21-301 4 517.00 46.02  0    
 (m) 31-402 7 491.71 108.62  1 582.00   
 
41-503 23 499.13 52.20 *6 3 511.67 27.54  
 
51-604 66 475.53 52.01 *6 27 505.89 83.83  
 
61-705 70 458.53 58.34  36 495.44 60.79  
 
71-806 49 437.80 60.70  21 462.48 72.43  
  81-907 1 420.00   1 456.00   
 n: number of individuals, SD: standard deviation, BMI: body max index, BP: blood pressure, HR: heart rate, 6MW: six-minute walk test, mmHg: millimeter 
of mercury, bpm: beats per minute, sig*: significant differences (p≤0.05), (MW): Mann-Whitney Test. Subscripts below age decades show the groups 
used for comparisons in the Mann-Whitney Test 
    
  
RESULTS 
 
76 
 
Follow-up tests (Table 13) showed that in height, in both women and men, a significant decreasing 
trend could be observed as age increased. Only among women, a significant (p<0.001) increase in 
weight occurred until the 61-70 age group where it started to drop. In both women and men, BMI 
was significantly (p<0.001) higher in the older age groups (51-60, 61-70 and 71-80) if compared to 
the younger groups (21-30, 31-40 and 41-50). Only among men, flexibility significantly (p=0.01) 
decreased as age increased. A similar trend was observed among women but was not statistically 
significant. Resting and after-exercise systolic blood pressure in women was the highest in the 71-80 
age group if compared to the younger groups. Resting heart rate in women showed a significant 
(p=0.04) decreasing trend as age increased. In men the same trend was observed but it was 
statistically no significant. Similarly, after-exercise heart rate in women and men was significantly 
(p<0.001)   lower in the older groups if compared to the younger groups. Total distance in the 6MW 
in women was significantly (p<0.001) lower in the 71-80 group if compared to the younger groups 
(41-50, 51-60). In both women and men, a decreasing trend of total distance could be observed as 
age increased even though it was not statistically significant among men (Table 13). 
 
4.3.2.3. Baseline physical measures by diagnosis 
When analyzing baseline physical measures among diagnosis groups in women and men, significant 
differences (p<0.05) in height, weight, BMI and flexibility were found in both men and women. Only 
among different diagnose groups in women, significant differences (p<0.05) were also found in waist 
circumference, resting and after-exercise systolic blood pressure, in resting and after-exercise heart 
rate and in total distance (Table 14). 
BMI categories also showed significant differences in women (X2(9) =372.9, p<0.001) and men (X2(9) 
=47.72(9), p<0.001) among diagnosis groups (Figure 27). Women on the diabetes, hypertension and 
obesity group and men on the hypertension group had more obese individuals than the other 
groups. No significant differences among diagnose groups were found in waist circumference 
categories but as can be seen in Figure 28, a high percentage of individuals in every group (80-100%) 
had an increased or substantially increased waist circumference.  
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Figure 27. BMI categories in different diagnose groups in total sample, women and men. Values are shown in 
percentages (%). 
 
 
Figure 28. Waist circumference categories in different diagnose groups in total sample, women and men. Values are 
shown in percentages (%). 
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Table 14. Differences in physical measures among different diagnose groups in women and men (Kruskal-Wallis test and pairwise comparisons). Values are shown in mean 
values and standard deviation (SD). 
 
 
   
Women 
     
Men 
   
                
 
 MSD1 D2 HYT3 O4 p Pairwise H(x) MSD1 D2 HYT3 O4 p Pairwise H(x) 
Height n 1372 77 354 105 
<0.001 
1-2*, 1-3*  340 38 141 14 
<0.001 
  
(cm) Mean 157.54 154.18 155.46 157.18 2-4* 1908(3) 172.33 165.97 168.50 170.29 1-2*, 1-3* 49.22(3) 
  SD 7.04 5.96 5.93 6.35   7.42 6.62 6.56 6.69   
Weight n 1411 81 365 108 
<0.001 
1-2*,1-3*  373 41 144 15 
<0.001 
1-3*, 1-4*  
(kg) Mean 65.21 73.26 73.81 84.78 1-4*, 2-4* 315(3) 78.34 80.38 82.36 89.34 2-4*, 3-4* 22.67(3) 
  SD 10.17 12.56 12.37 13.76 3-4*  10.59 13.51 13.35 9.52   
BMI n 1313 73 338 103 
<0.001 
1-2*,1-3*  334 35 137 14 
<0.001 
1-2*, 1-3*  
 Mean 26.22 31.02 30.45 34.20 1-4*, 2-4* 378.2(3) 26.41 28.83 28.96 30.78 1-4* 61.96(3) 
  SD 4.10 5.11 4.96 5.26 3-4*  3.43 4.77 3.80 3.64   
Waist circumference (cm) n 5 17 95 30 
0.004 
  2 10 49 3 
0.18 
  
 Mean 104.60 98.70 93.34 99.63 3-4* 13.29(3) 103.50 108.70 103.38 114.66 . 4.81(3) 
 SD 7.98 14.13 11.83 9.32   12.02 12.14 10.33 12.05   
Waist-hip ratio n 5 15 87 29 
0.06 
  2 10 49 3 
0.71 
  
 Mean 0.87 0.92 0.88 0.88 . 7.25(3) 1.03 1.01 0.99 1.01 . 1.35(3) 
  SD 0.07 0.06 0.06 0.05   0.05 0.06 0.07 0.06   
Flexibility n 1070 18 127 50 
0.002 
  239 4 40 4 
0.006 
1-3* (MW)  
(cm) Mean 12.52 12.22 9.56 11.87 1-3* 14.8(3) 9.00 14.25 4.18 16.38 3-4*(MW) 12.47(3) 
  SD 9.33 6.73 9.20 8.30   9.03 4.99 10.46 3.77   
Resting systolic BP n 48 37 332 13 
0.03 
1-3* (MW)  18 15 135 3 
0.83 
  
(mmHg) Mean 141.40 141.95 147.48 142.85 2-3* (MW) 8.76(3) 147.94 148.27 146.73 145.67 . 0.84(3) 
  SD 14.40 13.35 14.80 11.33   14.48 17.91 13.94 32.35   
Resting diastolic BP n 48 37 332 13 
0.08 
  18 15 135 3 
0.43 
  
(mmHg) Mean 83.77 81.65 84.75 81.23 . 6.68(3) 85.89 85.20 85.21 78.33 . 2.75(3) 
  SD 8.43 7.15 7.58 7.74   3.85 8.32 7.73 7.64   
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Women 
     
Men 
   
                
 
 MSD1 D2 HYT3 O4 p Pairwise H(x) MSD1 D2 HYT3 O4 p Pairwise H(x) 
After-exercise systolic BP n 42 34 308 11 
0.04 
1-3* (MW)  18 17 130 3 
0.43 
  
(mmHg) Mean 138.83 140.09 145.79 140.45 2-3* (MW) 8.2(3) 148.94 148.12 145.39 156.33 . 2.77(3) 
  SD 14.98 14.49 16.66 10.54   14.10 19.04 15.80 22.50   
After-exercise diastolic BP n 42 34 308 11 
0.08 
  18 17 130 3 
0.53 
  
(mmHg) Mean 81.86 82.38 83.44 81.18 . 6.64(3) 85.89 84.47 83.78 79.00 . 2.19(3) 
  SD 9.11 19.88 7.52 8.78   7.52 4.68 7.38 7.21   
Resting HR n 30 22 133 41 
0.003 
  5 9 71 4 
0.58 
  
(bpm) Mean 80.77 85.41 75.52 78.02 2-3* 14.14(3) 66.00 73.22 71.80 79.50 . 1.96(3) 
  SD 9.41 14.23 10.77 13.06   13.21 16.76 14.51 18.27   
After-exercise HR n 30 22 133 41    5 10 71 4 0.19   
(bpm) Mean 98.53 107.05 96.32 104.49 0.002 2-3* 14.33(3) 82.20 102.80 91.23 110.00  . 5.65(3) 
  SD 19.31 18.40 15.36 17.22    19.27 22.79 16.81 24.28    
Total distance in 6MW n 28 22 132 38 
0.04 
  5 10 70 4 
0.42 
  
(m) Mean 482.43 453.00 458.14 484.11 3-4*(MW) 8.06(3) 527.60 502.50 485.84 527.00 . 2.77(3) 
  SD 63.86 72.23 56.57 62.62   68.85 53.87 74.57 55.53   
MSD: musculoskeletal  disorders, D: diabetes, HYT: Hypertension, O: Obesity, n: number of individuals, SD: standard deviation, BMI: body max index, BP: blood pressure, HR: heart rate, 6MW: six-minute walk test, mmHg: 
millimeter of mercury, bpm: beats per minute, p: significance value, *significant differences H(x)= Kruskal-Walllis test (degrees of freedom), (MW): Mann-Whitney Test 
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In women, pairwise comparisons (Table 14) showed that weight and BMI were significantly (p<0.001) 
different among all the diagnose groups except between the diabetes (73.26±12.56 kg and 31.02±5.11 
kg/m2) and the hypertension group (73.81±12.37 kg and 30.45±4.96 kg/m2). The MSD group had the 
lowest weight and BMI (65.21±10.17 kg and 26.22±4.10 kg/m2) and the obesity group had the highest 
(84.78±13.76 kg and 34.20±5.26 kg/m2, respectively). Obese women also had significantly (p=0.004) 
greater waist circumference (99.63±9.32 cm) than the women in the hypertension group (93.34±11.83 
cm). Even though there were no significant differences in WHR among diagnose groups (p=0.06), it could 
be observed that the diabetes group had a higher index (0.92) than the rest of the groups (0.88). The 
MSD group was found to be significantly more flexible than the hypertension group (12.52±9.33 vs. 
9.56±9.19 cm, p=0.002).  
Regarding blood pressure, the MSD and the diabetes group had significantly lower resting systolic blood 
pressure than the hypertension group (141.4±14.4 and 141.95±13.35 mmHg vs. 147.48±14.80 mmHg, 
p=0.03) and also lower after-exercise systolic blood pressure (138.83±14.98 and 140.09±14.49 mmHg vs. 
145.79±16.66 mmHg, p=0.04).The diabetes group had significantly higher resting and after-exercise 
heart rate than the hypertension group (85.41±14.22 vs.75.52±10.77 bpm and 107.05±18.40 vs. 
96.32±15.36 bpm, respectively, p=0.003). Total distance in the obesity group was also found to be 
significantly higher than in the hypertension group (484.11±62.62 vs. 458.14±56.57 m, p=0.04). 
Among men, the MSD group had significantly (p<0.001) lower weight (78.34±10.59 kg) than the 
hypertension (82.36±13.35 kg) and the obesity group (89.34±9.52 kg). The obesity group had 
significantly (p<0.001) higher weight than the rest of the groups. The MSD group also had significantly 
(p<0.001) lower BMI (26.41±3.43 kg/m2) than the rest of the groups. The hypertension group had 
significantly (p=0.006) lower flexibility than the MSD and the obesity group (4.18±10.46 vs. 9±9.03 and 
16.38±3.77 cm). 
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4.3.2.3.1. Hypertension group characteristics 
In the hypertension group 65.2% of the participants were under hypertensive medication.  The most 
used medication types were angiotensin-converting enzyme inhibitors (ACEI) (23%) and diuretics (15%) 
(Figure 29). 
There were no significant differences between the medication group and the non-medication group in 
baseline physical measures except in resting and after-exercise diastolic blood pressure. Patients under 
medication had significantly (p<0.001) lower diastolic blood pressure than those taking no medication 
(Table 15). 
Significant differences (p=0.01) were also found among different medication groups in after exercise 
diastolic blood pressure and resting and after exercise heart rate (Table 16). Follow-up tests showed 
that the ACEI group had significantly (p=0.01) higher after exercise diastolic blood pressure than the 
Beta-blockers and the Calcium-blocker groups. Patients using beta-blockers had the lowest after 
exercise diastolic blood pressure (79.96±5.82 mmHg). Similar results were found in resting heart rate 
where Beta-blockers users had the lowest resting heart rate and the ACEI users the highest. Regarding 
after exercise HR, both Beta-blocker users and Calcium-blocker users had lower measures than the rest 
of the groups. 
 
Figure 29. Medication type use in the medicated patients in the hypertension group. Values are shown in percentages (%). 
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Table 15. Differences in blood pressure between medicated and non-medicated patients in the hypertension group (Mann-
Whitney Test). 
 
 
 
 
 
Table 16. Differences in physical measures among medication type groups (Kruskal-Wallis Test) and paiwise comparison 
between groups (Mann-Whitney Test). 
 
ACEI1 Diuretics2 ARB3 Beta-B4 Ca blockers5 
    n Mean±SD n Mean±SD n Mean±SD n Mean±SD n Mean±SD p Paiwise (MW) 
AE diast. BP  70 84.96±7.66 44 81.77±5.73 38 82.18±6.51 26 79.96±5.82 14 81.57±5.72 0.01 1-2*, 1-4* 
Rest.HR  40 79.25±12.46 21 76.71±8.61 25 74.56±9.88 10 63.20±13.54 5 66.20±8.04 0.01 
 
1-4*, 1-5*, 2-4*, 
2-5*,3-4* 
AE HR 40 97.95±13.97 21 97.71±13.26 25 97.95±13.97 10 83.10±12.76 5 78.40±14-18 0.01 1-4*, 1-5*, 2-4*, 2-5*, 3-4* 
n: number of individuals, SD: standard deviation, ACEI:angiotensin-converting enzyme inhibitor, ARB: angiotensin receptor blocker, Beta-B: beta blocker, Ca: 
calcium, AE: after-exercise, Rest: resting, diast: diastolic, BP: blood pressure, HR: heart rate, ,p: significance value,  (MW): Mann-Whitney Test 
 
Medicated Non-medicated  
 
n Mean SD n Mean SD p 
Resting systolic BP (mmHg) 314 146.82 13.639 153 148.19 16.261 0.55 
Resting diastolic BP (mmHg) 314 84.11 7.679 153 86.48 7.251 <0.001 
After-exercise systolic BP (mmHg) 313 144.87 14.956 125 147.68 19.456 0.22 
After-exercise diastolic BP (mmHg) 313 82.86 7.110 125 85.27 8.087 <0.001 
n: number of individuals, SD: standard deviation, BP: blood pressure, mmHg: millimeter of mercury, p: significance value 
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4.4. Changes in physical measures 
4.4.1. Changes in physical measures in the total sample 
All physical measures showed significant (p<0.05) changes along the program except resting and 
after-exercise heart rate (Table 17). 
Table 17. Changes in physical measures along the program in the total sample (Friedman´s ANOVA). Values are shown in 
mean values ± standard deviation. 
 
n Baseline 3 month 6 month 9 month X2F p 
Weight (kg) 583 71.30±13.11 70.79±12.96 70.76±12.89 70.69±13.08 47.27 <0.001 
BMI (kg/m2) 562 28.27±4.86 28.08±4.79 28.06±4.79 28.03±4.87 46.49 <0.001 
Waist circumference (cm) 57 99.61±12.28 98.98±12.33 98.98±12.06 98.54±11.99 11.62 0.01 
Waist-hip ratio 54 0.92±0.07 0.91±0.07 0.91±0.07 0.91±0.07 9.40 0.02 
Flexibility (cm) 200 13.64±9.43 15.92±9.70 16.66±7.88 17.36±7.98 131.87 <0.001 
Resting systolic BP (mmHg) 115 147.66±14.01 144.76±12.74 144.88±13.57 142.35±14.51 10.06 0.02 
Resting diastolic BP (mmHg) 115 85.46±6.34 83.25±6.71 82.97±7.13 81.87±8.57 23.64 <0.001 
After-exercise systolic BP (mmHg) 103 146.58±16.82 144.17±14.21 142.95±13.13 141.03±12.75 8.28 0.04 
After-exercise diastolic BP (mmHg) 103 84.06±7.26 81.75±6.64 81.50±6.55 80.61±7.18 17.49 <0.001 
Resting HR (bpm) 87 75.01±12.53 75.44±13.13 76.05±12.68 74.22±15.21 5.85 0.11 
After-exercise HR (bpm) 87 98.55±17.83 96.05±16.01 98.10±17.36 97.01±16.56 1.60 0.65 
Total distance in 6MW (m) 86 479.32±59.63 494.19±53.02 495.50±57.31 502.22±61.27 28.43 <0.001 
n: number of individuals, BMI: body max index, BP: blood pressure, HR: heart rate, 6MW: six-minute walk test, mmHg: millimeter of mercury, bpm: beats per 
minute, X2F: Friedman´s ANOVA, p: significance value 
 
To follow-up these findings measurements at baseline were compared with measurements at three, 
six and nine months (Table 18). Results showed significant (p<0.05) changes in all physical measures 
between baseline and the three month measurement except in WHR and resting heart rate. Changes 
between baseline and six months were also significant (p<0.05) in all the physical measures except in 
waist circumference and resting and after-exercise heart rate. Similarly, changes after nine months 
showed significant (p<0.05) changes in all physical measures except in waist circumference and 
resting and after-exercise heart rate. 
At nine months, results showed very small effect sizes in weight (d=0.03), BMI (d=0.03) and WHR 
(d=0.14). Effect sizes for these variables at three months and at six months were also very small 
(Table 18).  
Flexibility significantly (p<0.001) improved after nine months, from 13.04±10.00 to 16.62±8.50 cm, 
with a small- medium effect size (d=-0.38). Significant (p<0.001)  changes also occurred at three 
months and at six months, however, effect sizes were lower in the first measurement (d=0.23) if 
compared to the six and the nine month measurements (d=-0.36 and d=-0.38 respectively). 
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Table 18. Changes in physical measures between baseline and 3, 6 and 9 months (Wilcoxon´s signed rank test). Values 
are shown in mean values ± standard deviation. 
  n Baseline 3 month p d 
Weight (kg) 1796 70.71±12.75 70.32±12.69 <0.001 0.03 
BMI (kg/m2) 1718 27.67±4.67 27.52±4.63 <0.001 0.03 
Waist circumference (cm) 159 97.97±12.22 97.65±12.17 0.02 0.03 
Waist-hip ratio 152 0.91±0.07 0.91±0.08 0.13 0.00 
Flexibility (cm) 999 11.45±9.59 13.73±9.75 <0.001 -0.23 
Resting systolic BP (mmHg) 418 146.88±15.16 143.56±15.91 <0.001 0.21 
Resting diastolic BP (mmHg) 416 84.74±7.53 82.87±7.85 <0.001 0.24 
After-exercise systolic BP (mmHg) 385 145.19±16.69 143.09±15.54 <0.001 0.13 
After-exercise diastolic BP (mmHg) 385 83.36±7.55 81.4±7.60 <0.001 0.26 
Resting HR (bpm) 250 75.92±12.74 75.76±12.77 0.73 0.01 
After-exercise HR (bpm) 250 97.36±16.80 95.12±15.82 0.005 0.14 
Total distance in 6MW (m) 242 476.31±62.04 492.59±57.53 <0.001 -0.27 
 n Baseline 6 month p d 
Weight (kg) 1456 71.01±12.73 70.61±12.63 <0.001 0.03 
BMI (kg/m2) 1378 27.97±4.65 27.80±4.59 <0.001 0.03 
Waist circumference (cm) 95 99.38±11.47 99.10±11.85 0.25 0.02 
Waist-hip ratio 87 0.92±0.07 0.91±0.07 0.04 0.14 
Flexibility (cm) 671 11.49±9.56 14.78±8.64 <0.001 -0.36 
Resting systolic BP (mmHg) 286 146.40±14.47 142.53±13.31 <0.001 0.28 
Resting diastolic BP (mmHg) 286 85.40±6.91 82.52±7.54 <0.001 0.40 
After-exercise systolic BP (mmHg) 263 145.33±16.77 140.82±12.95 <0.001 0.30 
After-exercise diastolic BP (mmHg) 263 83.92±7.45 81.29±7.18 <0.001 0.36 
Resting HR (bpm) 146 76.58±13.66 76.48±13.40 0.96 0.01 
After-exercise HR (bpm) 146 98.59±17.25 97.67±17.30 0.27 0.05 
Total distance in 6MW (m) 143 473.96±63.08 490.75±61.97 <0.001 -0.27 
 
n Baseline 9 month p d 
Weight (kg) 915 70.87±13.00 70.42±12.91 <0.001 0.03 
BMI (kg/m2) 867 28.02±4.84 27.84±4.79 <0.001 0.03 
Waist circumference (cm) 83 99.16±11.85 98.43±11.39 0.17 0.06 
Waist-hip ratio 76 0.92±0.07 0.91±0.07 0.02 0.00 
Flexibility (cm) 353 13.04±10.00 16.62±8.50 <0.001 -0.38 
Resting systolic BP (mmHg) 202 148.08±13.53 143.18±14.15 <0.001 0.35 
Resting diastolic BP (mmHg) 202 85.21±6.78 82.45±6.60 <0.001 0.41 
After-exercise systolic BP (mmHg) 184 146.37±15.34 141.53±12.89 <0.001 0.34 
After-exercise diastolic BP (mmHg) 184 84.14±10.48 80.74±7.65 <0.001 0.37 
Resting HR  (bpm) 118 75.80±12.35 75.05±13.97 0.44 0.05 
After-exercise HR (bpm) 118 98.93±17.11 97.29±15.25 0.38 0.10 
Total distance in 6MW (m) 114 474.09±60.41 497.28±58.40 <0.001 -0.39 
n: number of individuals, BMI: body max index, BP: blood pressure, HR: heart rate, 6MW: six-minute walk test, mmHg: millimeter 
of mercury, bpm: beats per minute, p: significance value, d: effect size (Cohen´s d) 
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Similarly, resting systolic and diastolic blood pressure and after-exercise systolic and diastolic blood 
pressure significantly (p <0.001)  decreased at all follow-ups but the largest effect sizes occurred at 
the nine months follow-up where resting systolic blood pressure decreased from 148.08±13.53 to 
143.18±14.15 mmHg (d=0.35), resting diastolic BP decreased from 85.21±6.78 to 82.45±6.60 mmHg 
(d=0.41), after-exercise systolic decreased from 146.37±15.34 to 141.53±12.89 mmHg (d=0.34) and 
after-exercise diastolic decreased from 84.14±10.48 to 80.74±7.65 mmHg (d=0.37)(see Figure 30). 
 
Figure 30. Mean changes in blood pressure measures along the program in the total sample (Friedman´s ANOVA). 
Standard deviations are shown in Table 17. 
 
Results in total distance in the 6MW also showed the greatest improvements (d=-0.39) in the last 
follow-up (from 474.09±60.41 to 497.28±58.40 m) even though changes were already occurring at 
the first and second measurement points (d=-0.27). 
 
4.4.2. Changes in physical measures by groups 
4.4.2.1. Changes in physical measures by gender 
Changes in physical measures along the program in women and men can be observed in Table 19 
and Figures 31-34. In women, all physical measures significantly (p<0.05) changed over the nine 
months except resting and after-exercise heart rate. In men, weight, BMI, flexibility, resting diastolic 
blood pressure and after-exercise systolic and diastolic blood pressure showed significant (p<0.05) 
changes along the program. 
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Followed-up tests can be seen in Tables 20-21. In women, results showed significant (p<0.003) 
changes at three months in all physical measures except in waist circumference, WHR and resting 
heart rate. However, only flexibility (d=-0.24), resting diastolic blood pressure (d=0.23), after-
exercise diastolic blood pressure (d=0.29) and total distance in the 6MW (d=-0.24) showed effect 
sizes greater than 0.20. At six months, all physical measures showed significant (p≤0.03) changes 
except waist circumference and resting and after-exercise heart rate. Flexibility and resting and 
after-exercise diastolic blood pressure increased their effect sizes if compared to the previous 
follow-up (Table 20). Moreover, WHR (d=0.20), resting systolic blood pressure (d=0.32) and after 
exercise systolic blood pressure (d=0.32) reached effect sizes greater than 0.20. At nine months, 
effect sizes continued increasing except in resting and after-exercise diastolic blood pressure. WHR 
decreased from 0.89±0.05 to 0.88±0.04 (d=0.22), flexibility improved from 13.97±9.75 to 17.56±7.87 
cm (d=-0.40), resting systolic blood pressure decreased from 148.33±13.75 to 142.80±14.35 mmHg 
(d=0.39), resting diastolic blood pressure decreased from 85.06±7.04 to 82.42±8.73 mmHg (d=0.33), 
after-exercise systolic blood pressure decreased from 146.19±16.33 to 140.72±12.31 mmHg 
(d=0.39), after exercise diastolic blood pressure decreased from 84.05±12.05 to 80.67±7.47 mmHg 
(d=0.33) and total distance increased from 467.93±60.82 to 491.64±55.35 m (d=-0.41). 
In men, after three months, weight, BMI, flexibility, resting systolic and diastolic blood pressure, 
after-exercise systolic  and diastolic blood pressure and total distance significantly (p≤0.01) changed 
but  effect sizes in weight and in BMI were small (d=0.03)(Table 15). At six months, the previous 
same variables maintained their significant changes except resting systolic blood pressure and after 
exercise diastolic blood pressure. The effect sizes in these variables increased from the first 
measurement except in total distance where the effect size decreased (d=-0.31). At nine months, 
only flexibility, resting and after-exercise diastolic blood pressure and total distance showed 
significant (p≤0.01) changes although after-exercise systolic blood pressure showed a trend towards 
significance (p=0.07). These variables reached their highest effect sizes if compared to the previous 
follow-ups. Flexibility improved from 7.87±9.87 to 11.37±9.96 cm (d=-0.35), resting systolic blood 
pressure decreased from 147.5±13.08 to 144.1±13.75 mmHg (d=0.25) even though it did not reach 
statistical significance (p=0.11), resting diastolic blood pressure decreased from 85.55±6.19 to 
82.51±8.32 mmHg (d=0.41), after-exercise systolic blood pressure decreased from 146.75±13.17 to 
143.18±13.98 mmHg (d=0.26, p=0.07), after-exercise diastolic blood pressure decreased from 
84.35±6.17 to 80.88±8.07 mmHg (d=0.48) and total distance increased from 491.36±60.82 to 
513.06±64.58 m (d=-0.36) (Table 21). 
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Table 19. Changes in physical measures along the program in women and men (Friedman´s ANOVA). Values are shown in 
mean values ± standard deviation. 
Women n Baseline 3 month 6 month 9 month X2F p 
Weight (kg) 463 68.89±12.55 68.38±12.38 68.40±12.36 68.30±12.52 37.21 <0.001 
BMI (kg/m2) 445 28.30±5.11 28.10±5.03 28.10±5.03 28.06±5.11 35.88 <0.001 
Waist circumference (cm) 44 97.20±11.59 96.45±11.56 96.50±11.14 95.86±10.76 12.61 0.01 
Waist-hip ratio 41 0.89±0.04 0.88±0.04 0.88±0.04 0.88±0.04 8.53 0.03 
Flexibility (cm) 170 14.18±9.33 16.39±9.58 17.35±7.65 17.95±7.97 114.75 <0.001 
Resting systolic BP (mmHg) 76 147.84±14.20 146.04±13.29 144.17±13.94 141.24±14.39 9.37 0.02 
Resting diastolic BP (mmHg) 76 85.00±6.66 83.17±6.62 82.28±7.56 81.57±8.82 14.94 0.002 
After-exercise systolic BP (mmHg) 66 145.65±17.97 145.45±13.06 141.56±12.88 140.00±11.64 12.26 0.01 
After-exercise diastolic BP (mmHg) 66 83.21±7.83 81.85±6.59 80.61±6.33 80.45±6.14 10.06 0.02 
Resting HR (bpm) 61 77.64±11.85 78.23±12.47 78.69±12.63 77.82±15.57 2.22 0.52 
After-exercise HR (bpm) 61 102.61±17.26 100.26±15.19 102.92±16.35 100.26±16.37 2.87 0.41 
Total distance in 6MW (m) 60 473.45±59.1 486.95±49.8 489.70±50.9 497.28±58.1 21.46 <0.001 
Men n Baseline 3 month 6 month 9 month X2F p 
Weight (kg) 120 80.59±10.92 80.07±10.80 79.87±10.68 79.90±10.93 10.98 0.01 
BMI (kg/m2) 117 28.18±3.78 27.99±3.73 27.93±3.73 27.94±3.83 11.31 0.01 
Waist circumference (cm) 13 107.77±11.36 107.54±11.31 107.38±11.62 107.61±11.86 1.72 0.63 
Waist-hip ratio 13 1.02±0.04 1.02±0.05 1.02±0.04 1.02±0.04 1.27 0.73 
Flexibility (cm) 30 10.60±9.55 13.24±10.13 12.72±8.10 14.00±7.28 17.32 <0.001 
Resting systolic BP (mmHg) 39 147.31±13.82 142.26±11.33 146.26±12.88 144.51±14.70 3.94 0.27 
Resting diastolic BP (mmHg) 39 86.36±5.63 83.41±6.96 84.31±6.07 82.46±8.12 10.75 0.01 
After- exercise systolic BP (mmHg) 37 148.24±14.63 141.89±15.99 145.43±13.39 142.86±14.49 11.09 0.01 
After-exercise diastolic BP (mmHg) 37 85.57±5.91 81.57±6.81 83.11±6.71 80.89±8.83 13.41 0.004 
Resting HR (bpm) 26 68.85±12.12 68.88±12.50 69.85±10.63 65.77±10.37 4.74 0.19 
After-exercise HR (bpm) 26 89.04±15.64 86.15±13.52 86.81±14.35 89.38±14.62 0.66 0.88 
Total distance in 6MW (m) 26 492.88±59.5 510.92±57.2 508.88±69.1 513.61±67.7 7.24 0.06 
n: number of individuals, BMI: body max index, BP: blood pressure, HR: heart rate, 6MW: six-minute walk test, mmHg: millimeter of mercury, bpm: beats per 
minute, X2F: Friedman´s ANOVA, p: significance value 
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Table 20. Changes in physical measures between baseline and 3, 6 and 9 months in women (Wilcoxon´s signed rank 
test). Values are shown in mean values ± standard deviation. 
 
n Baseline 3 month p d 
Weight (kg) 1390 68.12±11.86 67.71±11.74 <0.001 0.03 
BMI (kg/m2) 1331 27.74±4.92 27.58±4.86 <0.001 0.03 
Waist circumference (cm) 113 95.28±11.81 94.97±11.64 0.07 0.03 
Waist-hip ratio 107 0.88±0.05 0.87±0.06 0.11 0.18 
Flexibility (cm) 812 12.13±9.46 14.44±9.50 <0.001 -0.24 
Resting systolic BP (mmHg) 290 146.58±15.30 143.42±17.02 <0.001 0.19 
Resting diastolic BP (mmHg) 288 84.35±7.61 82.55±7.95 <0.001 0.23 
After-exercise systolic BP (mmHg) 262 144.76±16.80 142.49±15.52 0.003 0.14 
After-exercise diastolic BP (mmHg) 262 82.96±7.59 80.79±7.47 <0.001 0.29 
Resting HR (bpm) 174 77.86±11.26 77.82±12.08 0.82 0.03 
After-exercise HR (bpm) 174 100.35±15.75 97.37±15.20 0.002 0.19 
Total distance in 6MW (m) 168 469.16±58.02 482.38±53.48 <0.001 -0.24 
 n Baseline 6 month p d 
Weight (kg) 1145 68.69±12.07 68.26±11.91 <0.001 0.03 
BMI (kg/m2) 1084 28.07±4.89 27.88±4.82 <0.001 0.03 
Waist circumference (cm) 72 97.33±10.95 96.98±10.50 0.24 0.03 
Waist-hip ratio 64 0.89±0.05 0.88±0.05 0.03 0.20 
Flexibility (cm) 569 11.91±9.66 15.24±8.60 <0.001 -0.36 
Resting systolic BP (mmHg) 203 146.73±14.82 142.17±13.45 <0.001 0.32 
Resting diastolic BP (mmHg) 203 85.23±6.93 82.20±7.60 <0.001 0.41 
After-exercise systolic BP (mmHg) 183 145.35±17.58 140.32±13.19 <0.001 0.32 
After-exercise diastolic BP (mmHg) 183 83.70±7.68 80.56±6.93 <0.001 0.42 
Resting HR (bpm) 105 77.95±12.09 78.05±12.60 0.95 -0.01 
After-exercise HR (bpm) 105 101.24±16.74 100.69±16.74 0.39 0.03 
Total distance in 6MW (m) 102 466.30±60.79 481.47±56.74 <0.001 -0.26 
 
n Baseline 9 month p d 
Weight (kg) 727 68.63±12.50 68.18±12.41 <0.001 0.03 
BMI (kg/m2) 690 28.08±5.06 27.89±5.02 <0.001 0.03 
Waist circumference (cm) 67 97.85±11.45 96.89±10.71 0.09 0.08 
Waist-hip ratio 60 0.89±0.05 0.88±0.04 0.004 0.22 
Flexibility (cm) 299 13.97±9.75 17.56±7.87 <0.001 -0.40 
Resting systolic BP (mmHg) 142 148.33±13.75 142.80±14.35 <0.001 0.39 
Resting diastolic BP (mmHg) 142 85.06±7.04 82.42±8.73 <0.001 0.33 
After-exercise systolic BP (mmHg) 124 146.19±16.33 140.72±12.31 <0.001 0.39 
After-exercise diastolic BP (mmHg) 124 84.05±12.05 80.67±7.47 <0.001 0.33 
Resting HR (bpm) 88 77.56±11.81 77.69±14.04 0.93 -0.01 
After-exercise HR (bpm) 88 101.59±16.82 99.81±14.99 0.42 0.11 
Total distance in 6MW (m) 84 467.93±60.82 491.64±55.35 <0.001 -0.41 
n: number of individuals, BMI: body max index, BP: blood pressure, HR: heart rate,  6MW: six-minute walk test, mmHg: 
millimeter of mercury, bpm: beats per minute, p: significance value, d: effect size (Cohen´s d) 
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Table 21. Changes in physical measures between baseline and 3, 6 and 9 months in men (Wilcoxon´s signed rank test). 
Values are shown in mean values ± standard deviation. 
 
n Baseline 3 month p d 
Weight (kg) 406 79.59±11.66 79.28±11.72 <0.001 0.03 
BMI (kg/m2) 387 27.43±3.73 27.32±3.73 <0.001 0.03 
Waist circumference (cm) 46 104.59±10.70 104.22±10.97 0.07 0.03 
Waist-hip ratio 45 0.99±0.07 0.99±0.05 0.71 0.00 
Flexibility (cm) 187 8.49±9.61 10.63±10.25 <0.001 -0.21 
Resting systolic BP (mmHg) 128 147.55±14.90 143.88±13.13 <0.001 0.26 
Resting diastolic BP (mmHg) 128 85.62±7.33 83.60±7.61 0.006 0.27 
After-exercise systolic BP (mmHg) 123 146.09±16.49 144.36±15.56 0.05 0.11 
After-exercise diastolic BP (mmHg) 123 84.21±7.43 82.68±7.74 0.01 0.20 
Resting HR  (bpm) 76 71.47±14.75 71.06±13.15 0.79 0.03 
After-exercise HR (bpm) 76 90.51±17.23 89.97±16.11 0.55 0.03 
Total distance in 6MW (m) 74 492.55±68.01 515.77±60.01 <0.001 -0.36 
 n Baseline 6 month p d 
Weight (kg) 311 79.55±11.43 79.25±11.42 0.05 0.03 
BMI (kg/m2) 294 27.62±3.64 27.5±3.62 0.04 0.03 
Waist circumference (cm) 23 105.78±10.86 105.74±11.06 0.96 0.00 
Waist-hip ratio 23 0.99±0.08 1.01±0.05 0.67 -0.29 
Flexibility (cm) 102 9.14±8.70 12.20±8.43 <0.001 -0.36 
Resting systolic BP (mmHg) 83 145.60±13.60 143.42±13.01 0.12 0.16 
Resting diastolic BP (mmHg) 83 85.84±6.89 83.31±7.39 0.003 0.35 
After-exercise systolic BP (mmHg) 80 145.28±14.87 141.95±12.40 0.02 0.24 
After-exercise diastolic BP (mmHg) 80 84.42±6.92 82.97±7.51 0.10 0.20 
Resting HR  (bpm) 41 73.07±16.71 72.46±14.63 0.95 0.04 
After-exercise HR (bpm) 41 91.83±16.87 89.93±16.42 0.52 0.11 
Total distance in 6MW (m) 41 493.00±65.37 513.83±68.85 0.02 -0.31 
 
n Baseline 9 month p d 
Weight (kg) 188 79.51±11.18 79.05±11.09 0.12 0.04 
BMI (kg/m2) 177 27.80±3.84 27.62±3.82 0.09 0.04 
Waist circumference (cm) 16 104.62±12.32 104.87±12.27 0.44 -0.02 
Waist-hip ratio 16 1.01±0.05 1.01±0.04 0.61 0.00 
Flexibility (cm) 54 7.87±9.87 11.37±9.96 <0.001 -0.35 
Resting systolic BP (mmHg) 60 147.5±13.08 144.1±13.75 0.11 0.25 
Resting diastolic BP (mmHg) 60 85.55±6.19 82.51±8.32 0.01 0.41 
After-exercise systolic BP (mmHg) 60 146.75±13.17 143.18±13.98 0.07 0.26 
After-exercise diastolic BP (mmHg) 60 84.35±6.17 80.88±8.07 0.002 0.48 
Resting HR (bpm) 30 70.63±12.65 67.3±10.74 0.18 0.28 
After-exercise HR (bpm) 30 91.13±15.77 89.93±13.73 0.72 0.08 
Total distance in 6MW (m) 30 491.36±56.68 513.06±64.58 0.01 -0.36 
n: number of individuals, BMI: body max index, BP: blood pressure, HR: heart rate, 6MW: six-minute walk test, mmHg: 
millimeter of mercury, bpm: beats per minute, p: significance value, d: effect size (Cohen´s d) 
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Figure 31. Mean changes in weight and BMI in total sample, women and men (Friedman´s ANOVA). Standard deviations 
are shown in Table 17 and 19. 
 
 
Figure 32. Mean changes in waist circumference and flexibility along the program in total sample, women and men 
(Friedman´s ANOVA). Standard deviations are shown in Table 17 and 19. 
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Figure 33. Mean changes in blood pressure measures along the program in total sample, women and men (Friedman´s 
ANOVA). Standard deviations are shown in Table 17 and 19. 
 
Figure 34. Mean changes in total distance along the program in total sample, women and men (Friedman´s ANOVA). 
Standard deviations are shown in Table 17 and 19. 
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4.4.2.2. Changes in physical measures by age  
Tests performed in different age groups (Table 22 and Figures 35-38) showed significant changes 
(p≤0.04) in weight and BMI in the 21-30 age group, in weight, BMI and flexibility in the 31-40 age 
group and in waist circumference and flexibility in the 41-50 age group. Also, the 51-60 age group 
showed changes in weight, BMI, WHR, flexibility, resting diastolic blood pressure and total distance 
and the 61-70 age group in weight, BMI, waist circumference, flexibility, resting systolic and diastolic 
blood pressure, after-exercise diastolic blood pressure and total distance. The 71-80 age group 
showed significant (p≤0.04) changes in flexibility and resting diastolic blood pressure. Tests could not 
be performed in the 81-90 age group and in some of the physical measures in other age groups due 
to the null or low sample size (n≤1). 
Follow-up tests (Tables 23-26) showed that statistically significant (p≤0.05) changes in weight and 
BMI in all age groups had effect sizes smaller than d=0.03. In the 21-30 decade group, changes in 
flexibility became significant after three months (11.82±7.75 - 13.89±7.84 cm, d=-0.26, p=0.03) and 
six months (8.50±6.06 - 10.81±6.99 cm, d= -0.35, p=0.04). No significant changes were found 
between baseline and nine months. 
In the 31-40 age group, changes in flexibility were significant (p≤0.03) in the three follow-ups but the 
largest effect size (d=-0.42) was found between baseline and the nine month measurement (Table 
23). 
In the 41-50 age group, only changes in flexibility (12.10±9.99 - 14.40±9.98 cm, d=-0.23, p≤0.001) 
and total distance (498.62±50.63 - 515.24±54.07 m, d=-0.32, p=0.02) were significant between 
baseline and the three month measurement. Between baseline and six months, changes in waist 
circumference (97.25±9.05 – 94.62±8.89 cm, d=0.29, p=0.04) and in flexibility were significant 
(11.45±10.22 - 14.41±8.47 cm, d=-0.31, p<0.001). Between baseline and nine months only changes in 
flexibility were significant (15.38±10.25 - 17.90±8.88 cm, d=-0.26, p<0.001). 
In the 51-60 age group, changes in flexibility, resting systolic and diastolic blood pressure, after-
exercise diastolic blood pressure and total distance were significant (p≤0.04) between baseline and 
three months (Table 24). Similar results were found between baseline and six months except in 
changes in resting systolic blood pressure. However, after-exercise systolic blood pressure became 
significant (p=0.004) at this time. In the last follow-up at nine months, changes in flexibility, in total 
distance and in all blood pressure measures were significant (p≤0.007) with effect sizes greater than 
the previous follow-ups (Table 24). 
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In the 61-70 age group, significant (p≤0.02) changes were found in flexibility, all the blood pressure 
measures and total distance between baseline and the other follow-ups. Changes in waist 
circumference were only significant at three months but had small effect size (98.40±11.86 – 
97.95±11.77 cm, d=0.04, p=0.05). Effect sizes were highest between baseline and the nine month 
measurement in resting systolic blood pressure and total distance (Table 25). In the other variables 
the improvement reached a peak at six months and then stayed the same or even decreased (resting 
diastolic blood pressure from d=0.34 at six months to d=0.26 at nine months). 
In the 71-80 age group, changes in flexibility, resting and after-exercise diastolic blood pressure and 
total distance were significant (p≤0.04) between baseline and three months (Table 26). Resting 
systolic blood pressure was not statistically significant (p=0.06) but values showed possible 
important changes (148.37±13.33-144.85±15.39 mmHg). Between baseline and six months, changes 
in flexibility and resting systolic and diastolic blood pressure were significant (p<0.001). At nine 
months, changes in flexibility were the only significant (p<0.001) ones (Table 26). 
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Table 22. Changes in physical measures along the program in different age groups (Friedman´s ANOVA). Values are 
shown in mean values ± standard deviation. 
 
21-30 age group n Baseline 3 month 6 month 9 month X2F p 
Weight (kg) 6 63.96±16.93 63.72±16.78 63.75±17.52 65.25±17.66 10.39 0.01 
BMI (kg/m2) 6 24.84±6.91 24.74±8.84 24.76±7.14 25.34±7.21 10.39 0.01 
Waist circumference (cm) 1 107 106 109 109 . . 
Waist-hip ratio 1 .89 .88 .89 .88 . . 
Flexibility (cm) 2 12.00±1.41 17.50±0.7 16.50±4.95 19.00±1.41 4.16 0.24 
Resting systolic BP (mmHg) 1 140.00 120.00 130.00 140.00 . . 
Resting diastolic BP (mmHg) 1 80.00 70.00 75.00 80.00 . . 
After-exercise systolic BP (mmHg) 1 120.00 130.00 130.00 130.00 . . 
After-exercise diastolic BP (mmHg) 1 80.00 70.00 75.00 70.00 . . 
Resting HR (bpm) 1 76.00 100.00 93.00 80.00 . . 
After-exercise HR (bpm) 1 139.00 142.00 147.00 125.00 . . 
Total distance in 6MW (m) 1 537.00 564.00 552.00 561.00 . . 
31-40 age group n Baseline 3 month 6 month 9 month X2F p 
Weight (kg) 20 74.06±17.94 73.06±17.85 72.49±17.40 72.49±17.52 11.18 0.01 
BMI (kg/m2) 20 26.32±5.88 25.98±5.92 25.79±5.86 25.78±5.84 11.18 0.01 
Waist circumference (cm) 0 . . . . . . 
Waist-hip ratio 0 . . . . . . 
Flexibility (cm) 9 11.33±9.12 13.44±10.34 15.11±7.50 15.66±10.41 8.74 0.03 
Resting systolic BP (mmHg) 0 . . . . . . 
Resting diastolic BP (mmHg) 0 . . . . . . 
After-exercise systolic BP (mmHg) 0 . . . . . . 
After-exercise diastolic BP (mmHg) 0 . . . . . . 
Resting HR  (bpm) 0 . . . . . . 
After-exercise HR  (bpm) 0 . . . . . . 
Total distance in 6MW (m) 0 . . . . . . 
41-50 age group n Baseline 3 month 6 month 9 month X2F p 
Weight (kg) 103 68.98±12.75 68.52±12.57 68.52±12.66 68.27±12.85 7.29 0.06 
BMI (kg/m2) 98 26.11±4.21 25.95±4.17 25.95±4.31 25.85±4.38 6.58 0.08 
Waist circumference (cm) 6 99.50±9.46 97.83±11.25 96.00±10.04 96.16±8.63 8.14 0.04 
Waist-hip ratio 5 0.91±0.04 0.9±0.02 0.89±0.03 0.89±0.03 5.67 0.13 
Flexibility (cm) 44 15.32±10.28 17.40±10.72 16.45±8.67 17.18±9.20 14.29 0.003 
Resting systolic BP (mmHg) 2 165±49.49 157.5±31.82 142.5±24.74 140±14.14 3.94 0.26 
Resting diastolic BP (mmHg) 2 92.5±17.67 95±7.07 87.5±3.53 89±5.65 0.60 0.89 
After-exercise systolic BP (mmHg) 2 175±70.71 160±42.42 142.5±31.82 146±19.79 1.80 0.61 
After-exercise diastolic BP (mmHg) 2 95±21.21 87.5±3.53 85±7.07 88±2.82 1.40 0.71 
Resting HR (bpm) 8 88.37±14.97 89.37±15.71 84.12±14.89 96.25±18.23 4.29 0.23 
After-exercise HR (bpm) 8 122.87±11.61 115.5±21.48 110.75±22.54 118.75±15.94 6.58 0.08 
Total distance in 6MW (m) 8 512.25±35.95 514.87±39.89 507.75±52.46 521.5±48.16 1.27 0.74 
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51-60 age group n Baseline 3 month 6 month 9 month X2F p 
Weight (kg) 201 71.84±13.43 71.32±13.19 71.28±13.10 71.19±13.34 14.49 0.002 
BMI (kg/m2) 198 28.95±5.20 28.73±5.09 28.71±5.03 28.68±5.13 14.07 0.003 
Waist circumference (cm) 18 99.89±11.15 99.78±11.48 100.33±11.39 99.39±11.22 3.69 0.30 
Waist-hip ratio 17 0.94±0.07 0.94±0.07 0.93±0.07 0.93±0.07 10.17 0.02 
Flexibility (cm) 78 14.62±9.09 17.01±9.11 17.69±6.92 18.53±7.18 58.54 <0.001 
Resting systolic BP (mmHg) 32 143.78±12.52 144.12±12.74 142.43±14.24 138.62±15.39 2.46 0.48 
Resting diastolic BP (mmHg) 31 85.87±5.32 84.29±5.83 83.58±7.97 81.22±7.24 9.01 0.03 
After-exercise systolic BP (mmHg) 28 144.14±9.70 143.14±11.23 140.25±14.76 139.75±8.87 4.46 0.21 
After-exercise diastolic BP (mmHg) 28 84.18±6.15 82.21±6.61 82.21±7.56 81.82±6.04 1.84 0.61 
Resting HR (bpm) 31 74.52±11.90 74.19±13.72 76.26±12.67 74.35±13.63 1.93 0.58 
After-exercise HR (bpm) 31 96.26±12.93 94.09±14.41 95.61±15.07 98.93±14.27 3.99 0.26 
Total distance in 6MW (m) 30 485.36±57.26 509.83±56.08 515.76±57.71 528.23±56.02 19.49 <0.001 
61-70 age group n Baseline 3 month 6 month 9 month X2F p 
Weight (kg) 167 72.72±13.16 72.05±12.99 72.04±13.00 71.99±13.28 26.62 <0.001 
BMI (kg/m2) 158 29.18±4.67 28.92±4.56 28.91±4.56 28.89±4.67 26.94 <0.001 
Waist circumference (cm) 21 101.33±14.87 100.09±14.78 99.81±14.30 99.52±14.62 17.51 <0.001 
Waist-hip ratio 21 0.91±0.08 0.91±0.09 0.91±0.08 0.91±0.08 2.60 0.45 
Flexibility (cm) 44 11.81±9.65 14.48±10.17 16.18±9.34 17.05±8.12 43.06 <0.001 
Resting systolic BP (mmHg) 55 148.76±14.34 143.96±12.24 147.02±13.46 142.67±14.02 10.68 0.01 
Resting diastolic BP (mmHg) 56 85.71±6.41 82.53±6.78 84.02±6.64 83.14±9.77 14.01 0.003 
After-exercise systolic BP (mmHg) 51 144.96±15.61 142.08±12.88 143.12±11.82 139.49±13.19 6.50 0.09 
After-exercise diastolic BP (mmHg) 51 83.88±7.72 81.53±6.42 81.21±6.63 79.98±7.99 13.21 0.004 
Resting HR (bpm) 30 72.4±10.86 72.7±9.28 73.73±11.46 70.8±12.07 4.40 0.22 
After-exercise HR (bpm) 30 94.56±17.34 92.5±13.28 96.56±17.82 92.36±15.29 1.57 0.66 
Total distance in 6MW (m) 30 468.9±71.97 477.3±51.14 484.56±53.01 487.6±62.53 12.99 0.005 
71-80 age group n Baseline 3 month 6 month 9 month X2F p 
Weight (kg) 85 69.92±10.62 69.77±10.90 69.85±10.59 69.84±10.48 1.65 0.65 
BMI (kg/m2) 81 28.18±3.65 28.12±3.72 28.17±3.69 28.15±3.68 1..54 0.67 
Waist circumference (cm) 11 95.27±10.69 95.54±10.25 95.91±10.20 95.64±9.97 1.80 0.61 
Waist-hip ratio 10 0.92±0.06 0.92±0.05 0.92±0.05 0.92±0.05 1.34 0.72 
Flexibility (cm) 23 11.66±8.53 12.98±8.42 15.02±6.80 14.81±6.96 19.25 <0.001 
Resting systolic BP (mmHg) 25 149.12±10.62 147.28±11.57 144.08±12.28 146.68±14.31 2.17 0.54 
Resting diastolic BP (mmHg) 25 84.04±6.35 83.16±6.51 79.8±6.55 79.32±6.88 7.94 0.04 
After-exercise systolic BP (mmHg) 21 152.33±17.06 149.81±16.55 146.81±12.29 146.52±14.81 2.98 0.39 
After-exercise diastolic BP (mmHg) 21 83.48±5.75 81.66±7.16 81.24±4.97 80.33±6.31 3.75 0.29 
Resting HR (bpm) 16 73.81±13.12 73.56±12.30 74.37±13.08 69.12±14.31 3.23 0.36 
After-exercise HR (bpm) 16 94.44±18.13 94.12±10.86 95.69±12.05 89.19±13.16 2.86 0.41 
Total distance in 6MW (m) 16 471.19±42.39 484.81±46.88 475.25±53.45 473.31±53.85 6.17 0.11 
n: number of individuals, BMI: body max index, BP: blood pressure, HR: heart rate, 6MW: six-minute walk test, mmHg: millimeter of mercury, bpm: beats per 
minute, X2F: Friedman´s ANOVA, p: significance value 
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Table 23. Changes in flexibility between baseline, 3, 6 and 9 months in the 31-40 decade group (Wilcoxon´s signed rank 
test). Values are shown in mean values ± standard deviation. 
n Baseline 3 month p d 
78 12.90±8.45 14.55±8.94 <0.00* -0.19 
n Baseline 6 months   
35 13.05±9.15 15.87±9.41 0.003 -0.30 
n Baseline 9 month   
12 10.75±7.99 14.42±9.18 0.03 -0.42 
n: number of individuals, p: significance value, d: effect size (Cohen´s d) 
 
Table 24. Significant changes in measures between baseline and 3, 6 and 9 months in the 51-60 age group (Wilcoxon´s 
signed rank test). Values are shown in mean values ± standard deviation. 
  n Baseline 3 month p d 
Flexibility (cm) 349 12.03±9.46 14.48±9.63 <0.001 -0.26 
Resting systolic BP (mmHg) 130 144.23±15.29 140.05±16.06 <0.001 0.27 
Resting diastolic BP (mmHg) 129 85.14±6.85 83.95±6.67 0.04 0.17 
After-exercise systolic BP (mmHg) 119 141.30±13.32 140.80±14.19 0.260 0.03 
After-exercise diastolic BP (mmHg) 119 83.82±6.59 82.30±7.09 0.02 0.22 
Total distance in 6MW (m) 76 487.72±64.47 507.97±55.70 <0.001 -0.34 
 n Baseline 6 month p d 
Flexibility (cm) 249 12.48±9.66 15.70±8.61 <0.001 -0.35 
Resting systolic BP (mmHg) 79 144.09±16.19 141.86±13.18 0.33 0.15 
Resting diastolic BP (mmHg) 79 85.58±6.97 83.49±7.09 0.04 0.30 
After-exercise systolic BP (mmHg) 69 143.16±17.50 138.16±13.05 0.004 0.32 
After-exercise diastolic BP (mmHg) 69 84.23±8.13 81.39±6.94 0.01 0.37 
Total distance in 6MW (m) 45 475.35±62.05 509.44±57.99 <0.001 -0.57 
 
n Baseline 9 month p d 
Flexibility (cm) 139 13.40±9.61 17.09±8.01 <0.001 -0.42 
Resting systolic BP (mmHg) 58 145.38±11.97 139.19±12.66 0.007 0.50 
Resting diastolic BP (mmHg) 57 86.63±6.09 82.18±6.53 <0.001 0.70 
After-exercise systolic BP (mmHg) 51 144.94±12.59 139.10±8.95 0.005 0.53 
After-exercise diastolic BP (mmHg) 51 86.75±15.96 81.55±6.01 0.005 0.43 
Total distance in 6MW (m) 36 481.86±56.48 520.81±54.81 <0.001 -0.70 
n: number of individuals, BP: blood pressure, 6MW: six-minute walk test, mmHg: millimeter of mercury, p: significance value, d: effect size 
(Cohen´s d) 
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Table 25. Significant changes in measures between baseline and 3, 6 and 9 months in the 61-70 age group (Wilcoxon´s 
signed rank test). Values are shown in mean values ± standard deviation. 
  n Baseline 3 month p d 
Flexibility (cm) 240 10.71±9.78 12.94±10.00 <0.001 -0.22 
Resting systolic BP (mmHg) 180 148.16±14.71 145.28±15.33 0.003 0.19 
Resting diastolic BP (mmHg) 180 85.02±7.73 82.76±8.06 <0.001 0.28 
After-exercise systolic BP (mmHg) 163 146.23±16.94 143.15±15.14 <0.001 0.19 
After-exercise diastolic BP (mmHg) 163 83.28±8.03 81.28±7.89 <0.001 0.25 
Total distance in 6MW (m) 89 473.53±58.81 489.15±51.86 <0.001 -0.28 
  n Baseline 6 month p d 
Flexibility (cm) 177 10.55±9.37 14.53±8.56 <0.001 -0.44 
Resting systolic BP (mmHg) 129 147.60±13.37 144.50±13.89 0.02 0.23 
Resting diastolic BP (mmHg) 129 85.62±6.72 83.09±8.01 <0.001 0.34 
After-exercise systolic BP (mmHg) 121 146.41±15.03 141.58±12.46 <0.001 0.35 
After-exercise diastolic BP (mmHg) 121 84.29±7.13 81.35±8.15 <0.001 0.38 
Total distance in 6MW (m) 52 474.75±66.93 492.91±56.45 0.005 -0.29 
 
n Baseline 9 month p d 
Flexibility (cm) 90 12.00±10.71 16.38±9.04 <0.001 -0.44 
Resting systolic BP (mmHg) 92 150.09±14.47 144.23±14.57 <0.001 0.40 
Resting diastolic BP (mmHg) 93 85.32±6.79 83.12±9.74 0.002 0.26 
After-exercise systolic BP (mmHg) 86 145.78±14.36 141.36±14.24 0.002 0.31 
After-exercise diastolic BP (mmHg) 86 83.22±7.45 80.16±8.64 <0.001 0.38 
Total distance in 6MW (m) 44 469.43±64.99 489.45±54.87 <0.001 -0.33 
n: number of individuals, BP: blood pressure, 6MW: six-minute walk test, mmHg: millimeter of mercury, p: significance value, d: effect size 
(Cohen´s d) 
 
Table 26. Significant changes in measures between baseline and 3, 6 and 9 months in the 71-80 age group (Wilcoxon´s 
signed rank test). Values are shown in mean values ± standard deviation. 
 
n Baseline 3 month p d 
Flexibility (cm) 94 8.70±9.12 10.91±9.12 <0.001 -0.24 
Resting systolic BP (mmHg) 81 148.37±13.33 144.85±15.39 0.06 0.24 
Resting diastolic BP (mmHg) 80 82.98±7.46 80.91±7.99 0.04 0.27 
After-exercise systolic BP (mmHg) 78 148.47±16.46 145.95±16.45 0.12 0.15 
After-exercise diastolic BP (mmHg) 78 82.40±6.36 80.41±7.32 0.02 0.29 
Total distance in 6MW (m) 47 449.27±61.55 461.70±59.47 0.04 -0.20 
 n Baseline 6 month p d 
Flexibility (cm) 65 9.75±8.67 12.58±8.82 <0.001 -0.32 
Resting systolic BP (mmHg) 62 147.29±11.71 141.66±10.95 <0.001 0.49 
Resting diastolic BP (mmHg) 62 84.35±6.27 80.08±7.05 <0.001 0.64 
After-exercise systolic BP (mmHg) 58 146.86±14.97 145.22±11.22 0.41 0.12 
After-exercise diastolic BP (mmHg) 58 82.36±6.42 81.12±5.91 0.27 0.20 
Total distance in 6MW (m) 31 459.77±55.53 459.09±67.65 0.74 0.01 
 
n Baseline 9 month p d 
Flexibility (cm) 41 10.91±9.71 13.76±7.92 <0.001 -0.32 
Resting systolic BP (mmHg) 45 147.51±10.82 147.16±12.49 0.99 0.03 
Resting diastolic BP (mmHg) 45 83.09±6.89 81.07±7.35 0.29 0.28 
After-exercise systolic BP (mmHg) 41 149.00±15.12 145.20±12.45 0.18 0.27 
After-exercise diastolic BP (mmHg) 41 82.61±5.68 80.66±6.68 0.18 0.31 
Total distance in 6MW (m) 22 462.50±51.81 468.95±55.48 0.42 -0.12 
n: number of individuals, BP: blood pressure, 6MW: six-minute walk test, mmHg: millimeter of mercury, p: significance value,  d: effect size 
(Cohen´s d) 
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Figure 35. Mean changes in weight and BMI in different age groups (Friedman´s ANOVA). Standard deviations are shown 
in Table 22. 
 
 
Figure 36. Mean changes in waist circumference and flexibility in different age groups (Friedman´s ANOVA). Standard 
deviations are shown in Table 22. 
 
 
Figure 37. Mean changes in total distance in different age groups (Friedman´s ANOVA). Standard deviations are shown in 
Table 22. 
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Figure 38. Mean changes in blood pressure measures in different age groups (Friedman´s ANOVA). Standard deviations 
are shown in Table 22. 
 
4.4.2.3. Changes in physical measures by diagnosis 
As mentioned before, considering the significant differences observed previously between men and 
women, changes in physical measures in different diagnose groups were also divided by gender (see 
Tables 27-30 and Figures 39-43).  
For the MSD group, both women and men showed significant (p≤0.01) differences in weight, BMI 
and flexibility along the program (Table 27).  
Follow-up tests showed that in women, changes in weight and BMI between baseline and the three 
other follow-ups were significant (p≤0.04). However, effect sizes of these changes were very small 
(d<0.04) (Table 28). Changes in flexibility were also significant (p<0.001) in all follow-ups and the 
highest effect size (d=-0.34) was reached by the six month follow-up (12.06±9.79 - 15.20±8.69 cm) 
staying constant until the next follow-up (d=-0.34). Changes in total distance were also significant 
(p=0.01) between baseline and three months (474.14±53.81 -487.76±55.41 m, d=-0.25) but not 
between baseline and the rest follow-ups. Changes in resting diastolic and after-exercise systolic 
blood pressure were also found significant (p≤0.04) only after six months (Table 28). 
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Table 27. Changes in physical measures along the program in the MSD group in women and in men (Friedman´s ANOVA). 
Values are shown in mean values ± standard deviation. 
Women n Baseline 3 month 6 month 9 month X2F p 
Weight (kg) 315 65.46±10.04 64.99±9.79 65.01±9.85 64.94±10.15 25.08 <0.001 
BMI (kg/m2) 300 26.58±3.92 26.40±3.81 26.39±3.82 26.37±3.96 23.29 <0.001 
Waist circumference (cm) 1 107 101 100 100 . . 
Waist-hip ratio 1 0.90 0.89 0.90 0.90 . . 
Flexibility (cm) 149 14.59±8.98 16.86±9.22 17.42±7.69 18.03±8.04 89.66 <0.001 
Resting systolic BP (mmHg) 7 140±15.27 145±5.0 138±11.49 133±7.55 5.37 0.15 
Resting diastolic BP (mmHg) 7 82±6.36 85±5.0 80±6.45 79±4.49 2.06 0.56 
After-exercise systolic BP (mmHg) 6 138±12.91 142±7.52 134±9.17 133±8.75 5.24 0.16 
After-exercise diastolic BP (mmHg) 6 80±8.36 85±5.47 79±5.84 80±6.32 4.16 0.25 
Resting HR (bpm) 2 73±9.19 78±21.92 82±21.92 73±18.38 3.32 0.35 
After-exercise HR (bpm) 2 88±12-02 86±7.07 96±3.53 83±0.00 1.80 0.62 
Total distance in 6MW (m) 2 503.5±38.89 507±32.52 541.5±23.33 534.5±50.20 4.80 0.19 
        
Men  n Baseline 3 month 6 month 9 month X2F p 
Weight (kg) 71 79.62±10.37 79.02±10.29 78.87±10.09 78.79±10.44 11.90 0.01 
BMI (kg/m2) 71 27.11±2.87 26.91±2.87 26.87±2.89 26.84±3.03 11.90 0.01 
Waist circumference (cm) 1 112 112 113 112 . . 
Waist-hip ratio 1 1.06 1.06 1.05 1.05 . . 
Flexibility (cm) 26 10.10±9.20 13.09±10.05 12.35±7.97 13.96±7.22 20.81 <0.001 
Resting systolic BP (mmHg) 2 150±14.14 142±3.53 142±10.60 152±3.53 1.67 0.64 
Resting diastolic BP (mmHg) 2 90±0.00 85±7.07 85±7.07 92±3.53 3.00 0.39 
After-exercise systolic BP (mmHg) 2 145±7.07 127±10.60 140±0.00 142±3.53 5.25 0.15 
After-exercise diastolic BP (mmHg) 2 87±3.53 75±7.07 82±3.53 85±7.07 3.00 0.39 
Resting HR (bpm) 2 77±15.55 65±4.95 62±3.53 62±0.07 3.95 0.27 
After-exercise HR (bpm) 2 98±14.14 85±11.31 75±15.55 87±2.82 3.60 0.31 
Total distance in 6MW (m) 2 518.5±47.37 496.5±74.24 479±101.82 483±74.95 4.20 0.24 
n: number of individuals, BMI: body max index, BP: blood pressure, HR: heart rate, 6MW: six-minute walk test, mmHg: millimeter of mercury, bpm: beats 
per minute, X2F: Friedman´s ANOVA, p: significance value 
 
 
In men, changes in weight and BMI showed to be significant (p<0.001) after three months, but 
similarly to women, effect sizes were very small (d<0.03)(Table 28). Changes in flexibility were also 
significant (p<0.001) in all follow-ups and the highest effect size was reached at the nine month 
measurement (7.93±9.07-12.09±9.10 cm, d=-0.46). After-exercise systolic blood pressure 
significantly (p=0.03) decreased at three months and at six months but not at nine months (Table 
28). The greatest effect size was reached at six months (146.36±14.33- 137.73±10.33 mmHg, 
d=0.69). 
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Table 28. Changes in physical measures between baseline and 3, 6 and 9 months in the MSD group in women and men 
(Wilcoxon´s signed rank test). Values are shown in mean values ± standard deviation. 
Women  n Baseline 3 month p d 
Weight (kg) 976 65.08±10.07 64.69±9.91 <0.001 0.04 
BMI (kg/m2) 936 26.26±4.08 26.11±4.02 <0.001 0.04 
Flexibility (cm) 694 12.29±9.45 14.57±9.49 <0.001 -0.24 
Resting diastolic BP (mmHg) 27 83.48±8.02 83.00±7.09 0.85 0.06 
After-exercise systolic BP (mmHg) 24 137.33±14.45 138.46±14.11 0.63 -0.08 
Total distance in 6MW (m) 21 474.14±53.81 487.76±55.41 0.01 -0.25 
  n Baseline 6 month p d 
Weight (kg) 797 65.55±9.96 65.15±9.77 <0.001 0.04 
BMI (kg/m2) 752 26.54±3.86 26.36±3.77 <0.001 0.05 
Flexibility (cm) 497 12.06±9.79 15.20±8.69 <0.001 -0.34 
Resting diastolic BP (mmHg) 18 85.44±7.07 82.06±6.79 0.03 0.49 
After-exercise systolic BP (mmHg) 14 142.50±12.67 138.57±9.69 0.04 0.35 
Total distance in 6MW (m) 2 503.50±38.89 541.50±23.33 0.18 -1.18 
  n Baseline 9 month p d 
Weight (kg) 507 65.31±10.14 64.92±10.10 0.004 0.04 
BMI (kg/m2) 480 26.53±4.07 26.37±4.05 0.003 0.04 
Flexibility (cm) 259 14.40±9.75 17.79±7.99 <0.001 -0.38 
Resting diastolic BP (mmHg) 15 84.00±7.37 84.00±9.67 0.84 0.00 
After-exercise systolic BP (mmHg) 12 140.42±13.39 142.50±18.28 0.76 -0.13 
Total distance in 6MW (m) 2 503.50±38.89 534.50±50.20 0.18 -0.69 
Men  n Baseline 3 month p d 
Weight (kg) 256 78.11±10.23 77.77±10.26 <0.001 0.03 
BMI (kg/m2) 243 26.47±3.09 26.35±3.09 <0.001 0.04 
Flexibility (cm) 160 9.10±9.26 11.33±9.95 <0.001 -0.23 
After-exercise systolic BP (mmHg) 14 148.64±14.07 140.71±11.74 0.03* 0.61 
  n Baseline 6 month p d 
Weight (kg) 185 78.90±11.19 78.58±11.26 0.06 0.03 
BMI (kg/m2) 174 26.71±3.25 26.59±3.26 0.05 0.04 
Flexibility (cm) 84 9.20±8.42 11.79±8.36 <0.001 -0.31 
After-exercise systolic BP (mmHg) 11 146.36±14.33 137.73±10.33 0.02 0.69 
  n Baseline 9 month p d 
Weight (kg) 112 77.71±10.38 77.27±10.21 0.14 0.04 
BMI (kg/m2) 106 26.59±3.11 26.43±3.14 0.09 0.05 
Flexibility (cm) 46 7.93±9.07 12.09±9.10 <0.001 -0.46 
After-exercise systolic BP (mmHg) 3 143.33±5.77 141.67±2.89 0.32 0.36 
n: number of individuals, BMI: body max index, BP: blood pressure, 6MW: six-minute walk test, mmHg: millimeter of mercury, 
p: significance value, d: effect size (Cohen´s d) 
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In the diabetes group, only women showed significant (p=0.05) changes and only in resting systolic 
blood pressure (Table 29). However, follow-up tests also showed significant (p≤0.02) changes in 
weight and BMI between baseline and three months (Table 30). Effect sizes of these changes were 
small (d<0.04).  Changes in total distance were found significant (p≤0.04) in all measurements with 
the highest effect size occurring at nine months (d=-1-01) (Table 30). Changes in flexibility showed 
also to be significant (p=0.04) at six months and after exercise systolic blood pressure at nine months 
(Table 30). 
 
Table 29. Changes in physical measures along the program in the diabetes group in women and in men (Friedman´s 
ANOVA). Values are shown in mean values ± standard deviation. 
Women n Baseline 3 month 6 month 9 month X2F p 
Weight (kg) 16 75.41±12.89 74.45±12.40 74.76±12.32 74.70±12.34 5.84 0.12 
BMI (kg/m2) 16 31.43±5.29 31.02±5.04 31.15±5.04 31.11±4.99 5.84 0.12 
Waist circumference (cm) 4 94.50±10.66 95.25±10.76 95.00±9.79 94.75±10.40 1.21 0.75 
Waist-hip ratio 3 0.93±0.02 0.90±0.03 0.91±0.02 0.90±0.01 2.04 0.57 
Flexibility (cm) . . . . . . . 
Resting systolic BP (mmHg) 3 150±10.0 137±5.77 133±5.77 142±2.88 7.96 0.05 
Resting diastolic BP (mmHg) 3 87±2.88 82±7.63 77±5.77 80±5.00 4.78 0.19 
After-exercise systolic BP (mmHg) 3 140±17.32 140±10.00 137±5.77 133±5.77 2.29 0.51 
After-exercise diastolic BP (mmHg) 3 80±10.00 78±7.63 80±0.00 80±0.00 0.14 0.99 
Resting HR (bpm) 6 87±15.22 80±16-13 82±16.26 90±21.51 4.90 0.18 
After-exercise HR (bpm) 6 112±20.63 108±21.14 111±22.51 115±24.52 3.00 0.39 
Total distance in 6MW (m) 6 454.3±38.31 483±47.09 478.83±26.92 491.67±63.37 6.60 0.09 
 
Men  n Baseline 3 month 6 month 9 month X2F p 
Weight (kg) 12 78.94±15.56 78.35±14.91 78.40±14.70 79.10±15.03 1.94 0.59 
BMI (kg/m2) 11 29.70±6.80 29.44±6.47 29.45±6.39 29.65±6.53 1.24 0.74 
Waist circumference (cm) 2 114.00±0.00 113.50±0.71 113.50±0.71 114.00±1.41 2.00 0.57 
Waist-hip ratio 2 1.05±0.07 1.04±0.81 1.04±0.08 1.04±0.07 4.00 0.26 
Flexibility (cm) 1 21 20 19 19 3.00 0.39 
Resting systolic BP (mmHg) 1 168 165 163 143 3.00 0.39 
Resting diastolic BP (mmHg) 1 92 88 84 80 3.00 0.39 
After-exercise systolic BP (mmHg) 1 168 169 170 136 3.00 0.39 
After-exercise diastolic BP (mmHg) 1 86 88 88 81 3.00 0.39 
Resting HR (bpm) 2 75±30.30 78±35.35 76±33.94 71±26.87 3.63 0.30 
After-exercise HR (bpm) 2 87±24.74 94±24.74 97±24.74 102±31.82 5.84 0.12 
Total distance in 6MW (m) 2 483.5±19.09 536.5±6.36 544±5.65 516±48.08 2.40 0.49 
n: number of individuals, BMI: body max index, BP: blood pressure, HR: heart rate, 6MW: six-minute walk test, mmHg: millimeter of mercury, bpm: 
beats per minute, X2F: Friedman´s ANOVA, p: significance value 
 
 
 
 
RESULTS 
 
103 
 
 
Table 30. Changes in physical measures between baseline and 3, 6 and 9 months in the diabetes group in women 
(Wilcoxon´s signed rank test). Values are shown in mean values ± standard deviation. 
Women  n Baseline 3 month p d 
Weight (kg) 60 72.67±11.46 72.24±11.45 0.01 0.04 
BMI (kg/m2) 56 30.82±4.94 30.64±4.87 0.02 0.04 
Waist-hip ratio 8 0.93±0.05 0.91±0.05 0.35 0.40 
Flexibility (cm) 8 13.13±6.17 15.13±7.02 0.07 -0.30 
After-exercise systolic BP (mmHg) 20 143.35±15.22 144.75±17.38 0.96 -0.08 
Total distance in 6MW (m) 15 461.00±59.31 481.13±60.05 0.02 -0.34 
 n Baseline 6 month p d 
Weight (kg) 52 73.19±13.84 73.23±13.92 0.79 0.00 
BMI (kg/m2) 48 31.18±5.54 31.22±5.53 1 0.00 
Waist-hip ratio 6 0.91±0.06 0.88±0.06 0.32 0.50 
Flexibility (cm) 5 10.90±7.30 15.60±8.35 0.04 -0.60 
After-exercise systolic BP (mmHg) 14 140.36±16.23 137.86±14.10 0.39 0.16 
Total distance in 6MW (m) 12 462.67±53.25 496.08±40.13 0.02 -0.71 
 
n Baseline 9 month p d 
Weight (kg) 26 75.59±13.23 75.26±13.31 0.38 0.02 
BMI (kg/m2) 24 31.68±5.17 31.53±5.18 0.37 0.03 
Waist-hip ratio 5 0.95±0.05 0.91±0.04 0.08 0.88 
Flexibility (cm) 3 9.67±6.66 10.67±6.43 1 -0.15 
After-exercise systolic BP (mmHg) 10 136.10±12.82 130.10±9.07 0.04 0.54 
Total distance in 6MW (m) 9 440.88±41.59 488.00±51.03 0.04 -1.01 
n: number of individuals, BMI: body max index, BP: blood pressure, 6MW: six-minute walk test, mmHg: millimeter of 
mercury, p: significance value, d: effect size (Cohen´s d) 
 
 
In the hypertension group (Table 31), women showed significant (p≤0.05) changes in waist 
circumference, flexibility, resting diastolic blood pressure, after-exercise systolic and diastolic blood 
pressure and total distance, and men showed significant (p≤0.03) changes in resting diastolic,  after-
exercise systolic and diastolic blood pressure and total distance along the program. 
Follow-up tests showed that in women, similar to other diagnose groups, changes in weight and BMI 
were statistically significant (p≤0.01) but effect sizes were small (d<0.02) (Table 32). Significant 
changes (p≤0.01) were also found in flexibility, resting systolic and diastolic blood pressure, after-
exercise systolic and diastolic blood pressure and total distance between baseline and all three 
follow-ups. Waist circumference did not show significant changes. Most of the variables, except 
resting and after-exercise diastolic blood pressure, reached their highest effect size at nine months 
(Table 32). 
 
 
RESULTS 
 
104 
 
Table 31. Changes in physical measures along the program in the hypertension group in women and in men (Friedman´s 
ANOVA). Values are shown in mean values ± standard deviation. 
Women n Baseline 3 month 6 month 9 month X2F p 
Weight (kg) 96 73.76±13.84 73.39±13.84 73.50±13.72 73.26±13.53 5.53 0.14 
BMI (kg/m2) 93 31.05±5.66 30.89±5.65 30.96±5.66 30.84±5.62 6.69 0.08 
Waist circumference (cm) 26 95.19±12.76 95.04±12.56 95.11±12.22 94.08±11.43 12.84 0.005 
Waist-hip ratio 25 0.88±0.05 0.88±0.05 0.88±0.05 0.87±0.05 4.70 0.20 
Flexibility (cm) 19 10.42±11.57 12.00±11.60 16.71±7.92 16.95±7.88 32.63 <0.001 
Resting systolic BP (mmHg) 66 149±14.17 147±14.0 145±14.14 142±15.00 6.91 0.08 
Resting diastolic BP (mmHg) 66 85±6.79 83±6.78 83±7.68 82±9.30 13.53 0.004 
After-exercise systolic BP (mmHg) 57 147±18.46 146±13.63 143±13.25 141±11.88 7.81 0.05 
After-exercise diastolic BP (mmHg) 57 84±7.71 82±6.62 81±6.57 81±6.33 10.69 0.01 
Resting HR (bpm) 37 75±9.95 76±10.69 76±11.98 74±12.21 3.97 0.27 
After-exercise HR (bpm) 37 99±14.14 97±10.10 101±13.88 98±12.20 2.07 0.56 
Total distance in 6MW (m) 37 466.62±63.70 478.35±48.82 480.67±51.20 486.86±56.08 9.32 0.03 
Men  n Baseline 3 month 6 month 9 month X2F p 
Weight (kg) 34 82.15±9.72 81.92±9.78 81.55±9.79 81.61±9.92 0.52 0.91 
BMI (kg/m2) 32 29.74±3.45 29.65±3.49 29.52±3.47 29.55±3.49 0.78 0.86 
Waist circumference (cm) 9 106.55±13.26 106.33±13.23 106.11±13.50 106.44±13.83 1.53 0.67 
Waist-hip ratio 9 1.01±0.04 1.02±0.04 1.02±0.04 1.01±0.04 0.71 0.87 
Flexibility (cm) 3 11.50±14.39 12.33±14.15 13.83±11.55 12.67±10.11 1.07 0.78 
Resting systolic BP (mmHg) 36 147±13.73 142±11.13 146±12.96 144±15.18 3.26 0.35 
Resting diastolic BP (mmHg) 36 86±5.71 83±7.10 84±6.21 82±8.06 10.07 0.02 
After-exercise systolic BP (mmHg) 34 148±14.81 142±15.51 145±13.24 143±15.08 9.01 0.03 
After-exercise diastolic BP (mmHg) 34 85±6.13 82±6.72 83±6.92 81±9.08 12.86 0.005 
Resting HR (bpm) 20 68±10.72 67±10.82 70±8.61 65±9.84 5.89 0.12 
After-exercise HR (bpm) 20 88±16.42 84±13.30 87±13.92 87±14.07 0.56 0.91 
Total distance in 6MW (m) 20 487±64.64 502.5±54.36 503.25±68.17 511.3±71.98 8.70 0.03 
n: number of individuals, BMI: body max index, BP: blood pressure, HR: heart rate, 6MW: six-minute walk test, mmHg: millimeter of mercury, bpm: beats per 
minute, X2F: Friedman´s ANOVA, p: significance value 
 
In men,  changes in flexibility were significant (p≤0.03) at three months and six months with the 
highest effect size reached at six months (6.16±10.60- 12.73±8.80 cm, d=-0.67). Changes in resting 
systolic blood pressure were only significant (p<0.001) after three months, changes in resting 
diastolic blood pressure were significant (p≤0.03) in all follow-ups and the highest effect size was 
reached at nine months (85.21±6.36 - 82.28±8.13 mmHg, p=0.40). Changes in after-exercise diastolic 
blood pressure were also significant (p=0.01) at three months and at nine months with the highest 
effect size at nine months (d=0.45) and total distance also significantly (p≤0.03) increased in all 
follow-ups with the highest effect size at nine months (d=-0.39)(Table 32).  
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Table 32. Changes in physical measures between baseline and 3, 6 and 9 months in the hypertension group in women 
and men (Wilcoxon´s signed rank test). Values are shown in mean values ± standard deviation. 
Women  n Baseline 3 month p d 
Weight (kg) 263 73.34±12.06 73.03±12.09 <0.001 0.02 
BMI (kg/m2) 252 30.54±4.84 30.41±4.85 <0.001 0.03 
Flexibility (cm) 79 10.16±9.86 12.70±10.07 <0.001 -0.25 
Resting systolic BP  (mmHg) 235 147.77±15.46 143.26±17.02 <0.001 0.28 
Resting diastolic BP  (mmHg) 233 84.64±7.60 82.36±7.84 <0.001 0.29 
After-exercise systolic BP (mmHg) 213 145.83±17.14 142.97±15.56 <0.001 0.17 
After-exercise diastolic BP (mmHg) 213 83.33±7.42 80.65±7.46 <0.001 0.36 
Total distance in 6MW (m) 104 462.26±58.00 473.56±50.09 <0.001 -0.21 
 n Baseline 6 month p d 
Weight (kg) 228 74.00±12.56 73.65±12.53 0.01 0.03 
BMI (kg/m2) 216 30.84±5.17 30.69±5.16 0.02 0.03 
Flexibility (cm) 55 10.58±9.05 15.73±8.55 <0.001 -0.58 
Resting systolic BP  (mmHg) 168 147.63±14.95 142.24±13.33 <0.001 0.38 
Resting diastolic BP  (mmHg) 168 85.46±7.00 82.20±7.84 <0.001 0.44 
After-exercise systolic BP (mmHg) 153 146.27±18.04 140.71±13.45 <0.001 0.35 
After-exercise diastolic BP (mmHg) 153 83.94±7.56 80.28±7.04 <0.001 0.50 
Total distance in 6MW (m) 63 460.03±59.84 473.60±59.89 0.004 -0.23 
 
n Baseline 9 month p d 
Weight (kg) 146 73.72±13.43 73.31±13.25 0.15 0.03 
BMI (kg/m2) 138 30.66±5.36 30.52±5.33 0.20 0.03 
Flexibility (cm) 30 10.33±10.31 16.44±7.46 <0.001 -0.68 
Resting systolic BP  (mmHg) 115 149.97±13.69 143.70±14.20 <0.001 0.45 
Resting diastolic BP  (mmHg) 115 85.37±7.11 82.37±8.89 <0.001 0.37 
After-exercise systolic BP (mmHg) 101 147.84±16.62 141.48±11.36 <0.001 0.45 
After-exercise diastolic BP (mmHg) 101 83.71±7.64 80.67±6.86 <0.001 0.42 
Total distance in 6MW (m) 49 462.47±61.85 483.00±54.78 <0.001 -0.35 
Men  n Baseline 3 month p d 
Flexibility (cm) 24 3.24±10.63 4.65±10.50 0.004 -0.13 
Resting systolic BP  (mmHg) 104 146.59±14.57 142.39±12.62 <0.001 0.31 
Resting diastolic BP  (mmHg) 104 85.40±7.69 83.43±7.67 0.02 0.26 
After-exercise systolic BP (mmHg) 99 144.62±16.15 143.69±15.48 0.23 0.06 
After-exercise diastolic BP (mmHg) 99 84.02±7.61 82.28±7.61 0.01 0.23 
Total distance in 6MW (m) 58 486.01±70.67 509.46±59.88 <0.001 -0.36 
  n Baseline 6 month p d 
Flexibility (cm) 13 6.16±10.60 12.73±8.80 0.03 -0.67 
Resting systolic BP  (mmHg) 67 145.06±13.39 143.69±13.12 0.35 0.10 
Resting diastolic BP  (mmHg) 67 85.75±7.36 83.70±7.68 0.03 0.27 
After-exercise systolic BP (mmHg) 64 144.14±14.87 142.67±12.20 0.51 0.11 
After-exercise diastolic BP (mmHg) 64 84.27±6.92 83.20±7.99 0.25 0.14 
Total distance in 6MW (m) 34 487.38±68.66 509.35±68.44 0.03 -0.32 
  n Baseline 9 month p d 
Flexibility (cm) 6 4.67±15.61 4.58±15.28 0.92 0.00 
Resting systolic BP  (mmHg) 53 147.11±13.36 144.11±14.09 0.18 0.22 
Resting diastolic BP  (mmHg) 53 85.21±6.36 82.28±8.13 0.02 0.40 
After-exercise systolic BP (mmHg) 52 146.48±13.72 143.46±14.40 0.14 0.21 
After-exercise diastolic BP (mmHg) 52 84.23±6.48 80.81±8.41 0.01 0.45 
Total distance in 6MW (m) 24 486.12±60.24 511.00±67.45 0.01 -0.39 
n: number of individuals, BMI: body max index, BP: blood pressure, 6MW: six-minute walk test, mmHg: millimeter of mercury, p: 
significance value, d: effect size (Cohen´s d) 
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Patients in the hypertension group under hypertensive medication (65.2%) showed more changes in 
physical measures than the non-medicated ones (Table 33). Patients with medication improved their 
waist circumference, flexibility, resting systolic and diastolic blood pressure, after-exercise diastolic 
blood pressure and total distance. Non-medicated patients showed significant (p≤0.003) changes in 
flexibility and in resting and after-exercise diastolic blood pressure. 
 
Table 33. Changes in physical measures along the program in medicated and non-medicated patients in the 
hypertension group (Friedman´s ANOVA). Values are shown in mean values ± standard deviation. 
Medication n Baseline 3 month 6 month 9 month X2F p 
Waist circumference (cm) 28 99.64±14.03 99.35±13.99 99.25±13.77 98.46±13.48 15.13 0.002 
Flexibility (cm) 10 12.85±10.87 14.40±11.13 15.80±9.98 15.21±9.83 17.64 <0.001 
Resting systolic BP 74 148.68±12.23 144.30±12.31 145.47±12.93 141.39±15.33 12.16 0.007 
Resting diastolic BP 74 85.12±6.15 82.51±6.81 83.61±6.67 81.91±9.47 18.36 <0.001 
After-exercise systolic BP 68 146.93±15.03 144.44±14.20 144.18±12.25 141.90±13.26 4.09 0.25 
After-exercise diastolic BP 68 83.40±6.74 81.53±6.83 82.24±6.81 80.84±7.38 10.95 0.01 
Total distance in 6MW(m) 46 466.39±65.20 481.54±53.72 483.30±58.27 491.04±64.22 19.28 <0.001 
Non-medication n Baseline 3 month 6 month 9 month X2F p 
Waist circumference (cm) 29 99.58±10.58 98.62±10.73 98.72±10.38 98.62±10.59 1.29 0.73 
Flexibility (cm) 12 8.68±12.31 10.08±12.10 16.75±6.86 17.33±6.57 14.08 0.003 
Resting systolic BP 28 145.75±17.91 146.21±15.54 145.82±15.73 146.57±13.72 0.31 0.96 
Resting diastolic BP 28 86.50±7.08 84.64±6.90 82.50±8.53 81.93±7.09 8.05 0.04 
After-exercise systolic BP 23 147.78±22.57 144.96±15.39 141.52±15.92 141.57±12.99 3.92 0.27 
After-exercise diastolic BP 23 87.22±7.80 82.30±6.08 79.78±6.37 79.78±7.71 14.37 0.002 
Total distance in 6MW(m) 11 504.72±51.54 508.90±36.06 510.72±54.58 513.81±54.10 1.91 0.59 
n: number of individuals, BP: blood pressure, 6MW: six-minute walk test, mmHg: millimeter of mercury, X2F: Friedman´s ANOVA, p: significance value 
 
When looking at changes in physical measures in different medication groups (Table 34), the ACEI 
group showed significant (p≤0.05) changes in waist circumference (97.57±12.67 cm at baseline, 
95.14±10.67 cm at nine months), WHR (0.92±0.07 at baseline, 0.89±0.06 at nine months) and in 
after-exercise diastolic blood pressure (82.83±4.04 mmHg at baseline 81.08±6.93 mmHg at nine 
months). The Angiotensin receptor blocker group (ARB) showed significant (p=0.03) changes in 
resting diastolic blood pressure (83.63±5.07 mmHg at baseline, 78.50±4.69 mmHg at nine months). 
The rest of the medication groups did not show significant changes in any physical measures. 
 
 
 
  
RESULTS 
 
107 
 
Table 34.  Significance values (p values) of changes in physical measures along the program in different medication 
groups (Friedman´s ANOVA). 
 
ACEI1 Diuretics2 ARB3 Beta-B4 Ca blockers5 
Waist circumference (cm) 0.05* 0.24 0.16 . . 
Waist-hip ratio 0.001* 0.61 0.14 . . 
Resting systolic BP 0.47 0.06 0.87 0.11 0.39 
Resting diastolic BP 0.09 0.58 0.03* 0.1 0.39 
After-exercise systolic BP 0.37 0.23 0.8 0.49 0.39 
After-exercise diastolic BP (mmHg) 0.006* 0.13 0.31 0.14 0.39 
Resting HR (bmp) 0.96 0.24 0.83 0.39 0.39 
After-exercise HR (bmp) 0.27 0.12 0.91 0.39 0.39 
Total distance in 6MW (m) 0.05 0.07 0.21 0.39 0.39 
 ACEI: angiotensin-converting enzyme inhibitor, ARB: angiotensin receptor blocker, Beta-B: beta blockers, Ca: calcium, BP: blood pressure, HR: heart rate, 
6MW: six-minute walk test, mmHg: millimeter of mercury, bpm: beats per minute, *: significant differences (p<0.05) 
 
In the obesity group, only women showed significant (p≤0.04) changes along the program (Table 35). 
Weight, BMI and WHR changed significantly. 
Table 35. Changes in physical measures along the program in the obesity group in women and in men (Friedman´s 
ANOVA). Values are shown in mean values ± standard deviation. 
Women n Baseline 3 month 6 month 9 month X2F p 
Weight (kg) 36 83.03±13.64 81.98±14.07 81.59±14.11 81.59±14.64 8.48 0.04 
BMI (kg/m2) 36 34.16±4.37 33.71±4.52 33.56±4.52 33.55±4.75 8.48 0.04 
Waist circumference (cm) 13 101.30±8.74 99.31±10.31 99.46±9.69 99.46±9.62 2.59 0.46 
Waist-hip ratio 12 0.89±0.03 0.88±0.02 0.88±0.01 0.88±0.02 8.89 0.03 
Flexibility (cm) 2 19.25±4.59 23.13±3.00 18.00±4.24 21.50±2.12 6.00 0.11 
Resting systolic BP (mmHg) . . . . .  . 
Resting diastolic BP (mmHg) . . . . . . . 
After-exercise systolic BP (mmHg) . . . . .  . 
After-exercise diastolic BP (mmHg) . . . . .  . 
Resting HR (bpm) 16 80±13.67 83±13.57 82±11.75 83±14.44 3.00 0.39 
After-exercise HR (bpm) 16 109±20.39 106±20.28 105±19.79 103±18.90 5.22 0.16 
Total distance in 6MW (m) 15 493.93±53.19 507.06±52.87 509.40±53.21 520.26±59.08 6.10 0.11 
Men n Baseline 3 month 6 month 9 month X2F p 
Weight (kg) 3 92.26±12.27 90.90±12.05 90.30±13.84 90.06±13.23 5.80 0.12 
BMI (kg/m2) 3 31.25±3.98 30.77±3.77 30.57±4.41 30.50±4.29 5.80 0.12 
Waist circumference (cm) 1 102 102 101 101 . . 
Waist-hip ratio 1 0.99 0.99 0.98 0.98 . . 
Flexibility (cm) . . . . . . . 
Resting systolic BP (mmHg) . . . . . . . 
Resting diastolic BP (mmHg) . . . . . . . 
After-exercise systolic BP (mmHg) . . . . . . . 
After-exercise diastolic BP (mmHg) . . . . . . . 
Resting HR (bpm) 2 64±6.36 78±2.82 73±7.07 70±2.12 5.40 0.15 
After-exercise HR (bpm) 2 89±1.41 97±0.70 81±5.65 97±0.70 5.40 0.15 
Total distance in 6MW (m) 2 535±32.52 584±79.19 560±103.23 565±32.52 3.00 0.39 
n: number of individuals, BMI: body max index, BP: blood pressure, HR: heart rate, 6MW: six-minute walk test, mmHg: millimeter of mercury, bpm: beats 
per minute, X2F: Friedman´s ANOVA, p: significance value 
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Follow-up tests showed that, similar to other diagnose groups, changes in weight and BMI were 
significant (p≤0.04) between baseline and all measurements but the effect sizes of these changes 
were small (d<0.10) (Table 36). Changes in WHR showed to be significant only at nine months 
(0.90±0.04- 0.88±0.03, d=0.56, p=0.04) and changes in flexibility only at three months (13.56±8.99-
15.88±8.38cm, d=-0.27, p<0.001). Total distance also significantly (p≤0.03) increased at three 
months and at nine months (Table 36). 
 
Table 36. Changes in physical measures between baseline and 3, 6 and 9 months in the obesity group in women 
(Wilcoxon´s signed rank test). Values are shown in mean values ± standard deviation. 
Women    n Baseline 3 month p d 
Weight (kg) 91 82.50±12.74 81.59±12.71 <0.001 0.07 
BMI (kg/m2) 87 33.51±4.68 33.15±4.67 <0.001 0.07 
Waist circumference (cm) 24 99.50±9.99 98.33±10.42 0.12 0.11 
Waist-hip ratio 24 0.88±0.05 0.87±0.04 0.31 0.22 
Flexibility (cm) 31 13.56±8.99 15.88±8.38 <0.001 -0.27 
Total distance in 6MW (m) 28 495.43±55.34 511.82±52.50 0.01 -0.30 
  n Baseline 6 month p d 
Weight (kg) 68 84.27±12.36 82.99±12.55 <0.001 0.10 
BMI (kg/m2) 68 34.05±4.29 33.52±4.25 <0.001 0.12 
Waist circumference (cm) 22 101.27±8.02 100.13±8.29 0.17 0.14 
Waist-hip ratio 21 0.88±0.04 0.88±0.03 0.41 0.00 
Flexibility (cm) 12 12.42±7.81 14.50±5.57 0.19 -0.31 
Total distance in 6MW (m) 25 480.88±67.04 489.48±53.71 0.33 -0.14 
  n Baseline 9 month p d 
Weight (kg) 48 84.47±13.21 83.21±13.73 0.04 0.09 
BMI (kg/m2) 48 34.33±4.43 33.79±4.44 0.03 0.12 
Waist circumference (cm) 21 101.47±8.15 99.61±9.10 0.21 0.21 
Waist-hip ratio 19 0.90±0.04 0.88±0.03 0.04 0.56 
Flexibility (cm) 7 15.93±4.99 17.00±3.65 0.44 -0.24 
Total distance in 6MW (m) 24 486.25±62.36 507.08±56.61 0.03 -0.35 
n: number of individuals, BMI: body max index, 6MW: six-minute walk test, p: significance value, d: effect size (Cohen´s d) 
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Figure 39. Mean changes in weight and BMI in different diagnosis groups in women and men (Friedman´s ANOVA). 
Standard deviations are shown in Tables 27, 29, 31 and 35. 
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Figure 40. Mean changes in waist circumference and flexibility in different diagnosis groups in women and men 
(Friedman´s ANOVA). Standard deviations are shown in Tables 27, 31 and 35. 
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Figure 41. Mean changes in resting blood pressure measures in different diagnosis groups in women and men 
(Friedman´s ANOVA). Standard deviations are shown in Table 31. 
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Figure 42. Mean changes in after exercise blood pressure measures in different diagnosis groups in women and men 
(Friedman´s ANOVA). Standard deviations are shown in Table 31. 
 
Figure 43. Mean changes in total distance in different diagnosis groups in women and men (Friedman´s ANOVA). 
Standard deviations are shown in Tables 31 and 35. 
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4.5. Association between changes in physical measures  
Percent changes after nine months are shown in Table 37. The greatest changes were observed in 
flexibility (64%), followed by total distance (5.6%), all the blood pressure measures (from -2.77% to -
3.27%) and the smallest changes in weight, BMI, waist circumference and WHR (from -0.56% to -
0.61%). 
Table 37. Percent changes in physical measures from baseline to 9 months. Values are shown in percentages (%). 
 
n Mean SD 
Weight (kg) 915 -0.56% 3.69 
BMI (kg/m2) 867 -0.58% 3.67 
Waist circumference (cm) 76 -0.61% 3.71 
Waist-hip ratio 76 -0.56% 3.57 
Flexibility (cm) 353 63.77% 280.98 
Resting systolic BP (mmHg) 202 -2.88% 9.84 
Resting diastolic BP (mmHg) 202 -2.87% 10.77 
After-exercise systolic BP (mmHg) 184 -2.77% 9.08 
After-exercise diastolic BP (mmHg) 184 -3.27% 10.59 
Resting HR (bpm) 118 -0.38% 14.24 
After- exercise HR (bpm) 49 2.11% 32.97 
Total distance in 6MW (m) 114 5.57% 10.64 
n: number of individuals, SD: standard deviation, BMI: body max index, BP: blood pressure, HR: heart rate,  
6MW: six-minute walk test, mmHg: millimeter of mercury, bpm: beats per minute 
 
Bivariate correlations between percent changes in physical measures were analyzed and changes in 
weight after nine months were found to be significantly correlated with changes in resting systolic 
blood pressure (rs =0.20 [0.05, 0.35], p=0.012) and in resting diastolic blood pressure (rs =0.17 [0.01, 
0.34], p=0.031). Changes in waist circumference were also found to be associated with changes in 
weight (rs =0.50 [0.24, 0.69], p<0.001) and changes BMI (rs =0.50 [0.26, 0.71], p<0.001). 
Significant relationships between changes in resting and after-exercise systolic and diastolic blood 
pressure are showed in Table 38.  The strongest relationships were found between changes in 
resting systolic and diastolic blood pressure (rs=0.57) and between changes in after-exercise systolic 
and diastolic blood pressure (rs=0.62) 
Table 38. Spearman´s correlations between resting and after-exercise systolic and diastolic blood pressure. 
 
Resting 
systolic BP 
Resting           
diastolic BP 
After-exercise       
systolic BP 
After-exercise  
diastolic BP 
Resting systolic BP 1 0.57***[0.452,0.663] 0.54*** [0.412, 0.639] 0.31***[0.164, 0.441] 
Resting diastolic BP   1 0.43***[0.296, 0.537] 0.49***[0.364, 0.599] 
After-exercise systolic BP     1 0.62***[0.511, 0.709] 
After-exercise diastolic BP       1 
*p< 0.05, **p< 0.01, ***p<0.001. Bias corrected bootstrap 95% CIs reported in brackets 
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Changes in after-exercise systolic blood pressure were also found to be associated with changes in 
resting heart rate (rs =0.34 [0.103, 0.544], p=0.005). Changes in after-exercise heart rate were 
significantly correlated with changes in WHR (rs =0.95 [0.620, 1.00], p<0.001). 
Correlation between adherence and changes in physical measures were also examined and average 
attendance was found to be significantly related to changes in weight (rs =-0.084 [-0.145, -0.018], 
p=0.012). However, number of days attended was not correlated with changes in any physical 
measure. 
Similarly, significant differences (H(4)=15.77, p=0.003) in changes in weight were found between 
participants who attended nine months with the summer break in the middle (-0.06%±3.64) and the 
ones that attended nine months straight, without the summer in the middle (-0.87%±3.20). Changes 
in resting and after-exercise systolic blood pressure were also found to be significantly lower 
(H(4)=11.12, p=0.03) and (H(4)=14.77, p=0.01) in the participants that attended  nine months with 
the summer break in between (-1.73%±10.86 and  -1.05%±8.85 respectively) if compared to the ones 
that attended nine months straight (-5.97%±8.19 and -6.41%±8.79 respectively). Moreover, 
participants that attended six months with the summer break in between increased their after-
exercise systolic blood pressure (2.45%±9.2) unlike the rest of the groups where all of them reduced 
their after-exercise systolic blood pressure. 
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4.6. Motivation and satisfaction 
Motivation and satisfaction questionnaires showed high scores with a mean of 7.63 points out of 8 in 
the motivation questionnaire and a mean of 6.56 points out of 7 in the satisfaction questionnaire. 
On the motivation questionnaire, after nine months, 93.8% of participants reported enjoying doing 
exercise. Regarding their general opinion about the program, 99.8% found their partners nice and 
pleasant, 99.6% also found the instructors nice and kind and 84.1% were satisfied with the sports 
facilities. Concerning their self-confidence, 95% believed that they were able to improve their 
physical condition and 93.6% had support from family and/or friends. 97.4% of participants reported 
being motivated to assist to the program and 99.6% believed that the program was going to benefit 
their health. 
There were no significant differences in the motivation questionnaire between women and men 
except in sports facility satisfaction, were significantly less women (81.8%) than men (91.1%) 
reported being satisfied with the facilities (x2(1)=6.098, p=0.014). No significant differences were 
found among age groups. Interestingly, among diagnosis groups, significantly more individuals (25%) 
from the diabetes group showed low self-confidence if compared to the other diagnosis groups, as 
they did not believe that they were able to improve their physical condition. 
On the satisfaction questionnaire, after finalizing the nine month program, 97.7% of the participants 
reported that they were feeling better with themselves since starting exercising. 91.4% also felt that 
they were more capable to perform everyday chores since the program started. In addition, 96.5% 
considered that they had achieved small improvements that would make them feel better and 
control their condition adequately. These achievements were larger than what they expected in 
73.5% of the participants. Regarding safety and controls, 97.7% considered appropriate the follow-
ups and controls performed by health professionals and 99.6% thought the same about the physical 
activity professionals. Moreover, 100% of the participants were satisfied with the individual 
attention received. 
No significant differences were found in the satisfaction questionnaire between women and men or 
among age groups. However, significant differences were found among diagnosis groups, were more 
individuals in the diabetes group (31%) reported low functionality if compared to the other diagnose 
groups, as they felt that they were not more capable to perform every day chores since the program 
started.
  
 
 
 
 
 
 
 
 
 
 
 
 
DISCUSSION 
 
 
 
 
 
DISCUSSION 
 
119 
 
5. DISCUSSION 
The primary objective of this study was to evaluate the effectiveness of a therapeutic exercise 
program designed for individuals suffering from diverse chronic conditions including musculoskeletal 
disorders, diabetes, hypertension and obesity. For this purpose different physical variables were 
measured such as weight, BMI, waist circumference, waist-hip ratio, flexibility, blood pressure, heart 
rate and cardiorespiratory fitness.  This investigation also assessed the baseline characteristics of the 
participants in order to describe the population being studied. Finally, an evaluation of the exercise 
program was performed in order to discern strengths and areas of improvement in order to steer 
prospective programs. 
 5.1. Characteristics of the sample and baseline physical measures 
According to recent surveys, more than half of the Basque population is overweight (BMI >25 kg/m2) 
and this proportion is larger in men (62%) than in women (42%) (INE, 2012). In our study, mean BMI 
was 27 kg/m2  and the proportion of overweight individuals was higher (69%) than the one described 
for the Basque population, somehow expected as the individuals included in this program were 
selected according to their risk factors, one of the inclusion criteria being having a BMI over 25 
kg/m2.  We also observed slightly more men being overweight if compared to women (74% vs. 68%). 
The tendency of BMI to increase with age and decrease in the oldest individuals over 75 years of age 
observed in the Basque population (Gobierno Vasco, 2013b) was equally detected in our study. 
Interestingly, the percentage of overweight individuals was not only elevated in the obesity group 
but also in the rest of the groups. 
Concerning waist circumference, in our sample only 11% of the participants had an optimal waist 
circumference with the rest having a waist circumference that could contribute to an increased risk 
of metabolic complications and CVD. Both women (78%) and men (56%), all age groups (84-91%) and 
all diagnosis groups (80-100%) showed a great number of individuals with increased waist 
circumference. This seems of great importance as waist circumference has been shown to have a 
direct independent association with mortality in the older population, especially in the ones with 
poor health status (Guallar-Castillón et al., 2009).  
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An increased appearance of mechanical disorders such as osteoarthritis, cervical and low back pain 
have been observed in overweight individuals, mainly explained by a greater mechanical loading at 
the joints but also related to other hormonal and systemic factors associated with obesity which 
cause changes in cartilage and bone metabolism (Padros-Torres et al., 2012; Stevens-Lapsely and 
Kohrt, 2010). Accordingly, in our sample a great proportion of obese individuals (77%) suffered some 
sort of musculoskeletal disorder, 19% of these suffering from osteoarthritis. The high percentage of 
overweight individuals in the diabetes and hypertension groups and the mechanical-obesity 
multimorbidity pattern just mentioned could also explain the high incidence of MSD in these two 
groups. 
Another multimorbidity cluster was also observed where a quarter of the diabetic individuals 
suffered from hypertension and 13% were obese. Similarly, among the hypertension group, 4% of 
the individuals were diabetic and 9% obese. This cardio-metabolic multimorbidity pattern also 
known as “metabolic syndrome” has previously been described by others (Padros-Torres et al., 2012; 
Schafer et al., 2010). It includes diabetes, hypertension, obesity and dyslipidaemia and its evolution 
over time leads to CV complications related to these disorders (Padros-Torres et al., 2012).  
Similar to our results, the prevalence of different chronic conditions and multimorbidity patterns 
have also been described to increase with age (Gobierno Vasco, 2013b; Padros-Torres et al., 2012; 
Schafer et al., 2010). In particular, 24% of the Basque population suffers from multiple chronic 
conditions while this proportion rises to 66% in the population over 65 years of age and to 76% in 
the population 80-84 years of age (Orueta et al., 2014). 
In agreement with the development of diabetes and hypertension observed in the Basque 
population (Gobierno Vasco, 2013a) and described by others (Padros-Torres et al., 2012), the onset 
of diabetes and hypertension in our sample was also observed to start in the 41-50 age group and 
increase after that. Consequently, the most prevalent disorders among the youngest groups in our 
study were those related with the musculoskeletal system. Fibromyalgia and osteoporosis were also 
observed to have a greater prevalence in women if compared to men, consistent with the trends 
observed in the Basque Country (Gobierno Vasco, 2013a) and worldwide (Busch et al., 2011). 
Regarding blood pressure, among the hypertensive participants a great percentage of individuals 
(77%) were found to have non-controlled blood pressure, possibly explained by the fact that only 
65% were under hypertensive medication. Nevertheless, as it has been described by others (Coca 
Payeras, 2005), only 40% of the hypertensive patients using medication have a controlled blood 
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pressure, influenced by factors such as lack of modification of ineffective treatment or insufficient 
patient compliance among others.  
Confirming the efficacy of the medication, individuals under medication had lower blood pressure 
values if compared to the non-medicated individuals. The well documented lowering effect of beta-
blockers on heart rate (ACSM, 2014; Kokkinos et al., 2006) was also observed in our hypertensive 
participants, with the patients under this medication having lower levels in both resting and after-
exercise heart rate if compared to other drug therapies. 
No differences in blood pressure were found between women and men. However, in agreement 
with the trends observed in the Basque population (Gobierno Vasco, 2013b), an increasing tendency 
with age was observed in resting and after-exercise systolic blood pressure.  
After-exercise values of both systolic and diastolic blood pressure were found to be slightly lower 
than the resting ones (≈1-2 mmHg). This immediate reduction of blood pressure after an acute bout 
of exercise, named post-exercise hypotension, occurs in most individuals, normotensive and 
hypertensive (Pescatello et al., 2004), sedentary (Cornelissen et al., 2010) and active older 
individuals (Brito et al., 2014). These small reductions are clinically relevant and highly significant in 
terms of public health, as they can decrease the risk of stroke by 16% and the risk of coronary artery 
disease by 8% with an isolated exercise bout (Pescatello et al., 2004). 
Concerning heart rate, even though mean resting heart rate in our sample was found to be slightly 
lower (76 bmp) than the threshold of 80 bmp that has been suggested to lead to an increased 
mortality risk (Palatini et al., 2002), subgroups analysis revealed levels close and above this 
threshold. In particular, 77 bmp in women, 84 bmp in women 41-50 years old, 78 and 79 bmp in 
obese women and men respectively, 81 bmp in women with MSD and 85 bmp in diabetic women, 
which could have important clinical implications. As observed by others (Antelmi et al., 2004; Palatini 
et al., 2002), in our sample resting and after-exercise heart rate were higher in women and showed a 
trend to decrease as age increased. Interestingly, women in the diabetes group had the highest 
heart rate if compared to the other groups. This association between elevated heart rate and 
diabetes it is believed to be caused by a low cardiorespiratory fitness (Carnethon et al., 2008) or by 
an impaired autonomic nervous system function where sympathetic over-activity increases heart 
rate and also blood glucose (Li et al., 2014; Grantham et al., 2013). Thus, apart from being a serious 
complication of type 2 diabetes (Vinik and Ziegler, 2007), it seems that elevated heart rate could also 
be an important marker in the diagnosis of diabetes (Carnethon et al., 2008), CVD (Fox et al., 2007) 
and mortality (Cooney et al., 2010). 
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In terms of hamstring flexibility and consistent with the literature (Gopi, Neeta and Megha, 2014; 
Sugimoto, Demura and Nagasawa, 2014), women were found to be more flexible than men and a 
decreasing trend in flexibility as age increased was also observed.  
Confirming other studies (Sugimoto, Demura and Nagasawa, 2014; Casanova et al., 2011), gender 
and age were also found to be important factors influencing the score in the 6MW, with greater 
scores observed in male and younger individuals. Mean scores in both women and men were found 
to be lower than other reference values reported in healthy individuals for the same age group 
(Sugimoto, Demura and Nagasawa, 2014; Casanova et al., 2011). Moreover, these values were on 
the 10th percentile in women and in the 5th percentile in men, which shows a below-average and 
poor cardiovascular fitness in our sample (Rikli and Jones, 2013). In comparison to individuals with 
chronic conditions, our sample still showed lower values (473 m) than the ones observed in obese 
participants (535 m) (Ekman et al., 2013), in women with fibromyalgia (519 m) (Sanudo et al., 2011) 
and similar to the ones in found in diabetic patients (476 m) (Tuttle et al., 2011). 
 5.2. Participation, adherence and motivation 
It seems important to investigate the factors that influence exercise participation, as 21% of the 
patients that attended the consultation with the sports doctor decided not to start the program. 
Grandes et al. (2008) observed that a great proportion of the sedentary subjects attending a primary 
care consultation were not ready to change their behavior towards physical activity and therefore 
were not appropriate candidates to start a physical activity intervention.  
The pronounced difference in participation between women (77%) and men (33%) also deserves 
some attention. Considering that the recruitment was performed through primary care, it could be 
expected that the number of women visiting the family doctor would also be greater and thus the 
larger proportion of women referred to the program. However, even though the number of Basque 
women visiting their family doctor has been observed to be higher than in men (80% vs. 74%) 
(Esnaola et al., 2013), this difference is not as prominent as the one observed in our study.  
As some authors have suggested (Molanorouzi, Khoo and Morris, 2015), health reasons is believed 
to be the strongest factor in adult women for physical activity participation which could explain their 
greater willingness to participate in the program. On the other hand, mastery and competition have 
been suggested to be the strongest intrinsic motivators in men (Molanorouzi, Khoo and Morris, 
2015). 
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Increasing age has also been observed to raise the number of individuals visiting their family doctor 
(Esnaola et al., 2013), hence, the greater proportion of participants (70%) above 50 years of age in 
our study.  Also, a greater concern for health outcomes in older individuals if compared to younger 
individuals (Trujillo, Brougham and Walsh, 2004) could clarify this participation disparity among age 
groups. Nevertheless, among the older individuals in our study (51-80 years of age) a descending 
participation trend was observed with the highest participation rates observed in the 51-60 age 
group (33%) and the lowest in the 71-80 age group (10%). A higher motivational readiness to change 
observed at younger age (Grandes et al., 2008) could explain this decline in participation in the 
oldest groups. 
Regarding diagnose, the prevalence of disorders diagnosed in primary care in a recent survey (INE, 
2014) are also in agreement with the proportion of participants suffering from these disorders in our 
study. In more detail, 54% of the disorders diagnosed in the general population were MSD (INE, 
2014). This proportion was greater in women (70%) and interestingly, it was identical to the 
participation rate observed in our sample possibly influenced by the significantly greater number of 
women in our study. 
Interestingly, Grandes et al. (2008) also observed that obese and hypertensive individuals had a 
greater probability of being motivated to change their physical activity behavior. However, in 
subjects who combined both risk factors the motivational readiness to change was inexistent 
(Grandes et al., 2008).  
In accordance with these observations, physical limitations or disorders have been suggested to be 
both, a primary barrier but also a key motivator for exercise participation (Ceria- Ulep, Serafica and 
Tse, 2011; Belza et al., 2004).  
Similarly, poor perceived health (Plotnikoff et al., 2004) and pain have been associated with early 
dropout (Tu et al., 2004) and also, a negative association between different chronic conditions 
(Morey et al., 2003), BMI and physical activity levels (Jancey et al., 2007) has been described in 
relation to exercise adherence. All these factors could explain the fact that less than half of the 
participants completed the full program and possibly also the lower adherence in our participants if 
compared to other interventions (Skrypnik et al., 2015; Davidson et al., 2009; Sigal et al., 2006). 
Nevertheless, other authors have reported similar adherence rates to the ones observed in our 
intervention in overweight (Stefanov et al., 2013) and dyslipidemic individuals (Bateman et al., 2011) 
after combined exercise.  
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In addition to health problems, lack of time due to family care (Garmendia et al., 2013; Ceria- Ulep, 
Serafica and Tse, 2011) and self-efficacy (Koeneman et al., 2011; Perkins et al., 2008)  have also been 
suggested to be main barriers to adherence and participation in physical and social activities in older 
adults.  
However, considering that a very high proportion of the participants reported feeling capable of 
improving their physical condition and also expressed being motivated to assist to the program, self-
efficacy does not appear to be the main barrier to exercise in our sample. Nevertheless, it is 
important to note that the diabetic participants in our intervention reported a lower self-confidence 
and a lower perceived functionality if compared to other participants, which could suggest the need 
of motivational interventions targeted to this population.  
“Personal reasons” was found to be the major attrition cause in our participants. Nonetheless, it 
does not elucidate the exact reasons for dropping out and consequently hampers the possibility of 
finding resources to improve adherence in future programs. 
Also, even though older age has been proposed as a factor negatively affecting physical activity 
participation (Bauman et al., 2012), in our study conflicting results were found with comparable or 
even slightly higher adherence rates recorded in the older groups. Similarly, several authors did not 
find associations between age and attrition (Koeneman et al., 2011; Jancey et al., 2007)  suggesting 
that the relationship between adherence and age might be confounded by physical health (Morey et 
al., 2003).  
The number of injury consultations also deserves some attention as even though the average 
number of consultations was similar to the injury rates reported by other authors (Stathokostas et 
al., 2013), some years showed greater rates close to 50%. Nonetheless, these results need to be 
interpreted with caution as it is plausible that the consultations could have been related to 
exacerbated existing conditions. These remarks certainly raise the issue of the risks associated with 
exercise. However, wide evidence supports the fact that the benefits obtained with physical activity 
offset the risks (ACSM, 2014). 
Interestingly, greater changes were observed in weight and in systolic blood pressure in the 
participants that attended nine months straight if compared to the ones that had the summer break 
in between, possibly explained by a detraining effect occurred during the summer. Supporting this 
fact, Tokmakidis, Spassis and Volaklis (2008) observed a total loss of the positive training-induced 
changes in body composition, strength and a decreasing tendency in aerobic capacity after four 
months of detraining. Carvalho, Marques and Mota (2009) also observed a significant decline in 
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functional performance in older women after three months of detraining. Similarly, strength and 
flexibility have been observed to decrease after three months of detraining (Fatouros et al., 2006).  
However, according to this author, the strength a flexibility levels were preserved above baseline 
levels for a longer period after moderate and high intensity resistance exercise if compared to low 
intensity resistance exercise (Fatouros et al., 2006). In agreement, Harris et al. (2007) also reported 
that despite significant strength losses during 20 weeks of detraining, these values were still greater 
than pre-training values. On the other hand, Henwood and Taaffe (2008) observed significant 
decreases in strength and power but not in functional ability after 12 weeks of detraining, suggesting 
that exercise performed at an appropriate intensity might preserve functional decline. 
Hence, these findings highlight the importance of incorporating exercise or physical activity in our 
daily living and throughout the life (Tokmakidis, Spassis and Volaklis, 2008) and also the use of 
sufficient intensities to ensure maintenance of appropriate physical fitness levels specially in the 
individuals that may see their exercise practice discontinued due to health problems or other issues 
(Fatouros et al., 2006). In addittion, these findings emphasize the importance of developing 
programs that support confidence building and assist in overcoming barriers to participation (Perkins 
et al., 2008). In this way, an increase in participation and adherence may possibly guarantee the 
effectiveness of community based interventions (Garmendia et al., 2013).  
 5.3. Changes in physical measures 
5.3.1. Body composition 
In a recent extensive review of physical activity interventions and their relationship with body 
composition (Weber et al., 2013), the mean effect for body composition outcomes was estimated in 
d=-0.16 and this effect was found to be greater in studies that included a structured exercise 
intervention (d=-0.48). In contrast, very small effect sizes (d<-0.03) were found in our intervention in 
all body composition outcomes (weight, BMI, waist circumference and WHR).  
Some authors have suggested that even though moderate physical activity alone might be 
appropriate for weight control or maintenance of weight loss (Jakicic and Otto, 2005; Slentz et al., 
2004), its effectiveness in weight loss is weak (Sweet and Fortier, 2010). In terms of body weight, it is 
important to consider both energy expenditure and energy intake when assessing weight loss after 
physical activity, as increases in energy expenditure might be compensated by increases in energy 
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intake (Church et al., 2009). In accordance, many studies have previously suggested that in order to 
achieve weight loss both physical activity and dietary behavior should be targeted (Foster-Schubert 
et al., 2012; Sweet and Fortier, 2010). Conversely, the review by Weber et al. (2013) reported no 
differences in body composition changes between interventions of physical activity with and without 
diet. This could suggest that participants of a physical activity intervention might be motivated to 
change their dietary habits on their own, which emphasizes the importance of controlling dietary 
changes when assessing weight loss after physical activity.  
Despite these remarks, several combined exercise interventions that controlled for changes in 
calorie intake have reported important reductions in body weight only attributable to physical 
activity, ranging from 2.71 kg to 1.5 kg (Skrypnik et al., 2015; Paoli et al., 2013; Willis et al., 2012; 
Bateman et al., 2011; Church et al., 2010; Davidson et al., 2009; Sigal et al., 2007). The modest 
reductions observed in our sample (0.5 kg) could be possibly explained by insufficient exercise 
stimulus, poor adherence, uncontrolled dietary intake or a combination of these factors. Also, an 
increase in lean mass induced by resistance exercise could explain the lack of weight loss (Church et 
al., 2010).  
Furthermore, inter-individual variation in weight loss seems to be a fundamental factor to be 
considered, as the analysis of the group mean weight loss could lead to incorrect conclusions since it 
does not account for individual metabolic and behavioural compensatory mechanisms such as 
increased energy intake or changes in non-exercise activity among others (King et al., 2008). For 
instance, while the mean percent change in weight in our sample was -0.56%, the standard deviation 
of 3.69% illustrates a great variability among participants. This variability could translate into an 
average weight loss of 2 kg, comparable to the decreases observed in similar combined exercise 
interventions. 
Regarding waist circumference, modest reductions of approximately 1 cm were observed in our 
participants after nine months. In comparison with other interventions of similar design, which 
combined aerobic and resistance exercise performed three days a week, the reductions observed in 
our study were minor, as others observed reductions that ranged from 4 cm to 7.65 cm (Skrypnik et 
al., 2015; Bateman et al., 2011; Davidson et al., 2009; Sigal et al., 2007). Interestingly, the greatest 
waist circumference reductions in these interventions were observed in individuals with the highest 
BMI which could suggest that the lower BMI of our participants hindered greater reductions in waist 
circumference. Supporting this notion, Freak-Poli et al. (2011) observed associations between a 
greater waist circumference at baseline and greater reductions after the intervention.  In agreement 
with these observations, McTiernan et al. (2007) also described that overweight or obese individuals 
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lose more weight than individuals of normal weight. Nevertheless, a 1 cm increase in waist 
circumference has been related with a 2% increase in risk of developing CVD (De Koning et al., 2007) 
which implies that our modest reductions could be clinically relevant. 
The reductions observed in our sample were significantly greater in women (1.5 cm) than in men 
(0.10 cm) which is in contrast with other reports. For instance, after a 12 month moderate-vigorous 
aerobic training performed six days a week, the mean reduction in waist circumference in women 
was 1.4 cm and 3.3 cm in men (McTiernan et al., 2007). Similarly, greater reductions of total and 
visceral fat were found in men if compared with women after aerobic exercise performed five days a 
week (Davidson et al., 2009). On the other hand, Freak-Poli et al. (2011) observed similar waist 
circumference reductions (1.6 cm) in both women and men after a four month workplace program. 
As previously mentioned, it could be presumed that the greater changes in the female participants in 
our program could be due to their greater baseline waist circumference (Freak-Poli et al., 2011), 
despite both women and men had an elevated baseline waist circumference, 17 cm and 13 cm 
above optimal levels respectively, considered high risk for metabolic complications and CVD (WHO, 
2008). 
 
As already mentioned in the introduction, abdominal fat has been suggested to be a better predictor 
of the incidence of type 2 diabetes and CVD than the total amount of fat (Ibañez et al., 2010; Fencki 
et al., 2006) and has a direct association with mortality in older adults independent of BMI (Guallar-
Castillón et al., 2009). This supports the use of waist circumference or WHR besides BMI in CVD risk 
assessments (Pischon et al., 2008; De Koning et al., 2007). 
Interestingly, some authors have observed significant decreases in waist circumference (Church et 
al., 2009) and improvements in cardiovascular risk (Cox et al., 2001) independent of changes in body 
weight. Similarly, important risk factors associated with obesity such as cardiorespiratory fitness and 
insulin sensitivity have shown improvements despite minimal or no weight loss (Fogelhom, 
Stallknecht and Van Baak, 2006; Jakicic and Otto, 2005), which emphasizes the health benefits of 
physical activity regardless of weight loss. In spite of this, it seems important to identify individual 
needs as in some circumstances weight loss could be essential in the improvement of 
musculoskeletal disorders such as symptoms of knee-osteoarthritis among obese individuals 
(Stevens-Lapsley, 2010). 
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5.3.2. Blood pressure and heart rate 
After our nine month intervention, small to medium effect sizes were observed in blood pressure 
measures (systolic and diastolic) with reductions of around 5 mmHg. These findings are in 
agreement with other reports which described reductions of 3-8 mmHg in systolic blood pressure 
and 2-6 mmHg in diastolic blood pressure (Wilmore, 2001). On the other hand, other reviews have 
claimed slightly greater reductions that ranged between 5 mmHg and 10.5 mmHg in systolic blood 
pressure and between 0 and 10 mmHg in diastolic blood pressure (Semllitsch et al., 2013). Similarly, 
Paoli et al. (2013) and Skrypnik et al. (2015) observed greater reductions of 9-11 mmHg in systolic 
blood pressure but comparable decreases to our findings in diastolic blood pressure (2-4 mmHg), 
after a combined exercise intervention.  In contrast, Cornelissen and Smart (2013) reported 
reductions only in diastolic blood pressure (2.2 mmHg) but not in systolic blood pressure after 
combined exercise training. 
Surprisingly, the aforementioned greater reductions in systolic blood pressure (9-11 mmHg) were 
described only after three months of intervention (Skrypnik et al., 2015; Paoli et al., 2013). 
Moreover, even one month interventions have induced significant reductions in blood pressure 
among pre- and stage 1 hypertensive subjects (Collier et al., 2008). Accordingly, the reductions 
observed in our intervention revealed to be as great as 3.3 mmHg in systolic blood pressure and 1.87 
mmHg in diastolic blood pressure after only three months.  
Nevertheless, it is important to note that the lower reductions observed in our interventions 
compared to other studies could be explained by differences in baseline blood pressure among 
participants. In more detail, Cornelissen and Smart (2013) detected greater reductions in 
hypertensive individuals if compared to pre-hypertensive or normotensive subjects. Similarly, 
greater changes in blood pressure among unhealthy individuals have also been described if 
compared with healthier individuals (Wilmore, 2001).  
In terms of gender differences, a lower effect of exercise in blood pressure has been suggested in 
women (Wilmore, 2001) and greater blood pressure reductions have been observed in men after 
dynamic endurance training (Cornelissen and Smart, 2013). However, in agreement with our results, 
other studies have not described these differences between genders (Pescatello et al., 2004; Cox et 
al., 2001). Similar to other reports, in our intervention, age did not seem to interfere with changes in 
blood pressure either (Manfredini et al., 2009). 
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As the ACSM (2014) has stated, minor reductions of 2 mmHg have the potential of considerably 
reducing the risk of stroke and of coronary artery disease in addition to decreasing risk of CV 
mortality and all-cause mortality (Rossi et al, 2012). Therefore, our findings have relevant 
implications in the health status of subjects with hypertension. It is also important to remark that 
reductions in blood pressure could be obtained independent of improvements in cardiorespiratory 
fitness or body composition (Collier et al., 2008, Cox et al., 2001). 
In regard of heart rate, significant reductions were not observed in the total sample after nine 
months.  In contrast, subgroup analyses showed reductions of 3.3 bpm in men, despite not being 
statistically significant, but not in women. The oldest age group (71-80) also showed statistically no 
significant resting heart rate reductions of 4.7 bpm. In accordance with our results, aerobic exercise 
has been observed to induce important reductions in heart rate of 5 bpm after only 10 weeks 
(Cornelissen et al., 2010) and four weeks (Collier et al., 2008). Skrypnik et al. (2015) also described 
decreases in heart rate (3.41 bpm) after a three months combined exercise training similar to ours. 
As Carter, Banister and Blaber (2003) described, endurance exercise induces various changes in the 
autonomic control of the heart that decrease resting heart rate such as an increase in the 
parasympathetic activity and a decrease in the sympathetic activity.  
Nevertheless, the unusual lack of effect on heart rate in women deserves some consideration.  
Despite some gender differences in autonomic cardiovascular control, both women and men are 
believed to benefit from autonomic control changes in the heart after aerobic exercise (Carter, 
Banister and Blaber, 2003). Deficient exercise intensity could explain this lack of effect on heart rate 
in women. However, Cornelissen et al. (2010) observed reductions in resting heart rate even after 
low-intensity aerobic training, despite the effects were greater with high-intensity training.  Another 
plausible explanation is the high variation of heart rate influenced by environmental factors (Palatini 
et al., 2007), circadian rhythm or posture (Fox et al., 2007), which supports the use  of 24-hour 
recording as a more reliable estimate of usual heart rate if compared to single measurements 
performed in a clinic setting (Palatini et al., 2007). Nevertheless, these results deserve more 
attention due to the relationship between elevated heart rate and increase risk in mortality 
described previously (Cooney et al., 2010; Palatini et al., 2002). 
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5.3.3. Flexibility 
Hamstring flexibility significantly improved after nine months (3.6 cm) showing similar 
improvements in both women and men, and also among age groups. These increases are in 
accordance to other interventions (3.3 cm) (Cancela and Ayán, 2007), but slightly lower than others 
that observed changes of 4.8 cm (Carvalho, Marques and Mota, 2009). Endurance and resistance 
interventions alone have also been observed to induce similar improvements (2-4 cm) (Sousa et al., 
2014; Hallage et al., 2010; Fatouros et al., 2006; Kalapothrarakos et al., 2005). 
In addition, despite more modest, the observed improvements were already noticeable at three 
months as others have described (Hallage et al., 2010). Surprisingly, even shorter interventions of 9-
10 weeks have also induced significant improvements in hamstring flexibility (Toraman, Erman and 
Agyar, 2004; Barbosa et al., 2002). 
Interestingly, hypertensive women showed the greatest improvements in hamstring flexibility (6 
cm). These results could be explained by a lower baseline levels if compared to other women. In 
particular, mean flexibility at baseline was lower in the hypertension group, both in women and men 
if compared to the total sample. In agreement with our observations, Kim et al. (2014) detected 
improvements in flexibility in sedentary individuals but not in active ones which reveals the necessity 
of individualized interventions according to personal physical general fitness and function. 
Considering the association between flexibility and functional status and  the consequent increase in 
the performance of activities of the daily live such as walking and stair climbing (Fatouros et al., 
2006), our improvements appear to be relevant as key contributors to independent living (Ernsth-
Bravell, Zarit and Johansson, 2011). 
 
5.3.4. Cardiorespiratory fitness 
Improvements of around 23 m (5%) were observed in the 6MW, used to assess cardiorespiratory 
fitness. These results are comparable to the improvements observed in other combined exercise 
interventions (4.5-6%) following six (Santana et al., 2012), nine (Sousa et al., 2014) and 12 month 
programs (Mian et al., 2007). On the other hand, other investigators have reported more 
pronounced increases of 10.5% (Hallage et al. 2010) and 13.4% (Toraman, Erman and Agyar,2004) 
after even shorter interventions, three months and nine weeks respectively, possibly explained by a 
lower baseline physical fitness of the participants. Increases in 6MW distance of 20 m have been 
related to small meaningful clinical changes and increases of 50 m related to moderate 
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improvements in healthy older adults (Perera et al., 2006). However, others have claimed an 
increase in 6MW distance of more than 50 m as clinically meaningful in individuals with some sort of 
disease (Rasekaba et al., 2009).  
Interestingly, some authors reported no significant differences in the improvement of 6MW 
between aerobic training and combined training despite a lower volume of aerobic exercise in the 
combined training arm (Sousa et al., 2014). It is necessary to consider that the performance on the 
6MW test is associated with both aerobic endurance and lower body strength (Rikli and Jones, 2013) 
which could explain the comparable improvements after combined training and aerobic training. 
These findings appear to be advantageous considering the added benefits of resistance training on 
body composition (Stensvold et al., 2010; Park et al., 2003) and functional status, especially in the 
older population (Bird et al., 2011), apart from the well documented benefits of aerobic exercise 
(ACSM, 2014). 
As other authors have reported (Skrypnik et al., 2015; Hallage et al., 2010; Stensvold et al., 2010; 
Toraman, Erman and Agyar, 2004), improvements in cardiorespiratory fitness were already apparent 
at three months, emphasizing the short-term benefits of physical activity.  
Interestingly, despite similar changes between women and men, greater changes (8%) were 
observed in the younger groups (51-60) if compared to the oldest group (71-80), were changes were 
minor (1.4%) and did not reach statistical significance. In agreement, Woo et al. (2006) observed no 
differences in exercise response between women and men reporting similar increases in VO2max. 
Also, these authors detected that the oldest subjects were not able to augment their VO2max to the 
same extent as the younger subjects, possibly explained by an age-related faster decline rate of 
VO2max (Woo et al., 2006).  
Nevertheless, greater training-induced improvements in the elderly individuals were described if 
compared to the younger subjects, including greater improvements in exercise efficiency, suggesting 
that the differences in cardiorespiratory fitness between older and younger populations might be 
confounded by lower fitness levels and therefore and most importantly, they could be reversed with 
exercise (Woo et al., 2006). 
Furthermore, diabetic women showed the greatest changes (10%), possibly explained by a floor 
effect, a low baseline cardiorespiratory fitness levels previously mentioned. Nevertheless, 
hypertensive women had similar baseline values to diabetic women in cardiorespiratory fitness but 
their improvements were not as pronounced.  The acute administration of diuretics and beta-
blockers in hypertensive individuals have been suggested to reduce exercise capacity and attenuate 
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the response to training (Ladage, Schwinger and Brixius, 2013; Fagard, Staessen and Amery, 1993). 
Others have also agreed on the diminished exercise capacity induced by beta-blockers but have not 
described reductions in the cardiovascular benefits caused by exercise such as enhanced 
endothelium-dependent vasodilation or blood pressure reduction (Westhoff et al., 2007). 
Comparisons between our medicated and non-medicated individuals showed significant 
cardiorespiratory improvements in the medicated ones but not in the non-medicated ones. Hence, 
despite hypertensive medication could have hindered the effect of physical activity in 
cardiorespiratory fitness it could be presumed that other factors might have affected these 
responses to exercise.  An uncontrolled increase in systolic blood pressure during exercise suffered 
by non-medicated hypertensive individuals (Kokkinos et al., 2006) could have interfered with the 
achievement of appropriate exercise intensity levels and consequently hampered beneficial 
cardiorespiratory modifications. 
It should be noted that even though the 6MW and cardiorespiratory fitness levels measured as 
VO2max are highly associated (Rikli and Jones, 2013), the relationship between the changes in 
distance in the 6MW and changes in VO2max is not clear, suggesting that the 6MW might not be 
appropriate to detect changes in cardiorespiratory fitness in healthy individuals (Santana et al., 
2012). Nevertheless, the 6MW  is considered essential in the evaluation of functional exercise and 
exercise tolerance, as it assesses the performance of different systems related with submaximal  
exercise such the cardiorespiratory system and muscle metabolism among others (Capodaglio et al., 
2012), in addition  to reflecting daily activity functioning better than laboratory tests (American 
Thoracic Society [ATS], 2002).  
 5.4. Association between changes in physical measures 
There is wide evidence that supports the association between weight loss and reductions in blood 
pressure in normotensive and hypertensive individuals (Winnicki et al., 2006) and also in non-obese 
and obese subjects (Mandai et al., 2015; Annesi, 2013). In agreement, in our intervention changes in 
weight were found to be associated with changes in resting blood pressure. Nevertheless, it is 
important to note that the changes in weight observed in our participants were minimal. 
Interestingly, Winnicki et al. (2006) described that the association between weight reduction and 
consequent decline in blood pressure was not linear, meaning that the dose-response association 
between these two variables was solely noticeable up to 13% of initial weight loss. These results 
emphasize the fact that blood pressure reductions can be achieved with minimal weight loss. In the 
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same way, and as previously mentioned, important improvements in key risk factors including CV 
fitness, insulin sensitivity, fat mass and muscle mass have also been observed with minor o no 
weight loss (Donelly et al., 2009; Ross and Bradshaw, 2009; Fogelhom, Stallknecht and Van Baak, 
2006; Jakicic and Otto, 2005). 
Strong relationships between systolic and diastolic changes were also found among our sample. In 
agreement, similar results have been reported by others showing decreases in both systolic and 
diastolic blood pressure after exercise (Semlitsch et al., 2013). A review by Cornelisen and Smart 
(2013) also showed reductions in both systolic and diastolic blood pressure after endurance and 
resistance training but surprisingly combined training only showed to reduce diastolic blood 
pressure. Despite, most authors have observed more pronounced post-exercise systolic blood 
pressure reduction if compared to diastolic blood pressure reduction (Semlitsch et al., 2013; 
Terblance and Millen, 2012), the differences observed in our total sample were minimal. 
Interestingly, these differences were noticeable in women but not in men. 
Also, associations between changes in after-exercise systolic blood pressure and changes in resting 
heart rate were observed in our sample. Apart from being an independent factor for cardiovascular 
morbidity and mortality, elevated heart rate has been described to be related to elevated peripheral 
blood pressure  (Reule and Drawz, 2012) and also to be associated with the onset of hypertension 
(Palatini, 2011). Despite several complex mechanisms could be behind this association, it appears 
that the negative effects produced by an increased heart rate in the cardiovascular system including 
impaired endothelial function, decreased shear stress and a consequent reduction in vascular 
compliance (Custodis et al., 2010), are believed to be responsible for increases in blood pressure 
(Manfredini et al., 2009). Therefore, the beneficial effect of exercise on vascular stiffness (Havlik et 
al., 2005) and on endothelium-induced vasodilation (Manfredini et al., 2009) could explain the 
improvements of both blood pressure and heart rate. Nonetheless, it is important to consider that 
the changes observed in heart rate were not statistically significant, thus, these results should be 
interpreted with caution.  
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5.5. Limitations 
There are several limitations in this study that need to be considered. The main limitation of this 
study is its retrospective design. Secondly, problems related with the measurement of variables such 
as inaccuracies caused by measurement tools among others. Next, inconsistent adherence also 
played an important role on the amount of data collected for each participant. Finally, issues related 
with funding obstructed the development of fundamental evaluation procedures.  
 
5.5.1. Design 
The retrospective design of this study has several limitations that could have affected the results. 
Firstly, it relied on the accuracy of the written records and for this reason, important data were 
missed. Second, the sample was biased as the participants were specifically selected by their family 
doctor and were self-motivated to participate in the program, thus these participants cannot be 
considered representative of the general population of the Basque Country. It is also possible that 
misclassification may have occurred due to difficulties in categorizing the participants according to 
their risk factors, considering that many of them had multiple. 
Also, the absence of a control group and the impossibility of performing a randomization hampered 
the possibility of controlling for possible bias and confounders.  Hence, the risk that the effects 
observed were provoked by other variables other than the intervention or the difficulty to discern if 
the observed effects could have been equally detected in subjects not taking part in the exercise 
program. For instance, the several informative workshops related with different disorders, physical 
activity and nutrition could have encouraged independent physical activity and possibly influence 
the results related with the physical condition.  
Especially in the early stages of the program, considering that a maximum participation was 
prioritized rather than a rigorous recruitment process, participants were allowed to start anytime 
regardless if the program had already started. These and other design flaws explained in the 
following paragraphs were handled and resolved along the years but could have also affected the 
results. 
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5.5.2. Measurement 
Among the variables used to measure the physical condition of the participants, fundamental 
variables related to MSD were not taken into account. Considering the different subgroups formed 
under MSD, including osteoarthritis, osteoporosis and fibromyalgia, more individualized follow-up 
test could have been administered in order to assess the effect of physical activity in key outcome 
measures related with these disorders such as strength, balance, pain, fatigue, quality of life or 
range of movement (Beckwee et al., 2012; Pedersen and Saltin, 2006). 
Also, even though attempts to measure glycemia in diabetic participants were made, these 
measurements were not performed rigorously and did not lead to any relevant conclusions apart 
from the acute effect of physical activity reducing blood glucose levels right after exercise (O’Hagan, 
De Vito and Boreham, 2013). 
Furthermore, motivation and satisfaction were measured by self-designed questionnaires which had 
not been rigorously tested for validity or reliability. Moreover, these self-report questionnaires could 
have produced a considerable measurement error (Field, 2013) considering that they were self-
administered instead of interviewer administered and also possibly subject to social desirability bias 
(Mortel, 2008). 
In addition, despite the main aim of improving symptoms of different chronic disorders was 
evaluated, some other specific objectives of the program were not measured or appropriate tools 
were not used for this purpose. In order to evaluate the increase in participants´ knowledge about 
their disorder and nutrition, self-designed questionnaires were used to assess initial knowledge but 
were not repeated afterwards hampering the possibility of estimating any learning. Similarly, 
independent participation in physical activity continuing the program was vaguely assessed 
controlling assistance in few of the open classes offered; however, the creation of walking groups 
and the assistance to supervised exercise lessons offered by the city council were not controlled. 
Thus, it could be difficult to ascertain to what extent the program increased autonomous 
independent physical participation. 
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5.5.3. Adherence 
A considerable amount of data was missing due to the absence of participants on the data collection 
dates.  As previously mentioned, apart from the health problems that might have caused low 
adherence in some participants, the exact reasons under “personal issues” are unknown. Also, and 
related with the design of the study, the community feeling of the program could have undermined 
the compromise of the participants if compared to the compromise that participants might have 
taken in a study with a more structured design. Nevertheless, the elucidation of the exact reasons 
for attrition deserves further attention in order to determine approaches to improve adherence in 
prospective programs. 
 
5.5.4. Funding 
The cessation of funding in the late stages of the program caused the immediate termination of the 
intervention and consequently hampered the possibility of continuing the analysis and evaluation of 
important aspects of the program. The impact of the intervention on physical activity independent 
participation and on the decrease of primary care visits and medication consumption was not 
possible to be fully performed due to this lack of means and support.  
 5.6. Strengths 
The main strength of this study is the extensive duration of the data collection which allowed a great 
number of individuals with chronic disorders to profit and learn from the benefits of physical activity. 
Consequently, a large sample size was possible to be collected for analysis purposes. This was mainly 
possible due to the efforts of the sports medicine centre staff, including doctors, nurses and physical 
activity professionals in the design, promotion and delivery of the program along several years.  Also, 
the involvement of the city council was considered vital as without the appropriate funding the 
development of this program could not have been possible. 
Additionally, the successful partnership and collaboration between the primary care system and the 
sport and physical activity professionals also appears to be fundamental in the recruitment of 
participants. As others have confirmed, this referral system appears to be appropriate as the target 
population of this type of programs, sedentary individuals and those suffering from chronic 
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disorders, generally have a relationship of trust with their family doctor, who could positively 
influence physical activity or exercise initiation on their patients (Garriga et al., 2013). 
Also, the length of the exercise intervention and the type of exercise, which combined endurance 
and resistance exercise, appeared to be adequate for the target population. Apart from being 
effective in improving different measures related with health benefits, it also showed to be 
appealing and enjoyable for the participants. In the same way, another important aspect to consider 
is the high satisfaction that participants showed and their willingness to continue participating in the 
program. 
Moreover, apart from the main objective of improving health, quality of life and symptoms related 
with different chronic disorders, an important aspect of the program was also the support towards 
independent participation in physical activity and exercise. For this purpose, the creation of walking 
groups and the participation in regular supervised exercise lessons offered by the city council were 
encouraged. Additionally, workshops related to different topics including chronic disorders, the 
beneficial effects of physical activity and nutrition were offered to the participants. All these 
initiatives are considered fundamental in the promoting of a healthy and active living. 
As mentioned before, despite the results are not generalizable to other populations due to 
fundamental study design issues, the findings of this study reveal crucial benefits on the physical 
condition and quality of life of individuals with diverse chronic disorders and offer insight into the 
development of future interventions. 
 5.7. Future recommendations 
Considering the important implications of this intervention in the physical condition and quality of 
life of individuals with different chronic conditions, it appears fundamental to suggest some 
directions in which to extend the present research. 
Regarding outcome measures related to the physical condition, some modifications and additions 
would be recommended. For instance, flexibility of the extensor muscles of the trunk and the 
hamstrings was measured by the “Sit-and-reach” bench. However, considering that the majority of 
the participants of the program were older and that some of these individuals may experience 
discomfort sitting on the floor, the modified version of Rikli and Jones (2013) performed in a chair 
(“Chair Sit-and-reach” test) could be considered more appropriate.   
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As previously indicated, the addition of several measures to assess factors related with different 
MSD would also be beneficial. Pain, muscle strength, balance and physical function appear to be 
common outcome measures in most MSD (Pedersen and Saltin, 2006), in addition to more specific 
measures for fibromyalgia such as fatigue and depression (Busch et al., 2011), bone mineral density 
for osteoporosis (Warburton et al., 2010) and range of motion for osteoarthritis and rheumatoid 
arthritis (Beckwee et al., 2012; Inversen, Braweman and Inversen, 2012).  
Also, to evaluate the effect of physical activity on diabetic individuals outcome measures such as 
HbA1c , a key marker for long-term glycaemic control (O´Hagan, De Vito and Boreham, 2013), fasting 
glucose, glucose tolerance or insulin-resistance index (Aguiar et al., 2014) could be included. 
Quality of life could be assessed using internationally validated instruments such as the The World 
Health Organization Quality of Life questionnaire (WHOQOL) or the SF-36 (Ware and Kosinski, 2001). 
Also, among many other validated instruments available, the Motives for Physical Activity Measure-
Revised questionnaire (MPAM-R) (Ryan et al., 1997) for assessing motives for participating in 
physical activity, the Physical Activity Enjoyment Scale (PACES) (Kendzierski and De Carlo, 1991) or 
various scales to evaluate self-efficacy and exercise (Marcus et al., 1992; Garcia and King, 1991; Sallis 
et al., 1988) could be used in order to allow comparisons among other studies. 
The assessment of the impact of the intervention on the amount of primary care visits and on 
medication consumption could also be very appropriate and relevant in terms of public health. 
Finally, it is vital to underline the fundamental paper that institutions play in the completion of 
interventions and research of this kind. Funding and support appear to be indispensable in order to 
guarantee the adequate initiation, development and evaluation of these studies. 
The efforts placed in the prevention and promotion of health will ensure the avoidance or delay of 
chronic conditions and improve the quality of life of our society.  
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6. CONCLUSIONS 
 
1. The general characteristics of the sample revealed a high proportion of overweight and 
obese individuals in all groups, particularly in men. Also, and an increasing trend of BMI as 
age increased was observed. Moreover, a great proportion of participants showed a waist 
circumference that could contribute to an increased risk of metabolic complications and 
CVD. Besides, the cardio-metabolic multimorbidity pattern known as “metabolic syndrome” 
was also detected among our participants. These outcomes emphasize the need for 
strategies to improve body composition and to reduce metabolic disorders, CV risk factors 
and mortality associated with obesity. 
 
2. The mechanical-obesity multimorbidity pattern observed, with a great proportion of 
overweight and obese individuals also suffering from mechanical disorders of the 
musculoskeletal system, deserves some consideration especially when assessing the impact 
of different comorbidities in the quality of life of obese individuals. 
 
3. In accordance with the general population, the onset of type 2 diabetes and hypertension in 
our participants was detected to start in the 41-50 age group. In addition, the prevalence of 
chronic conditions was observed to increase with age. Also, musculoskeletal disorders such 
as fibromyalgia and osteoporosis were found to have a greater prevalence in women if 
compared to men. For all these reasons, preventive strategies at early age and individualized 
interventions to reduce the impact of these conditions in the older population already 
suffering from these disorders appear indispensable.  
 
4. Among hypertensive participants a great percentage were found to have a non-controlled 
blood pressure, an important issue to be tackled particularly in primary care. Also, after-
exercise values of both systolic and diastolic blood pressure were found to be slightly lower 
than the resting values, confirming the immediate blood pressure lowering effect of physical 
activity and highlighting the beneficial effects of single bouts of exercise. 
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5. Heart rate levels in different subgroups revealed to be close and above the 80 bpm 
threshold believed to lead to an increased mortality risk. An association between diabetes 
and increased heart rate was also detected. Therefore, heart rate appears be an important 
marker to be considered in the diagnosis of diabetes and the estimation of CV risk. 
 
6. Women were found to be more flexible than men and younger individuals were found to be 
more flexible than older individuals. These differences in flexibility deserve individualized 
consideration when designing programs for diverse population groups. On the other hand, 
the whole sample showed a poor cardiorespiratory fitness showing an inmediate need to 
increase the fitness levels of the population described. 
 
7. Disparities in participation and adherence among subgroups could be explained by the 
differences in motives for participation in physical activity, which are known to vary across 
gender, age and type of activity, and also by differences in motivational readiness to change 
across individuals. However, the different barriers that could have affected participation and 
adherence are not completely identified. Therefore, this area deserves further attention in 
order to develop interventions that warrant high levels of participation and adherence in 
both genders and across all age groups. 
 
8. Continuous and uninterrupted participation revealed better results if compared to the 
results obtained with a break in between, possibly explained by a detraining effect occurred 
during this period.  Hence the importance of regular physical activity performed at 
appropriate intensities in order to compensate inactivity periods caused by health problems 
or by other barriers to physical activity participation. 
 
9. The whole sample and women showed statistically significant changes in most of the 
variables except in hear rate. On the other hand, men showed fewer statistically significant 
changes which could be due to motivational reasons previously mentioned or other causes 
that would need to be clarified.  
 
10.  Although statistically significant, very small effect sizes were found in all body composition 
outcomes. However, inter-individual variation illustrated by large standard deviations should 
be taken into account as could have implied important reductions in some individuals. Yet, 
the elucidation of the reasons responsible for this lack of change in some individuals appears 
fundamental in the control and treatment of obesity. Nevertheless, it is important to 
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consider that the reductions in blood pressure occurred independent of body composition 
changes, which highlights the importance of physical activity regardless of weight loss. The 
lack of significant reductions in heart rate also deserves additional exploration considering 
the association between elevated heart rate and increase risk in mortality.  
 
11. Reductions of 5 mmHg in systolic and diastolic blood pressure after nine months underline 
the valuable impact of physical activity in reducing risk of CVD and all-cause mortality. Also, 
changes in blood pressure did not differ between women and men or among age groups, an 
important aspect when assessing the effectiveness of different programs in different 
population groups. 
 
12. Improvements in cardiorespiratory fitness were modest but statistically significant and they 
could be clinically relevant for some individuals. Nevertheless, the minor improvements in 
the oldest group deserve further investigation in order to elucidate if this lack of effect was 
caused by an age-related faster decline of VO2max or other reasons. The reduced response in 
the increase of cardiorespiratory fitness observed in hypertensive individuals possibly 
caused by anti-hypertensive medication also deserves some consideration as 
cardiorespiratory fitness is believed to reduce CV mortality and lower the incidence of risk 
factors. 
 
13. Noticeable improvements in hamstring flexibility were observed already at three months 
which could be relevant as key contributor to functional status. Similarly, significant changes 
in blood pressure at three months emphasize the short-term benefits of physical activity. 
Nevertheless, the greater changes observed after nine months confirmed the dose-response 
association between physical activity and different health-related variables. 
 
14. A strong relationship between systolic and diastolic blood pressure reductions was 
observed. Moreover, associations between changes in after-exercise systolic blood pressure 
and resting heart rate were found which underlines the beneficial effect of exercise on 
vascular parameters such as vascular stiffness and endothelium-induced vasodilation. 
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